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The development of metabolic conditions has been associated with suboptimal nutrient 
provision to the embryo during pregnancy. Metabolic disorders have also been linked to 
subfertility; obese women produce fewer and smaller oocytes that are metabolically 
distinct from the oocytes of non-obese women. However, the impact of metabolic 
conditions on the secretions of the oviduct has not been extensively investigated. The 
work presented in this thesis has used an established in vitro model of the oviduct to 
determine the extent to which hyperglycaemia in the presence or absence of insulin 
modified oviduct secretions. These secretions were used to examine whether embryo 
survival and metabolism were also affected. Bovine oviduct epithelial cells (BOECs) were 
cultured under conditions designed to model acute and chronic hyperglycaemia, and in 
the presence or absence of physiologically relevant insulin concentrations. The fluid 
secreted by BOECs was analysed using ultramicrofluorometric assays and high-
performance liquid chromatography, and expression of key genes was also assessed. 
Chronic treatment of BOECs under the above conditions modified cell secretions, since 
the concentrations of glucose, alanine, glycine and glutamine were significantly altered. 
The data on concentrations of substrates was then used to inform the composition of 
embryo culture medium, using 1mM, 3.6mM and 8.9mM glucose for the ‘8.5’, ‘7.3’ / 
‘11+’, and ‘11-’ environments respectively, and modifying lactate, pyruvate and amino 
acid concentrations accordingly. The modified embryo environments did not affect 
preimplantation embryo cleavage and blastocyst rates; however, they modified the 
rates of pyruvate and glycine consumption, as well as arginine consumption/production. 
In summary, hyperglycaemia in the presence or absence of insulin modifies oviduct 
secretions, which in turn leads to altered embryo metabolism. Further experiments may 
elucidate whether a combination of molecules implicated in metabolic conditions exert 
a more pronounced effect on the composition of oviduct-derived fluid, as well as 
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The success of mammalian reproduction can be measured by the delivery of healthy live 
young.  However, there are many factors that may influence this, not least the health 
status of the mother. Indeed, compelling data now exists to show that events occurring 
prior to, and during pregnancy can influence the life-long health of the offspring.  Such 
a paradigm is best described by the Developmental Origins and Health and Disease 
hypothesis, proposed initially by David Barker (Barker, 2004). Clear examples of a 
prenatal exposure leading adverse health outcomes in the offspring include diseases 
such as spina bifida, which can result through an absence of dietary folic acid during 
early pregnancy, foetal alcohol syndrome disorders, which manifests as physical and 
behavioural problems and is caused by heavy maternal alcohol intake during pregnancy, 
and the so-called ’thalidomide syndrome’ that was caused by ingestion of the drug 
thalidomide to combat morning sickness, and led to phocomelia in the offspring. 
 
Examples such as these indicate clearly the sensitivity of the developing offspring to 
events during pregnancy.  The severe examples above result in a clear phenotype in the 
offspring, however data are now revealing that more subtle modifications to offspring 
health can arise in response to maternal health and fitness. Numerous studies on 
animals have indicated that dietary challenge, especially during the first few days of 
embryo development can lead to lifelong health impacts in the offspring. The embryo is 
very sensitive to environmental changes at the preimplantation stage, such as those 
induced by an imbalanced maternal diet (reviewed by (Watkins, Papenbrock and 
Fleming, 2008)). Embryo development in a low-nutrient environment promotes 
embryonic developmental plasticity to ensure embryo survival and growth, however, 
these mechanisms of plasticity may be associated with the development of metabolic 
conditions in the adult life of the offspring (Watkins et al., 2008).  
 
One of the challenges of understanding the links between maternal physiology during 
pregnancy and offspring health is the relative difficulty of sampling the environment in 
which early development usually takes place.  Indeed, we have very little knowledge of 
how maternal diet and health affects the composition of the environment in which early 
development occurs. These limitations in accessing the environment of the pre-
implantation embryo, combined with ethical implications associated with the use of 
20 
 
human tissue, have supported the use of animal models, and, in many cases, the bovine 
as a model organism for the study of reproductive tract pathologies. 
 
This thesis has set out to use an in vitro experimental model to examine how maternal 
hyperglycaemia affects the volume and the composition of the bovine oviduct epithelial 
cell secretions, as well as the impact of a hyperglycaemia-modified environment on 
embryo survival and metabolism. In order to fully introduce the work undertaken, it is 
necessary to summarise the key aspects of female reproductive physiology, and then to 
review the approaches that have been used to examine the links between maternal 
physiology and early development. 
 
1.1. Oestrous cycle 
 
The female reproductive tract provides the environment in which fundamental 
reproductive processes such as gamete transportation, fertilization and embryo 
development occur. The female tract facilitates the change from supporting gamete 
maturation to sustaining the first stage of a pregnancy. This cyclicity is hormonally 
regulated and may be thought of as having two components; the uterine cycle and the 
ovarian cycle, which differ functionally, but occur in parallel. 
 
1.1.1. Ovarian cycle 
In most mammals, the external manifestation of the internal cyclicity of the ovarian 
cycle is termed oestrous. The oestrous lasts for a short period, and coincides with 
ovulation. Oestrous is apparent through behavioural changes (Johnson, 2007), the most 
clear sign of sexual receptivity being the acceptance of the female of being mounted by 
the male (Orihuela, 2000). In the bovine, the oestrous cycle lasts between 18-24 days 
and consists of two distinct phases, the follicular and the luteal phase. The follicular 
phase, which lasts about 4-6 days in the bovine, involves the final maturation of the 
oocyte and ovulation to the lumen of the oviduct. The luteal phase, which lasts 
approximately 14-18 days in the bovine, follows ovulation and involves the formation of 




In humans and higher primates, ovarian cyclicity is exhibited through the menstrual 
cycle, rather than the oestrous cycle. There are key differences between the oestrous 
and the menstrual cycle. Firstly, at the end of luteal phase of the menstrual cycle, the 
endometrium is shed through a process called menstruation; in the oestrous cycle, the 
endometrium is re-absorbed. Additionally, in oestrous cycles, females are only receptive 
to males at oestrous and not during the luteal phase; on the contrary, in humans, 
females are receptive to males throughout the cycle. Furthermore, the menstrual cycle 
typically lasts about 28 days, whereas the oestrous cycle typically lasts about 21 days, 
although this can vary according to species. Moreover, in the menstrual cycle, day 1 is 
the first day of menstruation, as opposed to oestrous, where day 1 is the first day of 
oestrous (Johnson, 2007). 
 
As reviewed by Mwaanga and Janowski, there is another state, called anoestrus, during 
which animals do not exhibit normal oestrous cycle or manifestations of heat, a period 
physiologically occurring before puberty, as well as during and after pregnancy and 
parturition (Mwaanga and Janowski, 2000). 
  
In spite of the differences between the oestrous and the menstrual cycle, there are 
fundamental similarities between the two. The hormonal regulation shows notable 
similarities, even though the duration of the secretion of each hormone varies. 
Additionally, key biological processes throughout the cycle are induced by the same 
events, for example ovulation, described later in more detail, is induced by the LH surge 













1.1.2. Endocrine regulation of the oestrous cycle 
A schematic representation summarising the cyclicity of the oestrous cycle is shown in 





Figure 1.1.: a) Schematic representation of hormonal secretions during the oestrous cycle in the bovine and 
association with the pattern of ovarian follicle growth. The blue line represents FSH, which increases transiently 
before follicular growth, while LH pulsatile secretion patterns are modified in terms of amplitude and frequency 
according to the stage of the cycle (green line in inserts above). Day 0 of the cycle indicates the beginning of the 
early luteal phase, progressing to the mid-luteal phase and the to the follicular phase. Day 21 of the present graph 
is the day of ovulation. Progesterone levels (orange line), increase after day 2 of the cycle, almost plateauing on 
day 8 until day 17, when they drop significantly before ovulation. Red circles represent atretic follicles, whereas 
yellow circles are healthy follicles (Forde et al., 2011). b) Schematic representation of the endocrinological profile 
of the menstrual cycle (Draper et al., 2018). As discussed in the text, day 1 of the menstrual cycle is the day when 
menstruation begins. The hormonal profile of the two cycles is similar, with high levels of oestrogen preceding 
ovulation, high levels of progesterone following it and a surge of LH just before oocyte ovulation. 
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The gonadotrophins, follicle-stimulating hormone (FSH) and luteinising hormone (LH) 
are secreted by the anterior pituitary gland. This secretion of FSH and LH is regulated by 
the gonadotrophin-releasing hormone (GnRH), which is a decapeptide secreted in the 
hypothalamus (Schally et al., 1971). Similar to gonadotrophin secretion, GnRH secretion 
is also pulsatile (Forde et al., 2011). As a response to GnRH pulse, FSH and LH are 
released within a few minutes (Johnson, 2007), a process mediated by binding of the 
GnRH on the GnRH receptors in the pituitary gland (Kakar, Rahe and Neill, 1993).  
Each peak in the peripheral LH coincides with a GnRH pulse, and the amplitudes of LH 
pulses are determined by the frequency of GnRH pulses (Clarke and Cummins, 1985). 
This pulsatile secretion of GnRH and the pre-ovulatory surge of the hormone from the 
hypothalamus prevents the gonadotrophs in the anterior pituitary gland from becoming 
desensitised (Forde et al., 2011). FSH and LH can be stored in the same secretory 
granules, but their secretion is not synchronous, suggesting that secretion of the two 
gonadotrophs is differentially controlled and led by separate exocytosis pathways 
(Farnworth, 1995).  
As will be discussed in more detail in section 1.2, FSH and LH are crucial for ovarian 
follicular development, follicles being involved in mechanisms of positive and negative 
feedback of the hypothalamic – pituitary – gonadal axis (Johnson, 2007)(Forde et al., 
2011). In brief, LH acts on theca cells in the ovary to trigger androgen synthesis. FSH acts 
on granulosa cells in the ovary which convert androgens into oestrogens. Androgens and 
oestrogens are steroid hormones, derived from a common precursor molecule, 
cholesterol (Johnson, 2007). In the human ovarian cycle, the levels of oestrogens are 
highest before ovulation and are relatively low during the time when fertilisation occurs 
(Winuthayanon et al., 2015), following the broad profile of LH. The levels of 
progesterone follow the opposite pattern, being highest after ovulation and around the 
time of fertilisation (Johnson, 2007). Oestradiol is known to have a dual function in the 
regulation of gonadotrophin secretion. At low levels, it has an inhibitory role in the 
secretion of gonadotrophins through a negative feedback mechanism; conversely, at 
high levels, it induces a positive feedback mechanism, therefore inducing a surge of FSH 
and LH, necessary to trigger ovulation. On the other hand, high levels of progesterone, 
similar to those observed during the luteal phase of the cycle, exert a negative feedback 
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mechanism, thus maintaining low levels of FSH and LH. Additionally, high levels of 
progesterone block the positive feedback effect of oestradiol (Johnson, 2007). 
 
During the follicular phase of the ovarian cycle, the levels of oestrogen are low. Steadily, 
the levels of oestrogen rise, as the androgen synthesised by the thecal cells causes the 
granulosa cells to proliferate (Johnson, 2007).  These increased levels of oestrogen, in 
turn, exert a negative feedback effect, thus reducing the FSH levels, whereas LH levels 
plateau  (Hillier, 1994). At the time of selection of the dominant follicle, there is a further 
increase in oestrogen levels a switch from inhibin-B to inhibin-A occurs. This oestrogen 
surge exerts positive feedback over gonadotrophins, reflected by a surge in the levels of 
LH and FSH. At this time the follicle gets ovulated and directed into the oviduct (Johnson, 
2007). The FSH levels in the circulation are then reduced again due to oestrogen 
secretion from the dominant follicle, and the remaining follicles become atretic (Hillier, 
1994). 
The luteal phase of the cycle is dominated by the corpus luteum, which forms from the 
remnants of the ovulated follicle and by increased systemic levels of progesterone 
(Forde et al., 2011). Progesterone suppresses the levels of the gonadotrophins by 
negative feedback, and the levels of androgens also become suppressed. Even though 
oestrogen levels appear to rise during the luteal phase, there is no gonadotrophin surge, 
as progesterone suppresses that feedback mechanism (Johnson, 2007).  If pregnancy is 
not established, then, in the bovine, prostaglandin F is detected in the uterine fluids, 
suggesting that luteolysis (Lamothe, Bousquet and Guay, 1977), defined as the 
regression of the corpus luteum (McCracken, Custer and Lamsa, 2019),has occurred 
(Lamothe, Bousquet and Guay, 1977). This results in reduced levels of progesterone in 
circulation, increasing levels of oestrogen and GnRH stimulation, for the beginning of a 
new oestrous cycle (Forde et al., 2011). 
 
1.1.3. Uterine cycle 
In parallel to the ovarian cycle, the uterus also undergoes cyclical changes. The follicular 
phase of the ovarian cycle corresponds to the proliferative phase of the uterine cycle. 
During this phase, the endometrium thickens and re-epithelises in readiness for a 
pregnancy, should conception occur. During this phase of the cycle, oestradiol 17β is the 
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dominant hormone. The luteal phase of the ovarian cycle corresponds to the secretory 
phase of the uterine cycle, when the uterus increases its secretions in readiness to 
support a pregnancy; this phase of the cycle is progesterone-dominated (Johnson, 
2007).  
 
The hormonal fluctuation observed during the cycle regulates the action of the female 
reproductive tract and the ovary, which will be described in the next section. Previous 
work in the laboratory suggests that addition of oestrogen, progesterone, or 
pathologically high or low concentrations of androgens result in altered secretions of 
the oviduct epithelium (Simintiras et al., 2016). The importance of these findings has led 
us to explore the impact of other pathophysiological conditions, such as the ones 
























1.2. Oocyte development 
 
The ovary is the site of gametogenesis in females.  It is formed from a bipotential 
precursor, a non-differentiated genital ridge, during foetal life (Lucas-Herald and 
Bashamboo, 2014)., the coelomic epithelium that resides in the primitive gonad 
condenses and surrounds the primordial germ cells (Ungewitte and Yao, 2013).. This 
action forms the primordial follicle, and the germ cells cease mitotic proliferation and 
enter meiosis (Ungewitte and Yao, 2013) , which they arrest at the prophase stage 
(Sarma, Findlay and Hutt, 2019). Follicles can remain metabolically quiescent at the first 
meiotic prophase, at an arrested state, for up to 40 (Coticchio et al., 2014) to 50 years 
(Gosden and Lee, 2010), until the initiation of menstrual or oestrous activity at puberty 
(Jaffe and Egbert, 2018) . Follicular development is a very slow process, since, in the 
human, a primordial follicle may have been recruited approximately a year before it 
became dominant (Conti and Chang, 2016). 
 
At the stage of the primordial follicle, the primary oocytes are surrounded by the 
granulosa cells of the ovary (Jaffe and Egbert, 2018), which are flattened mesenchymal 
cells in the ovary. (Figure 1.2) As a primordial follicle progresses to form a pre-antral 
follicle, the oocyte grows significantly in size, approximately 100-fold, reaching a final 
size of approximately 120µM in the human (Gosden and Lee, 2010). At that stage, 
organelles, structural components and soluble components can be detected in 
abundance in the follicle (reviewed by (Gosden and Lee, 2010)).  Extensive RNA synthesis 
occurs (Johnson, 2007)(Gosden and Lee, 2010), which will be used in subsequent stages 
of oocyte maturation (Johnson, 2007) and in the first stages of embryo development, if 
fertilisation occurs (Coticchio et al., 2014). Also, during this phase, the oocyte secretes 
glycoproteins, which will eventually form the zona pellucida, separating the oocyte from 
the surrounding granulosa cells (Johnson, 2007). Moreover, at this stage, theca cells of 
follicle are formed from ovarian stromal precursor cells (Magoffin, 2005), and they 




Figure 1.2.: Oocyte maturation (figure from (Widmaier, Raff and Strang, 2006)). At the prenatal stage, primordial 
germ cells migrate to the foetal ovary and undergo mitotic divisions, followed by entry into meiosis and arrest at 
the prophase. At birth, they are at the primordial follicle stage and, at puberty, they resume the first meiotic 
division. Follicular growth occurs in parallel with entry into the second meiotic division, until the follicles reach the 
preovulatory stage and meiotic metaphase II. The oocyte will then get ovulated and will complete the second 
meiotic division post-fertilisation (Gosden and Lee, 2010)  
Follicular progression is known to progress relatively quickly at the antral stage, over 40 
to 50 days in the human (Conti and Chang, 2016). During the transition of pre-antral to 
antral follicles, the cells of theca layer are further differentiated to cells of the theca 
interna and theca externa (Magoffin, 2005). The cells of the theca interna are highly 
vascularised cells, associated with steroidogenesis, whereas the cells of the theca 
externa are more loosely organised, do not produce steroid hormones and reside 
between the cells of the theca interna and the interfollicular stromal area of the ovary 
(Magoffin, 2005). The granulosa cells secrete follicular fluid, which, in the end of that 
phase, will have formed the follicular antrum. The increase of the volume of follicular 
fluid produced and, consequently, the overall size of the follicle, results in the oocyte 
remaining in suspension in the follicular fluid (Johnson, 2007). The cells surrounding the 
oocyte are differentiated granulosa cells (Matzuk et al., 2002), called the cumulus 
oophorus, and are connected to the rest of the granulosa cells with a thin stalk of 
granulosa cells (Johnson, 2007), whereas the granulosa cells lining the wall of the follicle 
are the mural granulosa cells (Matzuk et al., 2002). At this stage, the androgens and the 
28 
 
oestrogens produced by theca and granulosa cells are closely linked to follicular growth 
and maturation. Androgens are produced in the theca cells then become aromatised to 
oestrogen in the granulosa cells (reviewed by (Forde et al., 2011)). The androgens act 
synergistically with FSH to promote granulosa cell proliferation. At the same time, 
oestrogens can also promote granulosa cell proliferation, therefore activating a system 
of positive feedback. Consequently, the levels of oestrogen surge just before ovulation 
(Johnson, 2007).  
 
The selection of the dominant follicle is associated with the responsiveness of granulosa 
cells of follicles to FSH, which at this time increases and induces aromatase synthesis in 
the granulosa cells. This follicle will be the first one to secret oestrogen (Hillier, 1994), 
whose levels increase. Increased levels of oestrogen and inhibin-A synthesis, rather than 
inhibin-B, indicate the development of the dominant follicle (Welt et al., 2001)which is 
the only follicle that remains viable and secretes oestrogen toward the end of the 
follicular phase (Hillier, 1994). If the LH surge, described in section 1.1.2, coincides with 
the appearance of receptors of LH in both the outer granulosa cells and the theca cells, 
then the follicle becomes dominant (Xu et al., 1995). 
 
After the surge of LH, significant endocrine changes occur in the follicle, mainly 
attributed to the granulosa cells, which, instead of aromatising androgens to oestrogens, 
start synthesizing progesterone (Johnson, 2007). Just before ovulation, the oocyte 
completes the first meiotic division. Even though the oocytes are characterised by radial 
symmetry, with the exception of the nucleus, which is positioned slightly eccentrically, 
the meiotic spindle migrates close to the oocyte cortex. Consequently, the first polar 
body is formed (Maro and Verlhac, 2002; Gosden and Lee, 2010), a process which 
enables chromosome segregation without loss of any of the products stored in the 
oocyte that will be of use after fertilisation (Maro and Verlhac, 2002). The second 
meiotic division is then initiated, where it arrests at the metaphase stage. This is 
accompanied by a simultaneous maturation of the cytoplasm; the oocyte detaches 
slightly from its surrounding granulosa cells, and the cortical granules are formed by its 
Golgi apparatus, which move to the surface to enable cortical reaction if fertilisation 




Ovulation completes the follicular phase of the cycle, which can vary across species. At 
ovulation, the follicle ruptures and follicular fluid enters the oviduct, along with the 
oocyte, surrounded by the cumulus cells (Johnson, 2007). 
 
During the luteal phase of the cycle, the corpus luteum is formed from conversion of the 
granulosa cells and inner theca cells to large and small luteal cells, respectively, and high 
levels of LH are associated with this conversion. Luteal cells secrete inhibin A, oxytocin 
and, in humans and greater apes, oestradiol (Johnson, 2007). The role of the corpus 
luteum is to produce adequate levels of progesterone to support a potential pregnancy 
and endometrial receptivity (Forde et al., 2011). As mentioned in section 1.1.2, if this is  
not established, luteolysis occurs, during which lutein cells collapse and progressive 
cellular death can be observed, which results in the formation of scar tissue, called 
corpus albicans (McCracken, Custer and Lamsa, 2019). 
 
There has been extensive research on the effect of external stimuli on the female 
reproductive tract and the ovary in particular, some of which will be discussed later in 
section 1.8. However, there are relatively limited data on the impact that such stimuli 
may exert on the environment where fertilisation and early embryo development will 
occur. The environment in which these events occur, the oviduct, will be discussed in 















1.3. The oviduct 
 
1.3.1. Oviduct structure  
The oviduct, known as the Fallopian tube or “tube” in the woman, , has been described 
as “a muscular tube with a mucous lining” by Leese (Leese, 1988). It is a tube-shaped 
structure, comprised of a single columnar epithelium, surrounded and supported by 
stromal cells and muscle cells, as well as a serosa (Winuthayanon et al., 2015). The 
oviduct can be anatomically divided in four regions: the utero-tubal junction, the 
isthmus, the ampulla and the infundibulum, which has fimbriae that open towards the 
peritoneal cavity (Figure 1.3), (Leese, 1988). The thickness of the oviduct increases from 
the infundibulum towards the utero-tubal junction (Hunter, 2012). The infundibulum is 
often termed the “pre-ampulla”, and the utero-tubal junction is referred to as the 
“intramural” or “interstitial” portion (Leese, 1988). 
 
 
Figure 1.3.: Structure of the oviduct. The infundibulum, ampulla, isthmus and utero-tubal junction are shown. The 
ampullary-isthmic junction is the site of fertilisation. Figure from (Aviles, Gutierrez-Adan and Coy, 2010) 
The subepithelial part of the oviduct consists of mesothelial cells, fibroblasts, collagen 
fibrils and inner and outer smooth muscle tissue (Clyman, 1966), (Figure 1.4). The 
mucosa of the oviduct has folds with a typical tree branch-like structure, a structure 
creating a variety of microenvironments and helping prevent a large number of 




Figure 1.4.: Electron microscopy picture of the sub-epithelial area of the oviduct. BM = basal membrane, St= stromal 
cells, Col=collagen (Clyman, 1966) 
 
1.3.1.1. Oviduct epithelium 
The isthmus and ampulla of the oviduct contain two epithelial cell types; secretory cells 
and ciliated cells (Joshi, 1995) (Figure 1.5). The ratio of ciliated to secretory cells 
decreases from the infundibulum to the utero-tubal junction (Leese, 1983, 1988). 
Secretory cells are involved in the production of the oviduct fluid, containing among 
others oviduct-specific glycoproteins. In contrast, ciliated cells are implicated in gamete 
transport to the site of fertilization, embryo transportation (Comer, Leese and 
Southgate, 1998), and sperm binding involved in the formation of a sperm reservoir, 
discussed later in section 1.4 (Comer, Leese and Southgate, 1998; Coy et al., 2012). 
Indeed, it has been found that the movement of a cumulus-oocyte complex into the 
oviduct is facilitated by interaction between the matrix of the cumulus-oocyte complex 




    
Figure 1.5.: a) Oviduct epithelial cells, distinguished in ciliated (CC, Ci=cilia) and secretory cells (SC). (Coy, Avile and 
Monde, 2012), b) Electron microscopy picture of the fallopian tube. Ciliated and Secretory Epithelial cells can be 
observed. The lumen can be clearly seen. Lu=lumen, S=secretory epithelial cells, C=ciliated epithelial cells, 
N=nucleus (Clyman, 1966). 
 
1.3.2. Role of the oviduct 
The oviduct plays a number of roles in facilitating early development. It is the site for 
final gamete maturation, fertilisation and the first stages of early embryo development, 
which is referred to as the preimplantation stage.   
 
The role of the oviduct in gamete activation is threefold: it mediates sperm capacitation 
and hyperactivation, which will be discussed later (section 1.4), it affects oocyte 
physiology and it guides oocyte-sperm interactions (Coy et al., 2012). The oocyte gets 
retrieved into the oviduct through interactions between the extracellular matrix of the 
cumulus cells and the crowns of the ciliated cells in the infundibulum of the oviduct, an 
interaction which is transitory and of appropriate strength (Lam et al., 2000). The 
passage of the cumulus-oocyte complex through the oviduct, to the site of fertilization, 
which is the ampullary-isthmic junction (Aguilar and Reyley, 2005) usually occurs in a 
few minutes (Croxatto, 2002), taking at most 15 minutes in rabbits and 45 minutes in 
pigs (Hunter, 2012). It then remains in this site for a few hours or days (Croxatto, 2002), 




remain in the oviduct until Day 4 of embryonic development (Maillo et al., 2016). As 
reviewed by Coy et al (2012), on arrival to the ampulla, the cumulus-oocyte complex has 
been observed to be attached to the epithelial cells in the bovine (Coy et al., 2012). In 
addition, in sheep and cows, at that time, the cumulus cells are removed from the 
complex, leaving a denuded oocyte. This suggests a quick response of the oviduct in 
releasing the sperm to fertilise the oocyte, before the oocytes become completely 
denuded (Coy et al., 2012).  
 
Additionally, the fluid secreted by the oviduct, which will be discussed in more detail 
later in this section, has the potential to promote embryo quality and development by 
protecting the embryos against adverse impacts of the environment on mitochondrial 
DNA (Lloyd et al., 2009). Transport of the embryo towards the site of implantation 
occurs as a result of three processes: (a) contraction of the muscles around the oviduct, 
(b) beating of ciliated oviduct epithelial cells, which combine to produce (c) oviduct fluid 
flow (Li and Winuthayanon, 2017). The frequency of ciliary beating is regulated by 
oestrogen and progesterone, the latter inducing frequency reduction (Mahmood et al., 
1998)(Bylander et al., 2010) and the former either increasing ciliary beating frequency 
(Li and Winuthayanon, 2017) or preventing the frequency reduction induced by 
progesterone (Mahmood et al., 1998). Muscle contraction is due to the movement of 
the myosalpinx, which is stimulated by prostaglandins (Li and Winuthayanon, 2017) 
although it also responds to the ratio of oestradiol to progesterone (Hunter, 2012). The 
combined action of ciliary beating and muscular contraction results in stirring of the 
contents of the tube, therefore enabling contact of the components of the fluid with the 
gametes/embryo (Muglia and Motta, 2001; Lyons, Saridogan and Djahanbakhch, 2006).  
 
Previous work has shown that there is extensive communication between the female 
reproductive tract and the gametes and/or the preimplantation embryo (Maillo et al., 
2016). The presence of gametes in the oviduct regulated the secretion of proteins 
associated with their survival, maturation and function, as well as the modification of 
the oviduct environment for the zygote, and most of these proteins were differentially 
regulated for spermatozoa and oocytes (Georgiou et al., 2005, 2007). The presence of 
multiple embryos in the bovine oviduct has been associated with differential gene 
expression by oviduct epithelial cells, and, in particular, with downregulation of gene 
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expression for genes associated with the immune system. The presence of a single 
embryo failed to exert the same effects, potentially because these effects would be local 
and therefore undetectable (Maillo et al., 2015). Study of the interactions described 
above can be performed with embryo co-culture with oviduct epithelial cells, oviduct 
fluid or oviduct extracellular vesicles (Maillo et al., 2016). 
 
In summary, the oviduct is much more than a tube in which the gametes are brought 
together and the embryo is transferred to the uterus; ; Abe referred to it as an “active 
organ that maintains and modulates a dynamic fluid-filled milieu” (Abe, 1996). Through 
the creation and secretion of fluid, it plays important roles in gamete activation, 
fertilization and early embryo development (Abe and Hoshi, 1997; Ulbrich et al., 2010). 
The walls of the oviduct lumen are moist with oviduct fluid, regardless of the presence 
of gametes or embryos (Leese, 1988), secreted, in most cases, in small, rather than 
copious amounts by the oviduct epithelium (Tay, 2003). The oviduct fluid is a mixture of 
plasma-derived molecules and epithelium-derived secreted proteins (Leese, 1988; 
Walker et al., 1996; Aguilar and Reyley, 2005). Its composition is termed dynamic, 
because it varies according to the presence of gametes or embryos as well as the stages 
of the cycle (Aviles, Gutierrez-Adan and Coy, 2010).  
 
1.3.2.1. Oviduct fluid composition  
Oviduct fluid contains a variety of substances, aiming to provide an optimum 
environment for gametes and preimplantation embryos (Aguilar and Reyley, 2005). 
Oviduct fluid composition has been described in humans, domestic animals and 
laboratory animals (Aguilar and Reyley, 2005), and a general overview of the fluid 
composition is described in the next sections, with reference to specific species where 
appropriate. 
 
In general, non-electrolytes are transported into the lumen using three different 
mechanisms: direct transportation from the blood, with the molecules remaining 
unchanged, synthesis de novo by the oviduct cells and secretion in the lumen, and 
synthesis from the cumulus cells, present in the lumen. Other sources of non-electrolyte 
production, such as follicular, seminal and peritoneal fluids, appear to have a minor 





In situ collection of oviduct fluid has shown the presence of a variety of electrolytes in 
the oviduct fluid (Hugentobler, Morris, et al., 2007). Potassium (Leese, 1988; Aguilar and 
Reyley, 2005) and bicarbonate (HCO3-) (Leese et al., 2001) are present in the oviduct 
lumen in high concentrations relative to that seen in the serum (Aguilar and Reyley, 
2005; Hugentobler, Morris, et al., 2007), and this observation applies to all species 
studied (Aguilar and Reyley, 2005). The maintenance of an environment containing high 
levels of potassium and bicarbonate is thought to be important for the maintenance of 
appropriate pH (7.1-8.0 depending on the time of oestrous cycle) and osmolarity levels 
(Leese, 1988), as well as for developmental progression, which is claimed to be higher 
for 2-cell mouse embryos cultured in a higher potassium concentration (Roblero and 
Riffo, 1986). The importance of bicarbonate ions for embryo development is also 
observed in in vitro fertilisation experiments, where these ions are associated with the 
maintenance of appropriate extracellular pH (Swain, 2010). Chloride ions, which are very 
important for regulation of oviduct fluid secretion (section 1.3.4), are believed to move 
mainly towards the oviduct lumen, and this ion movement is dependent on adrenergic 
agents (Leese, 1988). 
 
By contrast, the levels of calcium and magnesium differ across species and, for calcium, 
in different regions of the oviduct (Aguilar and Reyley, 2005), however calcium 
concentrations in the oviduct fluid are significantly lower than plasma concentrations 
(Leese, 1988). There is a positive correlation between the levels of magnesium and 
calcium in the oviduct fluid and their concentrations in serum, suggesting that their 
concentrations are dependent on blood concentrations (Hugentobler, Morris, et al., 
2007). In the early embryo, calcium has previously been associated with promoting the 
process of compaction at the morula stage (Miao and Williams, 2013), and the combined 
absence of calcium and magnesium in the medium used for the culture of early embryos 
has been found to facilitate blastomere removal for biopsy (Dumoulin et al., 1998), 
suggesting a role for these ions in developmental progression. pH in the bovine oviduct 
has been measured to be approximately 7.6, which is higher than the pH of the uterus, 
measured to be about 6.96. These values are not within the pH range used for in vitro 
embryo experiments, which is between 7.1 and 7.4 for the cattle, however it can be 
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hypothesized that this range may be optimal for in vitro embryo development to the 
blastocyst stage, which would encompass transition from the oviduct to the uterus 
(Hugentobler et al., 2004).  
 
Energy substrates 
The major energy substrates found in oviduct fluid are glucose, pyruvate, lactate and 
amino acids (Aguilar and Reyley, 2005). These are transported and accumulate at 
different rates in the lumen (Leese and Gray, 1985) although they tend to be present in 
the lumen of the ampulla at higher concentrations compared to the isthmus (Leese, 
1983). Concentrations are also dependent on the stage of the oestrous cycle. For 
example, the levels of glucose in the oviduct fluid in pigs fall after ovulation, compared 
to their levels before ovulation (Nichol et al., 1998). In cattle, glucose concentrations in 
the oviduct have been detected to be significantly lower compared to plasma glucose 
concentrations (Hugentobler et al., 2008). Lactate concentrations follow the reverse 
pattern, being significantly higher than the respective plasma concentrations 
(Hugentobler et al., 2008), and it has been suggested that lactate in the oviduct lumen 
is derived as a combination of metabolism of glucose in the circulation and lactate 
transport across the oviduct monolayer (Leese, 1988). Finally, pyruvate concentrations 
are higher than plasma concentrations in the first days of the oestrous cycle but are not 
different from the respective concentrations in the plasma on later days of the cycle 
(Hugentobler et al., 2008). There is no association between the concentrations of these 
energy substrates and the systemic concentrations of oestrogen and progesterone 
(Hugentobler et al., 2008). It is also reasonable to suppose that there exist specific 




The amino acids present in the oviduct fluid are detected in concentrations that vary 
depending on the stage of the cycle and the species studied, and are different from the 
respective concentrations in the circulation (Walker et al., 1996; Tay et al., 1997; Aguilar 
and Reyley, 2005). In the bovine, this variation according to the day of the cycle was not 
observed (Hugentobler, Diskin, et al., 2007). Similar to glucose, lactate and pyruvate, the 
concentrations of amino acids in the oviduct lumen in the bovine were unaffected by 
37 
 
systemic levels of progesterone and oestradiol (Hugentobler, Diskin, et al., 2007). Amino 
acids are crucial embryo substrates, and turnover of amino acids has been previously 
associated with embryo viability (Houghton et al., 2002; Brison et al., 2004; Sturmey, 
Brison and Leese, 2008). In agreement with the Quiet Embryo Hypothesis (Leese, 2002), 
viable embryos, showing lower DNA damage, had low amino acid turnover (Sturmey et 
al., 2009). Addition of physiologically relevant levels of amino acids to embryo culture 
media increases the number of embryos reaching the blastocyst stage and improves the 
number of nuclei in the blastocysts and their morphology (Walker et al., 1996).  
 
Proteins and enzymes 
The most abundant proteins in the oviduct fluid are albumin and immunoglobulin G 
(Oliphant et al., 1978; Leese, 1988), which are derived from the circulation (Oliphant et 
al., 1978). Apart from these, many non-plasma derived proteins have also been detected 
(Leese, 1988; Coy, Avile and Monde, 2012), of which the oviduct-specific glycoprotein, 
secreted by the oviduct epithelium (Aguilar and Reyley, 2005), is the best known and 
characterised. The oviduct-specific glycoprotein (OVGP1) has been identified in the 
oviduct fluid of several species examined (Leese et al., 2001), at different rates in each 
region of the oviduct (Aguilar and Reyley, 2005). Species-specific differences have been 
observed both in mRNA expression of the OVGP1 gene, in terms of gene expression 
across the oestrous cycle, and the amino acid length of the protein (reviewed by (Aviles, 
Gutierrez-Adan and Coy, 2010)). The levels of oviduct-specific glycoprotein in the fluid 
are highest during the periovulatory period, after which they decline. The precise role 
of OVGP1 remains elusive. The presence of oviduct-specific glycoprotein and heparin 
can reversibly interact with the zona pellucida of the oocyte, and mask sperm-binding 
sites, thus preventing polyspermy after fertilisation, as well as delaying proteolytic 
digestion of the zona pellucida by occupying pronase sites (Coy et al., 2008). It has been 
also suggested that this protein plays a role in immunological protection of the embryo 
in vivo (Leese et al., 2001). A role for the oviduct specific glycoprotein has been described 
in both the maintenance of sperm viability, motility and capacitation ((McNutt et al., 
1992), also reviewed by (Ghersevich, Massa and Zumoffen, 2015)),, and in zona pellucida 
hardening and modification for sperm-oocyte interactions, although species-specific 
differences suggest that its role is still unclear (reviewed by (Ghersevich, Massa and 




Apart from the proteins described above, there are a variety of other proteins secreted 
by the oviduct epithelium in the bovine, including growth factors, cytokines, proteases, 
protease inhibitors, enzymes and other protein associated with gamete and embryo 
maturation and development (Pillai et al., 2017). Growth factors regulate cell 
proliferation and differentiation, as well as cell invasiveness (Simmen and Simmen, 
1991). They have a role in support of gamete and embryonic development (Aviles, 
Gutierrez-Adan and Coy, 2010) (Pillai et al., 2017), and are also implicated in the 
regulation of embryo implantation (Simmen and Simmen, 1991). Cytokines are also 
associated with the recognition between the endometrium and the blastocyst-stage 
embryo, and together with growth factors, they promote implantation by facilitating 
contact between the embryo and the uterus (Simón, Gimeno and Frances, 1996), On the 
other hand, proteases and protease inhibitors are associated with the maintenance of 
homeostasis (Pillai et al., 2017) and, in the rat, they have been linked to promotion of 
embryo development (Ichikawa et al., 1985).  
 
Glycosidases, which are hydrolytic enzymes acting on glycosyl compounds, have also 
been detected in bovine oviduct fluid, their concentrations varying in different stages of 
oestrus (Carrasco et al., 2008). It has been hypothesized that these may play a role in 
the release of capacitated sperm into the oviduct fluid (Coy et al., 2012). Moreover, the 
oviduct fluid has been shown to contain prostaglandins E and F (Aguilar and Reyley, 
2005), which are of crucial importance to various reproductive processes, including 
induction of luteolysis (Ulbrich et al., 2009), ovulation, fertilisation, implantation and 
decidualisation, through cyclooxygenase-2 – related pathways  (Lim et al., 1997). Steroid 
hormones have also been detected in oviduct fluid, whose concentration varies across 
species and according to the stage of the oestrous cycle (Aguilar and Reyley, 2005). In 
particular, progesterone is present in the oviduct fluid of the golden hamster (Libersky 
and Boatman, 1995) and both oestrogen and progesterone have been detected in the 
oviduct fluid of rabbits, at different stages of the oestrous cycle (Richardson and 
Oliphant, 1981). Oestrogen and progesterone receptors have also  been previously 
found to be expressed in cells of the bovine epithelium (Rottmayer et al., 2001; 
Simintiras et al., 2016) and variable concentrations of these hormones modify bovine 
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Importantly, extracellular vesicles secreted by bovine oviduct epithelial cells have been 
detected, which have been claimed to improve embryo quality and enhance 
cryoprotection in in vitro embryo cultures, in terms of trophoectoderm and total cell 
number and survival after vitrification. This data suggest a potential role of these vesicles 
in mediating the communication between the oviduct and the preimplantation embryo 
(Lopera-Vasquez et al., 2016). Extracellular vesicles, in the forms of exosomes and 
microvesicles, have been previously detected in the follicular fluid and the uterus. In 
particular, microvesicles and exosomes containing microRNA have been detected in 
follicular fluid, where they may be involved in cell communication within the follicle (da 
Silveira et al., 2012), as has been previously described to be the case in other cell types 
(Camussi et al., 2010). Similarly, microRNA-containing exosomes and microvesicles have 
been identified in the uterus and in particular in the microenvironment where 
implantation will occur, where they are believed to contribute to the cross-talk between 
the embryo and the endometrium (Ng et al., 2013).  
 
Fatty acids 
Stearic acid, linoleic acid and oleic acid are the most commonly encountered fatty acids 
in the oviduct fluid, followed by arachidonic acid, palmitic acid and eicosapentaenoic 
acid. Interestingly, arachidonic, eicosapentaenoic and dihomo-γ-linoleic acid were 
detected at higher concentrations than in the circulation (Drews et al., 2018). Non-
esterified fatty acids (NEFAs) are present in the oviduct at concentrations reflecting 
plasma NEFA concentrations, and are positively correlated with the levels of cholesterol 
and lactate and negatively correlated with triglyceride levels in the oviduct fluid 
(Jordaens, Van Hoeck, De Bie, et al., 2017). NEFAs have also been shown to affect the 
metabolism and the barrier properties of the oviduct epithelium in a polarised manner. 
Apical-to-basal NEFA transport has been observed, potentially with the intention to 
shield the embryo from elevated NEFA levels in the oviduct lumen, whereas the reverse 
direction (basal to apical) of transport is limited, thus shielding the embryo from high 




Studies of embryo co-culture with bovine oviduct epithelial cells has shown a protective 
role of epithelial cells from toxic substances, such as ammonia, as well as providing 
embryotrophic support to the embryo (Ulbrich et al., 2010), and improvement of 
blastocyst rates in the presence of oviduct epithelial cells (Gandolfi and Moor, 1987). 
 
While we know much about the composition of the oviduct fluid, its dynamic nature and 
its potential to be modified according to the stage of the oestrous cycle and the presence 
of embryos and gametes, there is a need to deepen our understanding about how 
pathophysiological conditions of the mother affect this composition. In order to perform 
such studies, the establishment of good and representative models of the oviduct is 
necessary. 
 
1.3.3. Modelling the female reproductive tract  
The cow is a good model for investigating reproductive processes in the human since 
there are similarities in terms of genome structure (Elsik, Tellam and Worley, 2009), and 
the mechanisms required for oocyte maturation and regulation of the preimplantation 
embryo (Ménézo and Hérubel, 2002). The cow is considered a very useful model for 
studying in vitro embryo production experiments, as it pertains great similarities to the 
human with regards to the size of the oocyte to be used in in vitro experiments, timing 
to reach different developmental stages during preimplantation development, male 
gamete preparation protocols and embryo freezing procedures (Ménézo and Hérubel, 
2002). Limitations of in vivo studies in the bovine are mainly associated with the small 
number of offspring, as usually one embryo only is produced, the difficulty in capturing 
interactions between the embryo and the mother, since the embryo is not easy to be 
localised in the female tract, and the difficulty determining whether pregnancy fails to 
occur because of lack of fertilisation or because of embryonic death. In addition, cattle 
raised in slaughterhouses are not representative of normal growth conditions and it is 
believed that up to 40% of sacrificed cows display low fertility (Ulbrich et al., 2010).  
 
Knowledge of the composition of oviduct fluid can been derived with various in situ and 
in vitro methods (Leese et al., 2008). In situ methods include direct fluid retrieval from 
the oviduct and acute and chronic cannulation. As reviewed by Leese et al (2008) it is 
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possible to retrieve oviduct or uterine fluids directly, albeit in small amounts (Leese et 
al., 2008). The most commonly used in situ method is cannulation (Leese et al., 2008), 
either with the cannula directly inserted into the oviduct lumen of the anaesthetised 
animal or in vitro, using a preparation in which the ovarian artery is perfused (Aguilar 
and Reyley, 2005). Collection of oviduct fluid with cannulation is considered to provide 
a good representation of the in vivo oviduct environment (Aguilar and Reyley, 2005). 
However, chronic cannulation is associated with incidence of inflammation of the site of 
cannula insertion, hindrance of fluid flow to the peritoneal cavity and loss of fluid 
constituents due to the nature of long-term collection (Leese et al., 2008). The issues 
are resolved with the application of acute cannulation on anaesthetised animals (Kenny 
et al., 2002) for up to 3 hours (Hugentobler, Diskin, et al., 2007; Hugentobler, Morris, et 
al., 2007; Hugentobler et al., 2008).  
 
In vitro methods of fluid collection have been developed for reasons of ethical use of 
animal tissue, including vascular and luminal perfusion and excision and rapid sampling 
(Leese et al., 2008). Vascular and luminal perfusion, described first by Leese and Gray 
for the rabbit oviduct (Leese and Gray, 1985), and also used by Gott et al (Gott et al., 
1988), has also been performed in the human, where fallopian tube excision and artery 
cannulation and perfusion enabled collection of the fallopian tube fluid and substrate 
analysis (Dickens et al., 1995). Finally, excision of the reproductive tracts of animals after 
animal sacrifice can induce risks associated with post-mortem changes, especially due 
to cell necrosis and lack of a hypoxic environment, which may skew the results of the 
subsequent experiment. Rapid tissue excision, within a few minutes after sacrifice, 
ensures that post-mortem related changes are minimised (Leese et al., 2008). 
 
Three-dimensional culture of oviduct epithelial cells has been performed using a variety 
of techniques (Ferraz et al., 2018), including organoids (Kessler et al., 2015), perfusion 
culture (Reischl et al., 1999), and air:liquid interface (Chen, Einspanier and Schoen, 2013; 
Gualtieri et al., 2013). Adult stem cells have been detected in the fallopian tube, from 
which a monolayer of ciliated and secretory cells was produced, grown in a three-
dimensional organoid in vitro (Kessler et al., 2015). The perfusion system included cell 
growth on a perfusion chamber where the bovine oviduct epithelial cells were supplied 
continually with medium and, simultaneously, the metabolites secreted by the cells 
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were removed from cell culture (Reischl et al., 1999). Transwells have been previously 
used in the laboratory (Figure 1.6) (Simintiras et al., 2016). The first use of permeable 
supports for oviduct epithelial cell growth, where the same media was used in the apical 
and basal compartments, was performed on rabbit oviduct epithelium (Dickens, 
Southgate and Leese, 1993). Cells grown using this method have been shown to exhibit 
a negative charge in the apical side compared to the basal side (Dickens, Southgate and 
Leese, 1993; Dickens et al., 1996; Leese et al., 2001), providing evidence for the polarised 
nature of the cells in this preparation. This method was modified by Simintiras et al 
(Simintiras et al., 2016), by retaining the basal medium but replacing the apical medium 
with moist air, enabling the creation of an air-liquid interface and the secretion of in 
vitro-derived oviduct fluid, whose composition resembled the in vivo oviduct secretions 
(Simintiras et al., 2016).  
 
Figure 1.6.: In vitro model of the oviduct. (Simintiras et al., 2016) 
Recently, a microfluidic model of the female reproductive tract was created (Figure 1.7), 
mimicking the hormonal environment encountered in the ovary, the oviduct, the uterus, 
the cervix and the liver (Xiao et al., 2017). The system consisted of a donor module, 
where different experimental conditions were introduced, an acceptor module, where 
final products of the tissues were collected and five different tissue modules, 
representing each of the above tissues, and each module had pumps and valves, 
controlling fluid flow from one chamber to the next. In this model, cells for all in vitro 
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organs were harvested. Pressure and vacuum were applied to the valve and pump 
membranes therefore enabling fluid circulation within and between the modules 
involved. Before all five chambers were connected (Quintet-microfluidic platform, 
Quintet-MFP), a solo-MFP and a Duet-MFP were tested. This system was proved to be 
an efficient model of the female reproductive tract, by successfully supporting follicular 
development, maintaining cell viability, ciliary beating, and OVGP1 expression of 
fallopian tube epithelial cells, producing ectocervix tissue response, and hormonal 
control in the microfluidic culture. This system was successful in mimicking female 
hormone fluctuations at a pregnancy state, for a duration of approximately 100 days, 
due to the dynamic, compared to static, flow of media (Xiao et al., 2017). Whether there 
are any limitations associated with the use of this device remains to be confirmed. 
 
Figure 1.7: Microfluid platform model of the female reproductive tract. a) Mono-MFP, b) Dual-MFP, c) Quintet-
MFP, DO: Donor module, AC: accepting module. Figure adapted from (Xiao et al., 2017) 
Finally, “oviduct-on-a-chip” has been recently created (Figure 1.8). Bovine oviduct 
epithelial cells were grown on a porous membrane which separated two compartments, 
a basal, representing circulation and an apical, which contained pillars where embryos 
and oocytes could be trapped. The design described in this experiment allowed 
continuous perfusion from an apical direction of the oviduct epithelial cells, which 
allowed them to remain differentiated. The device also allowed for live imaging, where 
epithelial cells, embryos and gametes could be observed on the apical side of the chip. 
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This model enabled interactions between the gametes or the embryos and the female 
reproductive tract to be studied, and the preparation supported embryo development 
as well as the determination of gene expression associated with methylation patterns in 
the early embryo. The authors claim this model will enable further research on 
molecules involved in pathophysiological pathways, related to potentially lethal 
diseases such as ovarian cancer. The authors suggest that their system, allowing 
observation of cell migration processes, such as the ones observed in ovarian cancer, 
will allow personalised treatment for this disease (Ferraz et al., 2018). Whether this is 
indeed the case remains to be determined. 
 
Figure 1.8.: Oviduct-on-a-chip model, containing a porous membrane, which separates the apical and basal 
compartments. The apical compartment contains pillars where oocytes and embryos may be retained. Figure 
adapted by (Ferraz et al., 2018) 
In summary, there are multiple methods used to study oviduct fluid, each of which with 
its own advantages and limitations, all of which attempt to mimic as closely as possible 
the in vivo environment. For the experiments described in this thesis, Transwells were 
used to mimic the formation of the bovine oviduct epithelial cell monolayer, using the 
method described by (Simintiras et al., 2016), during which the cells were found to 





1.3.4. Mechanism of oviduct fluid secretion  
A potential mechanism of fluid secretion was proposed by Leese et al (2001) , based on 
the processes of transport described by (Quinton, 1990) (Figure 1.9). Quinton (1990) 
describes a widely accepted mechanism of fluid secretion found in various epithelial 
tissues, based on the movement of ions, which drives water movement across the 
epithelial monolayer (Quinton, 1990). In this model, the role of chloride ions in fluid 
secretion is fundamental (Keating and Quinlan, 2008, 2012). Intracellular sodium (Na+) 
concentration is maintained at a low level, through the action of the Na+/K+-ATPase 
enzyme, which is located in the basolateral membrane and exports Na+ from the cell in 
exchange for potassium ions. Clˉ flux is regulated via the Na+/K+/2Clˉ, which is an 
electroneutral carrier located in the basolateral membrane. Stimulation with a 
pharmacological agent or a neurotransmitter is shown to make the membranes 
permeable to Clˉ, and this switch induces a flux of Clˉ into the lumen, through the 
creation of an electrochemical gradient. The creation of this gradient, in turn, triggers a 
paracellular movement of Na+ through the tight junctions and into the lumen. The high 
osmotic pressure created in the lumen by the ion movement is restored through water 
flow to the lumen, in the direction of the osmotic gradient, leading to fluid secretion 
(Quinton, 1990). Leese et al suggested that a similar mechanism might be applied to the 
secretion of oviduct fluid, which may be triggered by higher oestrogen secretion around 
the time of ovulation (Leese et al., 2001).  
 
In two ion transport studies, Keating and Quinlan suggest a purinergic regulation of ion 
transport across the oviduct epithelium, with a highly important role of extracellular ATP 
in transiently activating calcium-dependent chloride channels, and, consequently, 
chloride ion secretion. In addition, they suggest a role for potassium channels on the 
basolateral side of the oviduct epithelial cells, in providing a driving force for this 
extracellular ATP-induced increase in chloride ion secretion (Keating and Quinlan, 
2012)(Keating and Quinlan, 2008). The observed increase in epithelial cell height during 
oestrus (Murray, 1995; Chen, Einspanier and Schoen, 2013) can be associated with 
higher rates of ion transfer and, consequently, higher volumes of fluid secreted (Leese 
et al., 2001). Application of blockers of Clˉ channels had a significant effect on the cells 
(Downing et al., 1997) suggesting the importance of this ion in fluid formation (Leese et 





Figure 1.9: Mechanism of oviduct fluid secretion (see text for more details) (Leese et al., 2001). 
 
Other molecules, such as the nutrients lactate and glucose, detected in the oviduct fluid, 
are also known to be transferred across the epithelial cells (Leese et al., 2001). In 
particular, Edwards and Leese, using the preparation for maintenance of the epithelial 
cells as a polarised monolayer in Transwells, showed that glucose is transported in the 
rabbit oviduct epithelium preferentially in a basal-to-apical, rather than an apical-to-
basal direction, via facilitated diffusion (Edwards and Leese, 1993), consistent with the 
requirement of early embryos for a source glucose, especially with blastocyst formation. 
The same study reports that approximately 80% of the glucose is metabolised into 
lactate, which appeared predominantly in the basal, rather than the apical medium 
(Edwards and Leese, 1993). A study performed in human fallopian tube epithelial cells 
also grown as a monolayer in Transwells (Dickens et al., 1996) has confirmed the above 
findings, suggesting the net movement of glucose into the apical compartment and net 
movement of lactate to the basal compartment. Interestingly, in rabbit oviduct epithelial 
cells, there was a decrease in the proportion of glucose and lactate appearing in the 
apical side of the cells, three days after mating compared to when the animals were at 
oestrous (Edwards and Leese, 1993), potentially indicating the passage of the embryo 
from the oviduct into the uterus and the observed decrease in oestrogen and increase 




Oestrogen and progesterone may affect the transepithelial flow of Cl- ions, which are 
associated with oviduct fluid secretion (Leese et al., 2001). This has been explored in a 
study published in our laboratory (Simintiras et al., 2016), where varying levels of 
oestrogen, androgens and testosterone have been shown to modify bovine oviduct 
epithelial cell secretions and to alter the gene expression profile of bovine oviduct 
epithelial cells (Simintiras et al., 2016). 
 
Different rates of fluid transport are observed in different areas of the oviduct and at 
different stages of the cycle. The direction of the fluid flow is not constant, but, as a 
general pattern, the fluid moves from the ampulla towards the abdominal cavity 
(Hunter, 2012), following the path of least resistance. It is worth noting that glucose, 
lactate and pyruvate enter the lumen of the ampulla at higher rates compared to the 
isthmus in the rabbit, most likely due to the larger surface of mucosa bordering the 
lumen of the ampulla (Leese, 1983). 
 
As mentioned above, the oviduct provides the environment where male and female 
gametes combine to create an embryo. The importance of the oviduct in gamete 
activation (Coy et al., 2012) is demonstrated by its important role in the formation of a 
sperm reservoir, which is associated with the maintenance of sperm viability and the 
















1.4. Sperm  
 
Spermatozoa in the epididymis are inactive and become activated when they are mixed 
with seminal plasma (Coy et al., 2012); this state is described as a state of “activated 
motility” (Yanagimachi, 1994). After ejaculation, the sperm begins its journey into the 
female reproductive tract. However, only a very small percentage of the sperm 
produced during ejaculation reaches the site of fertilization ( Coy et al., 2012). 
Movement of the sperm towards the site of fertilization is achieved through the 
combined action of both the spermatozoa and the muscular contractions of the female 
reproductive tract. The spermatozoa that manage to reach the isthmus are often bound 
to the ciliated epithelial cells of the oviduct (Coy et al., 2012), although electron 
microscopy scans have also shown binding to secretory cells (Suarez, 2002).  
 
Sperm cannot fertilise oocytes until they complete a process called capacitation. Sperm 
capacitation was defined by Suarez and Ho as “the process during which the sperm 
attains full fertilizing capacity” (Suarez and Ho, 2003). Sperm capacitation, which occurs 
within the female reproductive tract, is a reversible process, (Johnson, 2007), which is 
associated with removal of a coating of substances from the epididymis and the seminal 
plasma (de Lamirande, Leclerc and Gagnon, 1997). The removal of these substances is 
associated with sperm binding to the oviduct epithelium (de Lamirande, Leclerc and 
Gagnon, 1997). The interaction between the epithelial cells of the oviduct and the 
spermatozoa is possibly performed through interactions between carbohydrate 
residues, mainly glycoproteins localized on the epithelial cells, and proteins localized on 
the sperm head, as loss of proteins of the sperm head has been observed and associated 
with sperm capacitation (Suarez, 2002;). Furthermore, net transfer of sperm cholesterol 
to HDL detected in bovine oviduct fluid has been observed, with a potential to affect 
sperm capacitation (Ehrenwald, Foote and Parks, 1990). Overall, sperm capacitation and 
hyperactivation, as well as release from the oviduct are controlled by the environment 
of the oviduct (Coy et al., 2012), and, according to Fazeli (2011), they are a result of 





The interaction between sperm and oviduct epithelial cells results in the formation of a 
sperm reservoir (Coy et al., 2012), observed across mammalian species (Suarez, 2002). 
The sperm reservoir has multiple functions. On one hand, it enables the prevention of 
polyspermy by releasing only few spermatozoa at a time (Suarez, 2002). Release of the 
sperm from the sperm reservoir can be performed after sperm capacitation and 
hyperactivation (Suarez, 2002), since capacitated spermatozoa lose their binding affinity 
to the epithelial cells (Smith and Yanagimachi, 1991) and hyperactivation assists their 
detachment from the epithelial cell surface (Suarez, 2002). In hamsters, capacitated 
spermatozoa have been found to be released into the lumen of the oviduct, whereas 
non-capacitated spermatozoa remain firmly attached to the ampullary and isthmic 
mucosa (Smith and Yanagimachi, 1991). The activation of the oocyte, after penetration 
of its zona pellucida, results in increasing numbers of activated spermatozoa, which 
approach the oocyte, although polyspermic penetration will not be possible (Hunter, 
2012). After establishment of the block of polyspermy, which prevents the zygote from 
becoming triploid or polyploid (Johnson, 2007) binding of the spermatozoa relaxes and 
they are released from the oviduct epithelium (Hunter, 2012).  
 
On the other hand, the sperm reservoir maintains the fertilization capacity of the sperm, 
until the moment of entry of the oocyte in the oviduct (Suarez, 2002); sperm incubation 
with bovine oviduct epithelial cells has shown increased maintenance of sperm motility 
(Chian, Lapointe and Sirard, 1995). Activation of the spermatozoa hours before 
ovulation would result in their metabolic exhaustion before ovulation (Hunter, 2012). 
After the sperm becomes released from the sperm reservoir, it reaches a state of 
“hyperactivated motility”. This motility pattern can be observed in sperm located in the 
ampulla at fertilization (Suarez and Ho, 2003) and it is characterized by flagellar beating 
showing asymmetry and high amplitude (Coy et al., 2012).  
 
The presence of sperm is associated with alterations in the oviduct fluid viscosity, since 
the oviduct can sense the presence of sperm and increase the levels of antioxidants and 
heat-shock protein-70, to reduce the levels of stress in sperm (Georgiou et al., 2005). 
This increase in protein concentration is associated with an increase in viscosity (Li and 
Winuthayanon, 2017), with the involvement of TRPV4 receptors (Andrade et al., 2005) 
and this, in turn, results in modified patterns of ciliary beating frequency, aiming to 
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enhance sperm movement (Li and Winuthayanon, 2017). In addition, the oviduct 
responds to the presence of sperm via regulation of muscular contractions. These 
contractions are regulated by prostaglandins (PG), as PGE2 and PGF2a increased muscular 
contractions, whereas PGE1 was associated with reduced contractions (Wånggren et al., 
2008). In addition, interstitial Cajal-like cells of the muscle layer of the human oviduct 
express oestrogen and progesterone receptors, suggesting potential regulation of 































Fertilisation is the process in which the sperm, after entering the oviduct through the 
utero-tubal junction and becoming hyperactivated, meets the oocyte, which has also 
entered the oviduct through the infundibulum and is waiting at the ampullary – isthmic 
junction. The spermatozoa that reach the oocyte bind to the zona pellucida (Johnson, 
2007) and they undergo acrosome reaction, which is a process associated with the 
release of proteolytic enzymes from the acrosome of the sperm head, which enables 
sperm to penetrate the glycoprotein coat of the egg (Eisenbach and Giojalas, 2006). In 
particular, the acrosome in the sperm head swells and its plasma membrane fuses with 
the plasma membrane of the oocyte and the contents of the acrosome are released 
through exocytosis (Allen and Green, 1997). The sperm bind to specific proteins on the 
oocyte surface called ZP proteins, ZP2 and ZP3 being more directly involved in binding 
the sperm head (Hinsch and Hinsch, 1999).  
 
After penetration of the zona pellucida, the spermatozoon lies tangentially in the 
perivitelline space, which is located between the oocyte membrane and the zona 
pellucida and the membranes of the sperm and the oocyte fuse (Johnson, 2007). The 
union between sperm and oocyte is accompanied by intracellular calcium (Ca2+) 
oscillations, which are triggered by sperm-specific phospholipase C (PLCζ), localised on 
sperm and contributing to the initiation of embryo development (Saunders et al., 2002). 
The Ca2+ oscillations are linked to the release of the content of cortical granules 
(reviewed by (Coy and Avil, 2010)), which are adjacent to the oocyte membrane, to the 
perivitelline space, a process called the cortical reaction (Johnson, 2007). Release of 
ovastacin, a protein detected in cortical granules before fertilisation, results in cleavage 
of ZP2 (Burkart et al., 2012), which in turn is associated with hardening of the zona and 
establishment of the block of polyspermy (Li and Winuthayanon, 2017). At this stage, 
the male nucleus enters the oocyte to become the male pronucleus , thus successfully 







1.6. The pre-implantation embryo 
 
1.6.1. Pre-implantation embryo development 
After successful fertilisation, early embryo development involves a series of cellular 
divisions, which are called cleavage. These are time-sensitive and species-specific 
(Johnson, 2007). Embryos are characterised as cleavage-stage from the stage of 2-cell 
embryo up to the morula stage. Embryo cell divisions can be synchronous or 
asynchronous (Prados et al., 2012; Brison, Sturmey and Leese, 2014). Each division 
occurs normally at approximately 18-20 hours (Prados et al., 2012). After each division, 
the number of embryo cells, called blastomeres, increases, however the size of each 
blastomere is reduced; consequently, even though cell number increases, the net size 
of the embryo does not (Johnson, 2007). The homogeneity between the blastomeres is 
believed to be driven by the even distribution of the cell components after each division 
(Brison, Sturmey and Leese, 2014).  
 
Around the 8- to 16-cell stage (Johnson, 2007), which is the stage when the embryo will 
enter the uterus in the bovine (Lonergan et al., 2016), the individual blastomeres 
undergo a process called compaction (Brison, Sturmey and Leese, 2014) (Figure 1.10). 
This process results in a change in the blastomere cell shape from spherical to a flat, 
epithelial-like cells (Coticchio et al., 2019) and the formation of a morula stage-embryo 
(Lonergan et al., 2016). During compaction, the blastomeres become tightly connected, 
as demonstrated by movement of the cell-cell junction protein E-cadherin from the cell 
cytoplasm to the cell membranes at that stage (Alikani, 2005) and the detection of tight 
junctions in embryo cells at the morula stage (Gualtieri, Santella and Dale, 1992). As 
reviewed by Coticchio et al (2019), the process of compaction enables the segmentation 
of embryo cell populations into inner and outer cells and the preservation of a spherical 




Figure 1.10.: Preimplantation embryo development. After fertilisation in the ampllary-isthmic junction, the zygote 
undergoes cleavage division, resulting in an increase in the number of blastomeres. Around the 8-to-16 cell stage, 
the embryo undergoes compaction, forming the morula, which will then become a blastocyst. Figure adapted from 
(Schuel, 2006). 
Depending on this cell polarisation, the cells of the morula will then become either the 
inner cell mass (ICM) cells or the trophoblast cells, also called cells of the 
trophoectoderm (TE) (Johnson and McConnell, 2004). It is debated whether the 
allocation of cells which will form one cell population or the other is established at the 
4- to 8-cell stage, or even earlier (Brison, Sturmey and Leese, 2014; White et al., 2018); 
however it is believed that during the transition of 8- to 16-cell embryo, cell positioning 
and cell fate have already been made, but the allocation to a specific lineage is still 
reversible (Coticchio et al., 2019).  
 
In general, there is a level of uncertainty over the mechanisms behind the commitment 
of the inner cells of the morula into cells of the ICM of the blastocyst and the outer cells 
of the morula into the trophoectoderm cells of the blastocyst (Coticchio et al., 2019), 
although an important role in the allocation to the ICM of the TE seems to be played by 
the Hippo signalling pathway, which is a tumour suppressing pathway, originally 
detected in the Drosophila (Xenopoulos, Kang and Hadjantonakis, 2012; Coticchio et al., 
2019). The trophoblast cells of the blastocyst surround the blastocoelic cavity, 
containing blastocoelic fluid as well as the inner cell mass (ICM) cells, which are 
embedded into the wall of the trophoblast (White et al., 2018). Before implantation, the 
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inner cell mass population is subdivided into the cells of the epiblast, which is located in 
the interior of the ICM and the primitive endoderm, which is located in the periphery of 
the ICM and in contact with the blastocyst cavity. The epiblast cells will be the one which 
will provide most of the embryonic tissues, whereas the primitive endoderm and the 
cells of the trophoectoderm will form the extraembryonic tissues (Xenopoulos, Kang and 
Hadjantonakis, 2012; White et al., 2018). 
 
During early cleavage, the embryo relies principally on mRNA that was synthesised in 
the oocytes, but as development progresses, there is a transition from the use of 
maternally-derived mRNA, that is, mRNA stored in the oocyte before fertilisation, to 
embryo-produced mRNA, a process previously described by Jansz and Torres-Padilla as  
“embryonic genome activation” (EGA) (Jansz and Torres-Padilla, 2019). This process 
occurs in the oviduct, at different time points during development in different species. 
For cattle, this is around the 8-to-16 cell stage (reviewed by (Sirard, 2012))Embryonic 
genome activation is a highly regulated process, occurring in a stepwise manner, with 
an initial genome activation occurring at earlier stages, before a major genome 
activation event (Latham, 2001). For humans, Braude et al  reported that the 4-to-8 cell 
stage was the stage after which genomic activity was detected in the embryo (Braude 
P., Bolton V and Moore S., 1988). 
 
Epigenetic modifications 
Epigenetic modifications have been defined by Handy, Castro and Loscalzo (2011) as 
“heritable alterations that are not due to changes in the DNA sequence”; they are 
changes which modify the accessibility of DNA and the structure of chromatin, through 
processes such as histone modifications and DNA methylation or demethylation, thus 
regulating gene expression (Handy, Castro and Loscalzo, 2011). Chromatin is believed to 
be remodelled during EGA; in particular, CpG-rich promoters and chromatin regions 
overlapping with DNA hypomethylated domains are described as “accessible chromatin 
loci” before EGA, and the majority of these become inaccessible after EGA, in a manner 
that is transcription-dependent (Wu et al., 2018). A process of de-methylation and re-
methylation of specific parts of the genome occurs during EGA, which enables the 
removal of epigenetic modifications acquired during gamete maturation and the 
establishment of new methylation patterns in the embryo (Reik, Dean and Walter, 
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2001). Histone modifications are also associated with this process (reviewed by (Wu et 
al., 2018). Conceptus-derived genes are now responsible for RNA and protein synthesis, 
nucleotide and amino acid transport, as well as maturation processes occurring in a 
variety of cell systems, such as the Golgi apparatus and the mitochondria (Johnson, 
2007). 
 
1.6.2.   Pre-implantation embryo metabolism 
Pyruvate is the primary energy substrate consumed by early stage embryos, with 
increasing levels of glucose consumption, as the blastocyst stage approaches (Sturmey, 
Brison and Leese, 2008; Leese, 2012).  Indeed, oxygen consumption is relatively constant 
up to the morula stage, with a sharp increase being observed from the blastocyst stage 
onwards (Houghton et al., 1996; Sturmey and Leese, 2003; Leese, 2012). Glucose 
consumption follows a similar pattern, being undetectable up to the blastocyst stage, 
when it becomes the main substrate consumed by the embryo (Houghton et al., 1996; 
Sturmey and Leese, 2003; Leese, 2012; Guerif et al., 2013).  
 
Bovine and porcine embryos depend on oxidative phosphorylation throughout 
development (Thompson et al., 1996; Sturmey and Leese, 2003). The relationship 
between oxidative phosphorylation and glucose and pyruvate consumption is linear, 
suggesting an increase in consumption of all substrates to accommodate the increasing 
needs for ATP (Thompson et al., 1996). Other substrates, such as amino acids (Sturmey, 
Brison and Leese, 2008; Leese, 2012), fatty acids (R. G. Sturmey et al., 2009) and lactate 
(Leese, 2012) are also used by embryos in all stages to provide the embryo with a variety 
of energy sources to use. In a comprehensive review focusing on pre-implantation 
embryo metabolism, Leese highlights the relatively small body of evidence investigating 
the metabolism of the preimplantation embryo in situ and suggesting a need for further 
research in this field (Leese, 2012).  
 
The importance of the concentrations of energy substrates in the oviduct is 
demonstrated by their impact on embryo development in vitro. In particular, as 
suggested by the Quiet Embryo hypothesis by Leese (2002), the maintenance of low 
levels of embryo metabolism is associated with the achievement of highest embryo 
viability (Leese, 2002). More recently, this hypothesis has been adjusted to reflect the 
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fact that an ideal environment for optimal embryo development is a balanced 
environment, where the energy substrates are available to the embryo within an 
optimal range of concentrations, a concept called the “Goldilocks hypothesis” (Leese et 
al., 2016). In support of this hypothesis, highest embryo viability in the bovine is 
associated with a limited range of pyruvate consumption (Guerif et al., 2013).  
 
Maternal pathophysiology has been previously associated with altered or compromised 
embryo metabolism. Blastocysts produced by overweight and obese women had lower 
glucose consumption rates compared to women of healthy body mass index, as well as 
increased amino acid consumption/production and reduced triglyceride concentration 
in the embryos (Leary, Leese and Sturmey, 2015). In addition, embryo development 
under high NEFA conditions, which is a common symptoms of metabolic disturbances, 
resulted in altered patterns of gene expression related to REDOX maintenance in the 
embryo (Van Hoeck et al., 2013). In both these studies, the authors suggest that the 
observed modified patterns of embryo metabolism are traced back to the ovarian 
environment and its potential effect on oocyte health. Analysis of the follicular fluid of 
obese women is believed to be altered compared to women of healthy BMI (Robker et 


















1.7. Developmental Origins of Health and Disease hypothesis 
 
There is growing evidence that supports the notion that metabolic diseases arise from a 
combination of genetic and environmental factors, as well as epigenetic modifications 
(Rando and Simmons, 2015). The link between developmental events and health in later 
life was most effectively described by David Barker. His original work reported on 
association between adverse foetal environment and the development of 
cardiovascular disease (Barker, 1990, 1997; Barker and Martyn, 1992), however these 
now include a wider range of metabolic conditions. According to the Developmental 
Origins of Health and Disease Hypothesis (DOHaD), a number of diseases and syndromes 
appearing later in life, including type II diabetes and obesity, as well as the risk of 
developing coronary heart disease, are associated with deficiencies in nutrient support 
or with the physiology of the maternal environment during pregnancy (Barker et al., 
2002; Barker, 2004; Fazeli, 2011). This was further explored and it is now known that 
exposure to an adverse or stressful environment during prenatal and early post-natal 
development, could contribute to the development of chronic conditions later in life 
(Martin-Gronert and Ozanne, 2006; Feuer and Rinaudo, 2016). The environment in 
which development occurs appears to be influenced by a variety of factors, including 
the maternal body size and composition, nutritional status and metabolism; these, in 
turn, are affected by the environment at which the maternal organism was exposed as 
a foetus, a child and an adolescent (Martin-Gronert and Ozanne, 2006), as well as the 
lifestyle factors that confer health. Chronic conditions are believed to develop as a result 
of a mismatch between the energy provision during early development and the energy 
provision during the adult life (Feuer and Rinaudo, 2016).  
 
Given the molecular, epigenetic and developmental plasticity of the developing 
preimplantation embryo, this stage represents a particularly sensitive window of 
development.  Exposure of the early embryo to a suboptimal environment during critical 
stages of development can increase the susceptibility of resultant offspring to chronic 
metabolic conditions, including obesity, diabetes and cardiovascular diseases, during 
the adult life (Feuer and Rinaudo, 2016) (Figure 1.11). This is because embryo 
development in an adverse environment can impact on a wide range of processes, 
including cell proliferation and physiology as well as gene expression patterns (Watkins, 
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Papenbrock and Fleming, 2008). It is presumed that the maternal reproductive tract can 
usually buffer the adverse effects of the external environment to some extent (Rando 
and Simmons, 2015); however, a suboptimal uterine environment, such as that which 
might be seen in a diabetic or obese woman, is related to the development of disease in 
the adult life of the offspring (Barker, 2004; Rando and Simmons, 2015), such as type II 
diabetes, coronary heart disease and hypertension (Barker 2004).  
 
 
Figure 1.11: Impact of under- and over-nutrition on offspring health and diseases associated with malnuntrition 
during foetal life. A suboptimal environment in the female reproductive tract, originating from maternal 
overnutrition or undernutrition, which the embryo is exposed to, is associated with higher chance of susceptibility 
to metabolic conditions such as Type 2 diabetes, hypertension and cardiovascular disease (Martin-Gronert and 
Ozanne, 2006) 
 
Maternal undernutrition during pregnancy has been linked to the development of 
metabolic diseases in the adult life of the offspring, despite the buffer of the maternal 
environment (Rando and Simmons, 2015). The adaptations that a developing conceptus 
makes in response to the environment that it encounters during development, are 
intended to prepare the offspring for post-natal conditions that it “predicts” that it will 
encounter. However, disease susceptibility is presumed to be raised when the in utero 
conditions mismatch the post-natal conditions (Tarry-adkins and Ozanne, 2016). A well-
known example in support of this hypothesis is the Dutch Hunger Winter, observed 
during the Nazi-occupied Netherlands in the winter of 1944-1945. During that time, 
previously well-nourished individuals suffered a reduced calorie daily intake of between 
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400 and 800 calories. This was later linked to the appearance of a variety of metabolic 


































1.8. Obesity  
 
According to the World Health Organisation, “overweight and obesity are defined as 
abnormal or excessive fat accumulation that presents a risk to health” (WHO, 
http://www.who.int/topics/obesity/en/). The most widely used measure of obesity is 
Body Mass Index (BMI), which is determined as the ratio of body weight in kg to the 
height in metres squared (WHO, http://www.who.int/topics/obesity/en/). Obesity can 
be distinguished as mild, moderate and severe and it can be influenced by demographic 
characteristics and the sex of the individual (Azziz, 1989). According to the World Health 
Organisation, healthy body mass index (BMI) ranges from 18.5 – 24.99, whereas people 
with a BMI higher than 30.0 are characterised as obese, and people between with a BMI 
between 25.0 and 30.0 are overweight (WHO, 1995). However, BMI does not make the 
distinction between muscle-associated and fat-associated weight, and is not consistent 
across population. Therefore, the waist-to-hip ratio has also been identified as a useful 
tool for the measurement of abdominal fat accumulation, even though population 
restrictions also apply to it. More recently, the World Health Organisation has reported 
that the measurement of waist circumference as a  method of identifying overweight 
patients who are at risk of developing diseases associated with obesity, attributed to 
abdominal fat distribution (World Health Organization, 2000). 
 
Obesity is characterised as a metabolic disorder and has been associated with 
cardiovascular disorders, type II diabetes and cancer (Van Der Steeg et al., 2008). The 
increasing incidence of obesity has led to the definition of the metabolic syndrome. The 
metabolic syndrome is associated with glucose intolerance, insulin resistance, 
abdominal obesity, hypertension and dyslipidaemia (Eckel, Grundy and Zimmet, 2005). 
As reviewed by Stumvoll et al, insulin resistance is defined as the state when insulin 
exerts biological effects inferior to the expected ones, in terms of glucose disposal and 
suppression of glucose production (Stumvoll, Goldstein and Haeften, 2005). In 
abdominal obesity, insulin resistance results in compensatory development of 
hyperinsulinaemia (Brewer and Balen, 2010). Both insulin resistance and 
hyperinsulinaemia have been described to be major driving forces for the development 
of obesity, together with hyperandrogenaemia and disrupted steroidogenesis (Silvestris 




1.8.1. Obesity and fertility 
The relationship between obesity and fertility has been described in multiple studies 
(Metwally, Li and Ledger, 2007; Van Der Steeg et al., 2008; Robker et al., 2009; Lane et 
al., 2015), however it remains unclear which of the symptoms of obesity (ie. high 
adiposity, hyperglycaemia, hyperinsulinaemia) are associated with the poor quality of 
oocytes and consequently with poor embryo development (Lane et al., 2015). Reduced 
fertility in obese women has been attributed to dysregulation of steroidogenesis or 
production of poor quality embryos (Robker et al., 2009). Indeed, the latter has been 
supported by the detection of alterations in the follicular microenvironment of women 
with abnormally high BMI, which shows signs of dyslipidaemia, hyperinsulinaemia and 
inflammatory response (Robker et al., 2009). Obesity is associated with dysregulation of 
the hypothalamic-pituitary-ovarian axis (Silvestris et al., 2018), associated with a healthy 
endocrinological profile (Figure 1.13).  
 
Obesity has risen dramatically in recent decades, which has led to increasing evidence 
that maternal overnutrition during pregnancy, or even before the establishment of 
pregnancy, plays an important role in the development of metabolic diseases, even in 
early childhood (Rando and Simmons, 2015; Tarry-adkins and Ozanne, 2016). An 
obesogenic environment during gestation has been associated with the development of 
many metabolic diseases (Tarry-adkins and Ozanne, 2016), (Figure 1.12). A strong 
predictor of foetal growth is placental weight, which mediates the impact of maternal 
obesity, gestational diabetes and gestational weight gain on foetal growth and birth BMI 
(Ouyang et al., 2013). Balanced foetal and placental growth are associated with low 
rates of perinatal mortality (Matsuda et al., 2018). It is therefore believed that the 
placenta may play an important role in future development of metabolic conditions 
(Ouyang et al., 2013). It has also been reported  that, the higher the offspring weight at 
birth and the lower the parental BMI before puberty, the lower the risk for the offspring 





Figure 1.12: Summary of the impact of obesity on the regulation of the hypothalamic-pituitary-ovarian axis (Brewer 
and Balen, 2010). Obese women present a modified gonadotrophin secretion pattern from the hypothalamus, and 
increase LH secretion from the cells of the pituitary (Brewer and Balen, 2010). High levels of oestrogen are observed 
as a result of increased peripheral androgen aromatisation, as well as hyperandrogenaemia, attributed to insulin 
resistance and resulting hyperinsulinaemia (Silvestris et al., 2018). Leptin, a protein produced by the cells of 
adipose tissue (Broughton and Moley, 2017), is associated with this dysregulation (Brewer and Balen, 2010). Obese 
women have higher circulating levels of leptin than healthy-weight control subjects (Broughton and Moley, 2017) 
(Silvestris et al., 2018). High levels of leptin induce a reduction in oestrogen (Greisen et al., 2000) and progesterone 
(Brannian, Zhao and McElroy, 1999) production by luteinised granulosa cells. In addition, as reviewed by Silvestris 
et al (2018), obese women exhibit a reduction in the levels of sex hormone binding globulin (SHBG), insulin-like-
growth factor binding proteins (IGFBP) and growth hormone (GH) (Silvestris et al., 2018). Furthermore, insulin 
resistance and the consequent hyperinsulinaemia results in reduced levels of SHBG, hyperandrogenaemia and 
deranged insulin-growth factor system, all of which contribute to the development of menstrual and ovulatory 
disturbances (Brewer and Balen, 2010). 
It is now widely acknowledged that embryo development is largely affected by the 
maternal diet just before and at the time of conception, and this is to some extent 
associated with gamete quality (Lane et al., 2015). The exact mechanisms that underlie 
the links between maternal diet and gamete/embryo quality remain unclear, despite 
considerable research. For example, there are increased levels of expression of markers 
of oxidative stress and inflammation in the multiple tissues of obese women, which, in 
turn, can be associated with development of obesity in their offspring (Rando and 
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Simmons, 2015). Pre-gestational maternal obesity is associated higher expression of 
proinflammatory cytokines in the placenta and higher levels of circulating inteleucin-6 
during pregnancy (Roberts et al., 2011). Additionally, experiments in rats have shown 
that exposure of the females to a Western diet, containing high concentrations of 
carbohydrate and fat, before or during pregnancy is associated with the development 
of inflammation and oxidative stress, which in turn result in increased adiposity in the 
offspring, with altered patterns of adipogenic and lipogenic genes. Importantly, addition 
of an antioxidant supplement was associated with reduced adipogenity and normal 
glucose tolerance (Sen and Simmons, 2010).  
 
Obese women need longer to conceive (Jensen et al., 1999; Van Der Steeg et al., 2008; 
Robker et al., 2009) compared to women of normal weight. Obesity in young age or early 
adulthood has also been associated with menstrual problems, such as earlier onset of 
puberty, obese girls having been reported to experience the onset of menses earlier 
(Lash and Armstrong, 2009), as well as high risk of developing hypertension during 
pregnancy and subfertility in adulthood (Lake, Power and Cole, 1997; Lash and 
Armstrong, 2009). Additionally, obese women encounter low contraceptive efficacy, 
potentially associated with the variations observed in the distribution and metabolism 
of steroid hormones (Lash and Armstrong, 2009). Moreover, high BMI is associated with 
impaired success of assisted reproductive technologies (Broughton and Moley, 
2017)(Lash and Armstrong, 2009), obese women requiring higher levels of 
gonadotrophin for ovarian stimulation (Brewer and Balen, 2010).  
 
Obese women also produce a significantly smaller number of oocytes compared to 
overweight women (Robker et al., 2009) and both overweight and obese women 
produce significantly fewer oocytes than women of normal BMI (Leary, Leese and 
Sturmey, 2015). Oocytes from overweight and obese women are smaller than oocytes 
from women with weight within the healthy range and appear less likely to cleave and 
form blastocysts after fertilisation (Leary, Leese and Sturmey, 2015).  
 
There is no clear conclusion on the impact of obesity on successful establishment of 
pregnancy and embryo health and viability. As reviewed by Schulte et al, metabolic 
alterations, such as the ones observed in obesity, are associated with increased rates of 
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miscarriage and overall reduced fertility, by affecting endometrial receptivity (Schulte, 
Tsai and Moley, 2015). A study by Leary et al (2015) suggested that fertilised oocytes of 
obese women reached the morula stage earlier and the blastocysts were smaller and 
contained fewer cells, compared to the control group. Furthermore, the embryos were 
metabolically distinct from the embryos derived from women with normal BMI; they 
consumed lower amounts of glucose, their amino acid profile was altered and their 
triglyceride levels were increased compared to embryos from oocytes of women with 
normal BMI (Leary, Leese and Sturmey, 2015).  
 
On the other hand, a study by Styne-Gross et al (2005) showed that the implantation 
rates, the pregnancy rates and the rates of spontaneous miscarriage of embryos 
produced by fertilisation of the oocytes of women with healthy BMI are not affected by 
the BMI of the recipient. The results of this study highlight the importance of a healthy 
oocyte in achieving successful pregnancy outcomes, regardless of the presence of a 
suboptimal uterine environment (Styne-Gross, Elkind-Hirsch and Scott, 2005). Robker et 
al showed that obese women produced significantly fewer embryos than overweight 
and moderate women; however, the fertilisation rate of the oocytes was similar in all 
BMI groups (Robker et al., 2009). A study by Valckx et al (2012), indicated no association 
between BMI and success rates of IVF / ICSI. However, the number of oocytes collected 
and the total number of embryos produced was significantly lower in obese women 
compared to women with normal BMI (Valckx et al., 2012). Finally, a strong association 
has been reported between maternal hyperglycaemia and the development of 
chromosomal degradation and cell apoptosis at the blastocyst stage (Pampfer, 2000), 
which could be attributed to downregulation of glucose transporter gene expression by 
the blastocyst cells (Moley, Chi and Mueckler, 1998). 
 
These studies indicate a crucial link between maternal metabolic health and early 








1.9. Glucose homeostasis and metabolism  
 
1.9.1. Glucose homeostasis 
Glucose serves as the main energy source for most cell types, especially the brain. 
Glucose is normally derived in the body as a product of digestion and absorption of 
dietary polysaccharides, mainly starch, or disaccharides (mainly sucrose and lactose) or 
it is synthesized in the liver (Ostrowska, Jarczak and Zwierzchowski, 2015). The liver is 
crucial for glucose homeostasis, through glucose release via glycogenolysis or storage 
via glycogenesis (Röder et al., 2016). Glycogen is important for glucose homeostasis in 
mammals (Han et al., 2016). The importance of glucose is associated with its role as an 
energy fuel for biological processes, through its participation in the citric cycle, for the 
generation of ATP, as well as a metabolic intermediate, as  it can be converted into 
glycogen or triacyloglycerols and stored within tissues (Ostrowska, Jarczak and 
Zwierzchowski, 2015).  
 
Blood glucose levels are tightly regulated in the body, for the maintenance of normal 
body function. The maintenance of energy homeostasis in the body, performed by 
regulation of digestion and metabolism of macromolecules, is achieved by the release 
of hormones and digestive enzymes by the pancreas (Röder et al., 2016). Digestive 
enzymes are secreted by the exocrine or acinar cells (Röder et al., 2016), through the 
pancreatic ducts and into the duodenum (Chandra and Liddle, 2009). The acinar cells 
comprise approximately 75% to 90% of the pancreas. The cells of the pancreatic ducts 
secrete ions and fluid which deacidify the gastric fluid entering the duodenum (Chandra 
and Liddle, 2009). Finally, pancreatic hormones are released directly into the circulation. 
The endocrine cells form clusters called the islets of Langerhans, localised among the 
exocrine cells and comprise only 1% to 2% of the pancreas (Röder et al., 2016). The islets 
consist mainly of: alpha cells, which produce the hormone glucagon, beta cells, secreting 
insulin, amylin and C-peptide, delta cells, releasing somatostatin and PP cells or gamma 
cells, producing pancreatic polypeptide ((Röder et al., 2016), also reviewed by (Chandra 
and Liddle, 2009)). 
 
It has been long established that normoglycaemia is established through the balance 
between glucagon production by the alpha cells and insulin production by the beta cells 
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of the pancreas. In cases of high blood levels of glucose, the beta cells secrete insulin 
and the alpha cells reduce glucagon production, while in low glucose, glucagon is 
released from the alpha cells (Göke, 2008). Additionally, under the action of glucagon or 
insulin, glycogenolysis or glycogenesis, respectively, is performed in the liver (Röder et 
al., 2016). This regulatory mechanism ensures that glucose levels are maintained 
between 4 and 6mM in humans (Röder et al., 2016).  
 
It is well known that diabetes occurs from an imbalance created between glucagon and 
insulin secretion by the pancreatic cells (Unger and Orci, 1975). Type I diabetes is an 
autoimmune condition, which is characterised by destruction of the beta-cells of the 
pancreas. Its pathogenesis is mainly genetic, although an environmental component 
contributing to the disease cannot be excluded, even though it is still unknown 
(Gillespie, 2006). Patients with Type 1 diabetes have an obligatory requirement for 
insulin. On the other hand, type II diabetes is mainly associated with lifestyle, especially 
overweight and obesity, whereas genetic influence is secondary. Similar to type I 
diabetes, type II diabetes occurs as a result of beta cell dysfunction (Stumvoll, Goldstein 
and Haeften, 2005; Göke, 2008), combined with insulin resistance (Göke, 2008). In 
diabetic patients, beta cells have reduced mass, a fact which triggers the remaining beta 
cells to increase insulin secretion as a compensatory mechanism (Stumvoll, Goldstein 
and Haeften, 2005; Göke, 2008). Increasing levels of glucose observed in the circulation 
will result in beta-cell dysfunction due to glucose toxicity (Stumvoll, Goldstein and 
Haeften, 2005). Insulin levels will eventually decrease, therefore resulting in a surge in 
glucose levels (Göke, 2008). An association between type II diabetes and obesity has 
been established (Stumvoll, Goldstein and Haeften, 2005). 
 
1.9.2. Glucose metabolism 
Cell membranes are impermeable to glucose (Nishimoto et al., 2006; Zhang et al., 2012), 
therefore, its entry into cells is performed with two different mechanisms (Ostrowska, 
Jarczak and Zwierzchowski, 2015): facilitated transport, performed by glucose 
transporters (GLUT), which carry glucose molecules without consuming energy, using 
facilitated diffusion across the cell membrane (Gould and Holman, 1993; Ostrowska, 
Jarczak and Zwierzchowski, 2015; Dupont and Scaramuzzi, 2016), and SGLT transporters, 
which actively transport glucose molecules, a process requiring energy consumption 
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(Ostrowska, Jarczak and Zwierzchowski, 2015). GLUT proteins are coded by SLC2A genes 
(Ostrowska, Jarczak and Zwierzchowski, 2015). Once inside the cell, glucose can be 
metabolised through several different pathways, namely glycolysis, glycogen synthesis, 
the pentose phosphate pathway and the hexosamine pathway, the first step of all being 
the conversion of glucose to glucose 6-phosphate, mediated by hexokinase (Dupont and 
Scaramuzzi, 2016). These are summarised on Figure 1.13. 
 
Figure 1.13.: Different pathways of glucose metabolism (figure by (DeBerardinis and Chandel, 2016)). Glycolysis 
can be divided in three stages: (1) Conversion of glucose to fructose 1,6-biphosphate (2) Conversion of fructose 1,6-
biphosphate to two three-carbon interconvertible molecules, dihydroxyacetone phosphate (DHAP) and 
glyceraldehyde 3-phosphate (GAP), and (3) Oxidation of these molecules to pyruvate, with the formation of 2 ATP 
molecules (Berg, Tymoczko and Stryer, 2002c), (Stryer, 1995). Pyruvate may be converted to ethanol, which has 
been observed in the yeast, it may be reduced to lactate by NADH, which is catalysed by lactate dehydrogenase, or 
it may progress to the citric acid cycle, also called the TCA cycle. This latter process generates the highest amounts 
of energy compared with the other two. Conversion of pyruvate to acetyl CoA initiates the TCA cycle, which will 
generate electron carriers which will be fed to the electron transport chain, where oxidative phosphorylation 
occurs (Berg, Tymoczko and Stryer, 2002c). The NADH and FADH2 created through fatty acid oxidation, which is not 
described here, glycolysis, and the citric acid cycle contain electrons which are used to create ATP through the 
process of oxidative phosphorylation, a process occurring in the mitochondria, and containing a series of 
transformations collectively called cellular respiration. The electrons from NADH or FADH2 flow to the electron 
transport chain, in the inner mitochondrial membrane, by electron carriers, and the resulting pH gradient created 
by the uneven proton distribution leads to the creation of a proton-moving force. Proton flow back to the 
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mitochondrial matrix results in ATP synthesis (Berg, Tymoczko and Stryer, 2002d). The pentose phosphate pathway 
results in the synthesis of ribose 5-phosphate from glucose 6-phoshate and the production of ATP. This pathway is 
associated with the synthesis of fatty acids, cholesterol, neurotransmitters and nucleotides (Berg, Tymoczko and 
Stryer, 2002f). Lipid synthesis is largely dependent on intermediate products of the glycolytic pathway. The 
conversion of glyceraldehyde 3-phosphate to dihydroxyacetone phosphate (Berg, Tymoczko and Stryer, 2002c) and 
the subsequent reduction of this to glycerol 3-phosphate are the initial step for this conversion (Berg, Tymoczko 
and Stryer, 2002e). Citrate, a component of the TCA cycle is also an important regulator of fatty acid synthesis, by 
regulation of the acetyl-CoA carboxylase (Berg, Tymoczko and Stryer, 2002a). Finally, a variety of amino acids, such 
as serine, glutamine, glycine and cysteine are synthesised by intermediates of the glycolysis pathway and the citric 
acid cycle (Berg, Tymoczko and Stryer, 2002b) 
 
Glycolysis is a sequence of reactions which involves the conversion of glucose into 
pyruvate and the generation of small amounts of ATP. In the presence of oxygen, the 
resulting pyruvate is subsequently oxidised to CO2 and H2O in the mitochondria, 
whereas when oxygen is limited, glucose conversion to lactate is the only pathway 
(Stryer, 1995; Berg, Tymoczko and Stryer, 2002c).  
 
Another pathway of glucose metabolism, commonly encountered in diabetes, is the 
polyol pathway (Figure 1.14), which includes the conversion of glucose to sorbitol which 
in turn may be converted into fructose. Increased sorbitol concentrations are associated 
with increased levels of osmotic stress, which may eventually be associated with cell 
damage (Singh Grewal et al., 2015). 
 
Figure 1.14: Polyol pathway, consisting of glucose conversion to sorbitol and then fructose, observed usually in 
diabetic complications. Sorbitol accumulation is associated with osmotic stress, electrolyte imbalance, membrane 






1.9.3. Glucose in reproductive tissues 
High levels of glucose have detrimental effects later in foetal development (Greene et 
al., 1989), (Tarry-adkins and Ozanne, 2016); for example, glucose is known to cross the 
placental barrier, whereas insulin does not, and the combination of these two events 
leads to macrosomia in the embryo (Tarry-adkins and Ozanne, 2016), which is a high 
birth weight, defined by the American College of Obstetricians and Gynaecologists as  
“over 4000 grams or of 4500 grams irrespective of gestational age (Ng et al., 2010). High 
levels of glucose also delay embryonic stem cell (ESC) differentiation to neuronal cell 
types, thus impairing normal development of the nervous system in the embryo (Yang 
et al., 2016). However, the impact of high levels of glucose on early embryo 
development, from the zygote to the blastocyst stage, remains largely unknown (Yang 
et al., 2016). 
 
Glucose has been implicated in ovarian follicular development, dominant follicle 
maturation and ovulation and formation of corpus luteum (Zhang et al., 2012; Dupont 
and Scaramuzzi, 2016). Glucose transporters are present in ovarian tissues, their 
expression varying in different species, dependent on the hormonal levels in the follicle. 
So far, the evidence on the impact of intrafollicular glucose on follicle size and status is 
inconclusive (Dupont and Scaramuzzi, 2016). Although glucose transporters, as well as 
insulin receptor, are expressed in ovarian tissues, they are not believed to be associated 
with fertility; their ablation resulted in healthy, fertile females (Dupont and Scaramuzzi, 
2016). In the bovine, both GLUT1 and GLUT3 transport glucose in the follicle, ovary and 
corpus luteum, among others. GLUT3 has a high affinity for glucose, whereas GLUT1 is a 
common glucose transporter across blood barriers (Ostrowska, Jarczak and 
Zwierzchowski, 2015). Hormonal changes are known to affect glucose uptake in the 
ovary, by modifying GLUT1 and GLUT3 mRNA expression (Dupont and Scaramuzzi, 
2016).  
 
As reviewed by Dupont and Scaramuzzi (2016), GLUT4 is associated with insulin-
stimulated glucose uptake (Ostrowska, Jarczak and Zwierzchowski, 2015; Dupont and 
Scaramuzzi, 2016), whereas GLUT1 is a transporter which is insulin-independent 
(Ostrowska, Jarczak and Zwierzchowski, 2015). GLUT1, 3 and 4 are expressed in different 
stages of ovarian tissue, but GLUT4 is preferentially expressed in fat, heart and muscle. 
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Gene expression of glucose transporters in the follicles appears to vary according to the 
cell type; although GLUT1 has similar levels of expression between granulosa and theca 
cells, the former express higher levels of GLUT3 and lower levels of GLUT4 than the 
latter. Additionally, the expression of GLUT1 and 3 in follicles is comparable to their 
expression in other tissues (heart, brain, muscle), indicating their importance in this 
tissue, whereas GLUT4 has a very low expression compared to its expression in the 
muscle. During the luteal phase of the cycle, there is a decrease in the expression of 
GLUT1 and an increase in the expression of GLUT3, whereas the pattern of GLUT4 
expression was similar to that of progesterone. Finally, the concentration of glucose in 
the follicular fluid had a significant negative correlation with the expression of GLUT1 
and GLUT3 mRNA (Nishimoto et al., 2006). 
 
Glucose transporters have also been identified in the uterus (Frolova and Moley, 2011a). 
The uterine endometrium expresses glucose transporters 1,3,4 and 8. GLUT1 was the 
first transporter to be identified in the endometrium (Frolova and Moley, 2011a), and is 
the most abundant (Frolova and Moley, 2011b) with a role in progression of early 
pregnancy (Frolova and Moley, 2011a), as well as the process of endometrial 
decidualisation (Frolova and Moley, 2011b). Decidualisation is the process of 
morphological and functional adaptation of the endometrial stroma, with a crucial role 
in the successful establishment of pregnancy (Okada, Tsuzuki and Murata, 2018). GLUT3 
has also been identified in the uterus, although it has been studied much less than 
GLUT1. Similar to GLUT1, GLUT3 is expressed in the stromal cells and the decidua of the 
uterus and has an important role in stromal cell decidualisation, as well as during 
pregnancy (Frolova and Moley, 2011a). GLUT1, 3 and 4 have been detected in the 
uterine tissue of rats; in particular, GLUT1 staining increased in decidual cells with 
progression of decidualisation, whereas GLUT3 and 4 were detected throughout rat 
pregnancy in the uterus, with the exception of the endometrial glands and the smooth 
muscle cells of the uterus (Türkay Korgun et al., 2001). GLUT4 expression in the uterus 
is believed to be quite low, resulting in contradictory results in different studies (Frolova 
and Moley, 2011a). Finally, GLUT8 is believed to be involved in endometrial 




Tadokoro et al (1995) have reported the expression of glucose transporter 1 in the 
ampulla and the isthmus of the rat oviduct (Tadokoro et al., 1995). Additionally, a study 
by Kuchiiwa et al  demonstrated the expression of Glut1 and Glut3 in rat oviduct 
secretory epithelial cells (Kuchiiwa et al., 2011) and glucose transporters have been 
identified in the uterotubal junction in the bat (Roy and Krishna, 2013). In humans, high 
levels of GLUT1 expression have been detected in adenocarcinomas in the fallopian tube 
epithelium, compared to benign tissues (Kalir et al., 2005). However, research in glucose 
transporters in the oviduct remains limited. 
 
A study by Moley et al (1998) in mouse embryos showed that gene and protein 
expression of glucose transporters was affected by the glucose content of the 
environment in embryos at different stages of development. Specifically, SLC2A1 
expression was downregulated in diabetic mouse embryos compared to control mouse 
embryos at 48 and at 96 hours post-hCG administration, whereas SLC2A2 and SLC2A3 
expression was significantly higher in control mouse embryos compared to diabetic 
mouse embryos 96 hours after hCG administration. This reduction in glucose transporter 
gene and protein expression could have been associated with the reduced viability 
observed at the blastocyst stage in diabetic rats. However, it is worth noting that glucose 
transporter regulation is cell type – specific and  has to be determined for every system 
studied (Moley, Chi and Mueckler, 1998). 
 
Evidence focusing on the impact of insulin on the oviduct epithelium is limited. A study 
by Takeuchi et al showed no impact of insulin addition on the growth of human fallopian 
tube epithelial cells in culture (Takeuchi et al., 1991). Additionally, insulin receptors were 
not identified in the oviduct epithelial cells of the water buffalo, even though they were 
expressed in the early embryo and the blastocyst  stage embryo (Daliri et al., 1999). The 
impact of moderate concentrations of basal insulin supplementation on BOECs grown in 
air-liquid interface has been previously found to be beneficial for the morphology of the 
oviduct epithelium (Palma-Vera, Einspanier and Schoen, 2014). 
 
 




1.10. Hypothesis and Aims 
 
Based on the evidence that currently exists, it is reasonable to assume a link between 
hyperglycaemia and obesity. Barker’s hypothesis has highlighted an important link 
between an adverse environment during pregnancy and the development of metabolic 
abnormalities during puberty and adulthood (Barker, 2004) and research has 
demonstrated these may be traced back to the ovarian stage follicle. However, very little 
is known with regards to whether these adverse conditions affect the environment 
where the pre-implantation embryo spends the first few days of development, as well 
as embryo growth and metabolism. 
 
Therefore, this thesis sets out to test the hypothesis that abnormally high levels of 
glucose are associated with modified oviduct epithelial cell secretions, which may affect 
preimplantation embryo development. In order to test this hypothesis, the thesis had 
the following aims: 
 
1) To confirm and explore further the in vitro model of the bovine oviduct, 
previously established in the laboratory. 
2) To determine the impact of high glucose levels in the presence or absence of 
insulin on oviduct epithelial cells grown according to the above model, in terms of the 
composition of cell secretions and patterns of gene expression. 
3) To determine the impact of the modified embryo environment characterised in 





















2.1. Bovine Oviduct Epithelial Cell collection and maintenance 
 
2.1.1. Tissue harvest and Bovine Oviduct Epithelial cell seeding 
Bovine reproductive tracts at mixed stages of the oestrous cycle were harvested from a 
local abattoir, and transported to the laboratory approximately an hour after slaughter. 
Tracts were immersed in “Transport Buffer”, which comprised of HBSS (+phenol red, -
CaCl2, –MgCl2), 10mM HEPES and 1μM aprotinin from bovine lung, which inhibits the 
action of proteases by blocking their binding sites (Sigma-Aldrich). The animals from 
which tissue was dissected were 18-24 months old, usually after their first calving. 
 
Isolation of Bovine Oviduct Epithelial Cell (BOEC) population was performed as 
described by (Simintiras et al., 2016). The connective tissue surrounding the oviducts 
was dissected and the oviducts were immersed in HBSS. Oviduct cells were mechanically 
removed into HBSS, by gentle palpation of the isolated oviduct to free the epithelial 
cells, and centrifuged twice at 630xg for 5 minutes, in order to wash the cells. The cells 
were next re-suspended in 10mL BOEC cell culture medium (Table 2.1) and a cell count 
was performed with the use of a haemocytometer. Cell viability was assessed using a 
Trypan Blue exclusion test; cells with an intact cell membrane do not take up Trypan 
Blue. 2x106cells are seeded in T75 flasks in a final volume of 10ml of BOEC cell culture 
medium. 2x106cells are seeded in T75 flasks and they were incubated at 39oC, 5% CO2.  
 




DMEM 500mL N/A 
Nutrient Mix F12 500mL N/A 
Pen/Strep 26.5mL 239.2u/mL Pen/ 239.2 µg/mL Strep 
Amphotericin B 20mL 4.51μg/mL 
L-Glutamine 10mL 1.8mM 
Newborn Calf Serum (NCS) 25.5mL 2.3% v/v 
Fetal Bovine Serum (FBS) 25.5mL 2.3% v/v 
Bovine Serum Albumin (BSA) 7.5g 0.68% w/v 
 
After 18 hours of incubation, BOECs were isolated based on their different adhesion 
times, as described by (Cronin et al., 2012). This is based on the observation that 
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fibroblasts adhere to plastic cell culture vessels faster than epithelial cells; thus, after 
18h the majority of fibroblasts in the cell suspension are adhered, whereas the epithelia 
remain in suspension.  The purity of the epithelial cells was confirmed using fluorescent 
immunohistochemistry and haematoxylin and eosin staining, as described in sections 
2.3 and 2.4. 
 
Isolated BOECs were seeded in TranswellsTM, at cell density of 1x106 cells per Transwell 
(Figure 2.1). The cells were maintained by basal and apical supply of medium, to a final 
volume of 2mL in each chamber.  
a) b) 
Figure 2.15: a) Transwell plate used for growing Bovine Oviduct Epithelial Cells in a polarised epithelium. Picture 
from the Cole-Palmer website. b) Schematic diagram of a single Transwell. The bovine oviduct epithelial cell 
monolayer, growing on a semi-permeable transport, is indicated. Media is applied to the apical and basal side of 
the cells during cell growth (pink colour). Figure modified from (Simintiras et al., 2016). 
 
2.1.2. Cell maintenance 
 BOECs had their media replenished 24h after the first seeding and every 48 hours after 
that. Only primary BOEC cultures were used for the experiments described in this thesis, 
as passaging bovine oviduct epithelial cells in culture has been reported to impact on 
the expression of selected genes, specifically coding for mucins (MUC1, MUC4, MUC16), 
proteins associated with cell metabolism (GAPDH, SDHA, HK1), as well as OVGP1 gene 
expression and release, and IL8 release (Danesh Mesgaran et al., 2016).  
 
Attainment of an electrically integral confluent epithelial monolayer was determined by 
measuring the TransEpithelial Electrical Resistance (TEER), which is a useful measure for 
determining the creation of a barrier of cells growing on filter support (Chen, Einspanier 
and Schoen, 2015). Cell electrical resistance was measured using an EVOM 
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Voltohmmetre, connected to an STX2 electrode set (EVOM). Resistance measurements 
were performed by immersing the electrodes into the apical and basal chambers of the 
transwell inserts. The resistance of the medium was between 12Ω and 15Ω and the 
resistance of a blank transwell, containing only medium, was on average 130Ω. The 
surface areas of a Transwell and a Snapwell were 4.67cm2 and 1.12cm2 respectively. The 





Attainment of a TEER above a threshold value of  >700 Ωcm2  indicated the formation of 
an electrochemically confluent cell monolayer (Simintiras and Sturmey, 2017). 
 
2.2. Confirmation of cell identity  
The presence of the epithelial cell-specific surface protein Cytokeratin-18 (CK18) was 
used to confirm the identity of the cells isolated.  BOECs were seeded on glass coverslips, 
that had been pre-coated with 0.1mg/mL poly-L-lysine in double-distilled water (ddH2O) 
and left to air dry for 10 minutes, in order to enhance cell attachment to the coverslips 
(Sigma-Aldrich, 2008). BOECs were then cultured on the glass coverslips for 6 days in 
culture medium. Then, the cells were fixed stained with the antibody for against 
Cytokeratin-18 (Applied Biosystems), using appropriate controls.  
 
Cytokeratin-18 staining was performed follows. Unless stated otherwise, the cells were 
washed with PBS before each step. BOECs were fixed in 4% (w/v) paraformaldehyde PFA 
in PBS for 30 minutes, and then permeabilised with 0.25% v/v Triton X-100 in PBS for 10 
minutes. This was followed by incubation with 1%BSA/ 10% normal goat serum/ 0.3M 
glycine in 0.1% PBS-Tween for 1 hour, to block non-specific binding, as suggested by the 
manufacturer. Following this, the cells were incubated with the anti-Cytokeratin-18 
mouse primary antibody (Applied Biosystems, ab82254, diluted 1:100, or 1% BSA in 0.1% 
PBS-Tween (primary antibody control) at 4oC overnight. The following day, the cells were 
washed in PBS and incubated with goat anti-mouse, FITC-conjugated secondary 
antibody (Applied Biosystems, ab6785, dilution 1:3000 in blocking buffer) or with 
blocking buffer (secondary antibody control) for 1 hour in the dark. The coverslips were 
TEER = (resistance of cells in the transwell-(resistance of blank transwell–medium resistance)) 
*surface area  
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then incubated with anti-fade DAPI stain for 15 minutes and mounted on coverslides 
before observation under a Zeiss LSM 710 confocal microscope, using the ZEN2010 B 
software.  
 
2.3. Haematoxylin and Eosin (H&E) staining 
Haematoxylin and Eosin staining was performed using the following protocol to confirm 
successful isolation of epithelial cells of the oviduct. BOECs were seeded on coverslips 
at a density of 2x105cells/ml that had been pre-coated with poly-L-Lysine, as described 
in section 2.2. The cells were washed with PBS and fixed with 4% (w/v) PFA in PBS for 15 
minutes. After being washed for a second time with PBS, they were incubated with 
Hematoxylin Solution which had been filtered before use, for 3 minutes and then rinsed 
with distilled water. The slides were next incubated in 1% eosin for 3 minutes and 
washed 3 times in distilled water, for 1 minute each time. The slides were mounted using 
Hydromount and observed on a bright-field microscope (x20 magnification). 
Haematoxylin stained the BOEC nuclei dark purple, whereas eosin stained the BOEC 
cytoplasm pink. Post-acquisition image was modified to increase contrast for 
presentation purposes. 
 
2.4. Transmission Electron Microscopy 
In order to show the formation of an epithelial cell monolayer by BOECs in culture, 
Transmission Electron Microscopy (TEM) was performed on BOECs grown to confluence. 
The experiment was performed with microscopy facility technical assistance. Briefly, the 
day before the cells were ready for the experiment, a resin block was prepared and 
allowed to harden for 48 hours at 60oC. On the day of the experiment, the cells were 
fixed in glutaraldehyde in cacodylate buffer for 1 hour at room temperature. The cells 
were then washed twice for 5 minutes in cacodylate buffer and this was followed by 
fixation at 4 degrees for 1 hour in 1% Osmium tetra-oxide in cacodylate buffer. After 
washing the cells again twice in cacodylate buffer, they were incubated in 1% uranyl 
acetate for an hour, and then in increasing ethanol concentrations (30%, 50%, 70%, 90%, 
100%, 100%) for 10 minutes each. The cells were incubated in 1:1 ethanol:resin for 60 
minutes and then overnight in resin. The following day, the cells were incubated in fresh 
resin for 3 hours and then new resin was made and further incubated of 3 hours. Then, 
the cells were embedded onto a hardened resin block using fresh epon/araldite, for 72 
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hours at 60oC. After three days, they were removed from the oven and allowed to stand 
for 48 hours at room temperature. Once the resin was cured, a hacksaw was used to cut 
the block into smaller pieces and 70nm sections were cut with the use of glass knives 
using a Leica UC6 Ultramicrotome. Sections were collected onto carbon-coated copper 
grids and allowed to dry. Finally, images were obtained using a Gatan Ultrascan 4000 
camera attached to a Jeol 2010 Transmission Electron Microscope running at 120kV. 
 
2.5. Fluorescein rejection assay of epithelial monolayer integrity 
A fluorescein rejection assay was used to confirm the establishment of a physical intact 
epithelial monolayer of BOECs and validate the use of TEER as a non-invasive 
measurement of the epithelial barrier integrity. Fluorescein is a non-permeable dye of a 
molecular weight of 332.31g/mol and so is unable to cross an intact epithelial 
monolayer. Fluorescein was used at a concentration of 200 µM (Simintiras, 2016). BOECs 
were grown to confluence, determined by attainment of a TEER>700Ω.cm2 and then 
they were incubated in Krebs-Ringer buffer (Table 2.2), for 30 minutes, at 39oC, 5%CO2. 
 
Table 2.2: Composition of Krebs - Ringer buffer 
 Component Amount 
Stock 1: NaCl 6.896 g  
KCl 0.353 g  
KH2PO4 0.161 g  
MgSO4.7H20 0.291 g  
Stock 2: NaHCO3 2.092 g dissolved in 100mL ddH2O 
Stock 3: CaCl2.H2O 0.187 g dissolved in 100mL ddH2O 
 
Final medium: Stock 1 10mL 
 Stock 2 10mL 
Glucose 0.1g 
ddH2O 70mL 
Stock 3 10mL 
 
Fluorescein transport from the basal to apical compartment and vice versa was 
determined. Fluorescein was added to the receiving chamber and 50μl samples, 
collected at 30-minute time intervals for a total of 240 minutes, from both the apical 




and basal compartments. Samples were plated in a 96-well PCR plate. Every time a 
sample was collected, the TEER was also measured. The collected samples were then 
used to determine fluorescence in the basal and apical compartments, using a BMG 
plate reader, at excitation/emission of 485nm/520nm respectively.  
 
At 210 minutes of incubation, EDTA was added. EDTA is known to chelate the Ca++ in the 
tight junctions between the cells in the monolayer (Noach et al., 1993) and disrupt the 
barrier properties. This served as a positive control for fluorescein transport. 
 
2.6. In vitro model of the oviduct 
When BOECs cultured on Transwells had reached a TEER >700 ohms, the medium from 
the apical compartment was aspirated, but not replaced, and the cells were incubated 
in moist air at 39oC, 5% CO2. After 24 hours, a thin film of fluid, which had formed at the 
apical compartment, was collected. The fluid volume was measured using a Gilson’s 
pipette and the sample was stored at -20oC for short-term storage or at -80oC for long 
term storage. This fluid was termed in vitro Derived Oviduct Fluid (ivDOF) (Simintiras et 
al., 2016). 
 
2.7. Metabolic assays 
The quantification of energy substrates in ivDOF and spent culture media was 
determined using microfluorometric assays based on those developed by (Leese and 
Barton, 1984) and the principles of Lowry (Lowry et al., 1951).  These assays work by 
coupling the enzymatic conversion of NADH to NAD to substrate-level reactions and 
measuring the resulting change in fluorescence. 
 
The glucose assay is based on the conversion of glucose to glucose-6-phosphate, a 
reaction facilitated by hexokinase. Glucose-6-phosphate is then converted to 6-
phosphogluconate through the activity of G6PD, and during this reaction, NADP+ is 
reduced to NADPH. Consequently, the higher the levels of glucose which are present in 
the solution, the higher the levels of fluorescence produced (Figure 2.2). The 
fluorescence was detected using a plate reader fitted with excitation and emission filters 





Glucose Glucose 6-phosphate      6-phosphogluconate                    
      ATP                NADP+ 
      ADP             NADPH 
 
Figure 2.2: Glucose conversion to glucose-6-phosphate and then to 6-phosphogluconate. This reaction results in 
the production of NADPH, which produces fluorescence that can be detected by a plate reader. 
 
The principle behind the lactate assay relies on the conversion of lactate to pyruvate, a 
reaction catalysed by LDH, during which NAD+ is reduced to NADH. Consequently, the 
higher the levels of lactate which are present in the solution, the higher the levels of 
fluorescence produced (Figure 2.3). The fluorescence was detected at 
excitation/emission of 355nm /460nm, using the BMG plate reader. 
 
 
Lactate + NAD+   Pyruvate + NADH 
 
Figure 2.3: Conversion of lactate conversion to pyruvate, during which NAD+ is converted to NADH, which produces 
fluorescence that can be detected by the BMG plate reader. 
 
The pyruvate assay works on the on the conversion of pyruvate to lactate, a reaction 
catalysed by LDH, during which NADH is oxidised to NAD+. Consequently, the higher the 
levels of pyruvate which are present in the solution, the lower the levels of fluorescence 
produced (Figure 2.4). The fluorescence was detected at excitation/emission of 355nm 
/460nm, using the BMG plate reader. 
 
 
Pyruvate + NADH    Lactate + NAD+ 
 
Figure 2.4: Conversion of pyruvate to lactate, during which NADH is oxidised to NAD+. The more the NADH that 








2.7.1. Glucose assay 
The quantification of glucose present in ivDOF and basal culture media, as well as in 
spent media from embryo culture, was carried out using the method described by 
(Guerif et al., 2013). Briefly, 1 µL of sample was added to 9 µL of glucose cocktail, 
consisting of 0.42mM Dithiothreitol, 3.08mM magnesium sulphate, 1.3mM NADP, 
0.45mM ATP and 20 IU/ml Hexokinase/G-6-P, all dissolved in EPPS buffer at pH=8.0. The 
solution was aliquoted and stored in -20oC for a maximum of three months. The 
concentrations of the samples were determined against a standard curve 0-1mM (Figure 
2.5). Any standard curve with an R2<0.98 was rejected and the respective samples run 
with it were excluded. All samples were analysed in triplicates. 
 
 
Figure 2.5: Example of standard curve used for glucose assays 
 
2.7.2. Lactate assay 
The measurement of the amount of lactate was performed according to (Guerif et al., 
2013). Briefly, 1 µL of sample was added to 9 µL of lactate cocktail; this consisted of 
glycine buffer (which in turn included 4mM glycine, 1.6mM hydrazine sulphate, 0.02mM 
EDTA, all made up to a pH of 9.4), 4.8mM NAD and 40 IU/ml Lactate dehydrogenase 
(LDH). The solution was aliquoted and stored in -20oC for up to three months. The 
concentrations of the samples were determined against a standard curve 0-2.50mM 
(Figure 2.6). Any standard curve that yielded an R2<0.98 was rejected and the respective 






Figure 2.6: Example of standard curve used for lactate assays. 
 
2.7.3. Pyruvate assay 
Pyruvate determination was performed according to Guerif et al 2013 (Guerif et al., 
2013). Briefly, 1 µL of sample was added to 9 µL of pyruvate cocktail; this included EPPS, 
NADH Disodium salt, LDH and sodium hydroxide. The solution was aliquoted and stored 
in -20oC for up to three months. The concentrations of the samples were determined 
against a standard curve 0-0.45mM (Figure 2.7). Any standard curve with an R2<0.98 was 
rejected and the respective samples run with it were excluded. All samples were 
analysed in triplicate. 
 
Figure 2.7.: Example of standard curve used for pyruvate assays. 
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2.8. High-Performance Liquid Chromatography 
Reverse Phase – High Performance Liquid Chromatography (RP-HPLC) was used to 
determine the amino acid composition of the fluid collected and the basal media. Using 
RP-HPLC, 17 amino acids could be detected: aspartic acid, asparagine, serine, histidine, 
glutamine, glycine, threonine, arginine, alanine, tyrosine, tryptophan, methionine, 
valine, phenylalanine, isoleucine, leucine and lysine (Figure 2.8). 
 
Figure 2.8: Amino acid detection with the use of HPLC. The peaks correspond to different amino acids, which are 
indicated above the respective peaks. 
 
The method of amino acid detection was performed as previously described (Houghton 
et al., 2002)(Partridge and Leese, 1996) (Humpherson, Leese and Sturmey, 2005), which 
separates amino acids on the basis of size and hydrophobicity. Briefly, mixtures 
containing the amino acids underwent pre-column derivatisation with O-
phthaldialdehyde (OPA), supplemented with 1mg/ml 2-mercaptoethanol, which 
resulted in the formation of amino acid conjugates with OPA. This step labels the amino 
acids to generate a fluorescent signal, detectable at 450nm, which may be detected by 
a fluorescence detector attached to the HPLC system.  Derivatisation and sample loading 
was performed using an Autosampling Injecting Unit connected to the HPLC system. 
Following derivatisation, samples were injected onto a HyperClone™ 5 µm ODS (C18) 
250 x 4.6 mm column (Phenomenex, UK). Individual amino acids were eluted from the 
column using a gradient method comprising two buffers: Buffer A (80% 83mM sodium 
84 
 
acetate : 19.5% methanol : 0.5% tetrahydrofuran) and Buffer B (80% methanol : 20% 
83mM sodium acetate), both at pH 5.9.  
 
Chromatography was performed at a flow rate of 1.3ml/min A gradient of Buffer A to 
Buffer B was applied throughout the sample run: The system ran at 1.3mL/min buffer A 
for the first 9.5 minutes of the run. Then, the proportion of Buffer B gradually increased 
to 14%, where it remained stable for 5 minutes. Over the course of the next 7 minutes, 
the proportion of buffer B gradually increased to reach 50%, and remained stable at this 
for 3 minutes. Following this, the proportion of buffer B increased for the next 13 
minutes, until it reached 100%, where it remained stable for 6 minutes. Finally, the 
proportion of Buffer B was brought back to 0%. Due to the different proportions of 
Buffers A and B, the organic phase of the solvent increased and the aqueous phase 
decreased, thus resulting in the different retention times of the amino acids. The buffer 
gradient ensured amino acid separation at different retention times, based on the 
interaction with the solid phase of the column. The concentration of each amino acid 
was quantified according to the area under the curve (AUC) and compared to those 
given by validated standard samples (Sigma, AAS18) of known concentrations (12.5uM) 
(Figure 2.9). Prior to loading samples, the efficiency of the method was tested, by 
running standard samples and measuring the coefficient of variation (standard deviation 
of peak area /mean peak area); any coefficient of variation below 5% was considered 
acceptable. 




















































































































































































































































































1 0 0 0
1 5 0 0
b) 
Figure 2.9: Example of amino acid separation of amino acid standard samples as detected using the HPLC. The 




2.9. RNA extraction 
RNA was extracted from cells grown in Transwells immediately after ivDOF collection. 
BOEC cells were detached from the Transwell membrane using Trypsin, applied on the 
cells for 15 minutes. The trypsin was inactivated by adding of cell culture medium, which 
contains FBS and can de-activate trypsin. The detached cells were centrifuged at 630xg 
for 5 minutes and then washed twice in Hank’s Balanced Salt Solution at 13,000xg, 4oC 
for 6 minutes. Following this, 1ml of Trizol and 200μl chloroform were added and the 
samples mixed and incubated at room temperature for 20 minutes. These were then 
centrifuged at 12,000xg for 10 minutes, at 4oC, to achieve phase separation: the top, 
aqueous layer contained the RNA, the interphase and the bottom, organic layer contain 
the DNA and proteins (Rio et al., 2010). The aqueous phase was then removed and 
precipitated with isopropanol prior to storage in -20oC (minimum time 20 minutes, 
maximum 6 months).  
 
Following isopropanol precipitation, the samples were centrifuged at 12,000xg, 4oC for 
40 minutes, and the pellet was resuspended in 70% (v/v) EtOH in ddH2O and centrifuged 
at 12,000xg, at 4oC for 10 minutes. Then, any residual organic solution was removed by 
pulse centrifugation and air-drying of the samples for 10 minutes. Finally, the RNA was 
re-suspended in 50μl of ddH2O. The concentration and the purity of the RNA isolated 
was assessed using the ratio of A260/A280, which is indicative of protein contamination of 
the sample. The absorbance was measured using a Nanodrop spectrophotometer and 
samples of known concentration and purity were immediately stored at -80oC. 
 
2.10. Complementary DNA (cDNA) synthesis 
cDNA libraries were generated from the extracted RNA using the High Capacity cDNA 
Reverse Transcription Kit (ThermoFisher Scientific, 4368814). The RNA was diluted with 
water, so that all samples contained 11.1 ng/μl of RNA, and to a final volume of 10μl. A 
master mix (Table 2.3) containing necessary components for cDNA synthesis was 







Table 2.3: Master mix prepared for cDNA synthesis 
Component Volume (ul) Final concentration in master 
mix 
10xRT buffer 2 1x 
25xdNTP mix (100mM) 0.8 8mM 
10xRT random primers 2 1x 
MultiScribeTM Reverse Transcriptase 1  5 U/μl  
ddH2O H2O 4.2 n/a 
Total volume 10  
 
The master mix was then mixed with the diluted RNA, the samples were gently mixed 
loaded onto an Applied Biosystems 2720 Thermal Cycler for cDNA synthesis. The 
conditions are described in Table 2.4. cDNA samples were stored at -20oC for short term 
use or at -80oC for long term storage. 
 
Table 2.4.: Thermocycler conditions for cDNA synthesis. 
 Step 1 Step 2 Step 3 Step 4 
Temperature (oC) 25 37 85 4 
Time 10 min 120 min 5 min ∞ 
 
2.11. Polymerase Chain Reaction – agarose gel electrophoresis 
 
2.11.1. Primer design 
Forward and reverse primer design was carried out using the PrimerBlast tool by 
Pubmed (https://www.ncbi.nlm.nih.gov/tools/primer-blast/), for genes encoding for β-
actin, OVGP1, ERα, ERβ, PR, GLUT1, GLUT3 and INS-R. Primers for the RPL19 reference 
gene had been previously designed in the laboratory and were therefore not re-
designed. The primer sequences were designed to match the exon sequences of the 
target genes only, and for this purpose, the cds sequence was used, where introns are 
excluded. The PCR target product sizes were set to a maximum of 250bp, although 
100bp was considered as the optimal. The ideal CG content was 50% and each primer 
was aimed to contain 20 nucleotides. Where possible, the primers were designed to 
span exon-exon junctions and the melting temperature (Tm) was set between 58oC and 
62oC, with optimal Tm of 60oC. The resulting primers were tested using PrimerBlast for 




2.11.2. Optimal annealing temperature  
 
Polymerase Chain Reaction was performed using the Platinum Taq DNA polymerase kit 
(Invitrogen, 10966018), in order to amplify target sequences using the specificity of the 
primers designed according to section 2.11.1 and used for qRT-PCR. The cDNA 
synthesized previously was used and a master mix was prepared as described in Table 
2.5: 
Table 2.5: PCR master mix for determining optimal annealing temperature. 
Component Volume per PCR reaction Final concentrations 
10x reaction buffer – MgCl2 5 1x 
50mM MgCl2 1.5 1.5 mM 
10mM dNTPs 1 200μM 
10μM Forward Primer 1 200 nM 
10μM Reverse Primer 1 200 nM 
Taq polymerase 0.25 2U/reaction 
cDNA (25ng/μl) 1 0.5 ng/μl 
ddH2O 39.25 - 
Total volume 50  
 
In order to delineate the optimal primer-cDNA annealing conditions, a temperature 
gradient was applied to determine the optimal annealing temperature, which was set to 
annealing temperatures of 70oC, 68.9oC, 67.1oC, 64.4oC, 60.9oC, 59.5oC, 56.4oC and 55oC, 
by adjusting the thermocycler to apply all the above temperatures in different wells of 
the thermocycler within the same run. The thermocycler conditions were set as 
described in Table 2.6. 
Table 2.6: Thermocycler conditions for PCR reactions. 
STEP TEMP (oC) Time 
Initial denaturation 94 3 minutes 
Annealing (x50 cycles) 
94 45 seconds 
gradient of Tann 30 seconds 
72 90 seconds 
Final extension 72 10 minutes 
Hold 4 forever 
 
A 50x stock solution of Tris-Acetic Acid- EDTA (TAE) buffer was made by mixing 24.2g of 
Tris, 5.71ml of glacial acetic acid and 10mL of 0.5M EDTA (pH=8.0), to a final volume of 
100mL and the solution was stored at room temperature. The PCR products were then 
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loaded on a 2% agarose gel in TAE buffer. with the addition of 10000x SYBRSafe DNA 
staining dye. TAE buffer was made up at a 50x concentration, by mixing 24.2g Tris, 10ml 
of 0.5M EDTA, pH=8.0 and 5.71mL glacial acetic acid. Loading dye, which makes the 
cDNA solutions more visible during loading, was used to load the buffers to the agarose 
gel and a 50bp ladder was used to determine the size of the products. Samples were run 
at 100V for approximately 1 hour. The DNA bands were then observed using a 
VersaDocTM (BioRad) Molecular Imager, using the VersaDoc software. 
 
For all genes, the optimal annealing temperature was determined to be 60oC. 
Additionally, all gene expression experiments were performed according to the MIQE 
guidelines (Bustin et al., 2009). 
 
 
2.11.3. Optimal primer concentration 
The optimal primer concentration was determined with the use of qRT-PCR. Serial 
dilutions of primer concentrations were assessed, ranging from 200nM to 12.5nM. Cycle 
threshold (Ct) values were assessed, which describe the number of cycles which are 
required for the fluorescence produced by the PCR reaction to cross the background 
level. The expected outcome of this experiment was higher Ct values for lower primer 
concentrations. The optimal primer concentration was the one where the Ct values 
produced during qRT-PCR were the same as those of the immediately higher primer 
concentration; this suggested that the minimum amount of primer that would give 





Figure 2.10: Representative amplification plot for the determination of the optimal primer concentration. 200μΜ 
and 100μΜ primer concentrations appear to produce the same Ct values; therefore, 100μM primer concentration 
is considered to be optimal. 
 
The master mix used for this experiment is described in Table 2.7: 
Table 2.7: Master mix for qRT-PCR reactions for house-validated genes. 
Component Volume (μl) 
2xSYBR Green master mix  12.5 
Forward and Reverse primer mix 4 
ddH2O 7.5 
cDNA (25ng per reaction) 1 
Final volume 25 
 
For this experiment, the thermocycler conditions used were as described in Table 2.8, 
as previously validated in the lab to be optimal for BOEC gene expression experiments: 
Table 2.8: Thermocycler conditions for qRT-PCR for house-validated genes. 
STEP TEMP (oC) Time 
Initial denaturation 94 5 minutes 
Annealing (x55 cycles) 
94 30 seconds 
60 45 seconds 
72 45 seconds 
Melting curve 
95 15 seconds 
60 1 minute 




2.11.4. qRT-PCR efficiency 
When primers bind to the target sequence efficiently and exclusively, they produce two 
copies of the target sequence for every cycle of PCR. Such an instance would be 
described as 100% efficiency. Any efficiency less than 90% suggests that the primers lack 
specificity to the target and so do not amplify the product as efficiently as they are 
expected to, i.e. they produce less than 2 copies of the DNA template per cycle. 
Extremely high efficiency, on the other hand, suggests that the primers bind and amplify 
efficiently multiple target sequences, beyond the target sequence, thus making it 
impossible to determine the amplification of the target template. 
 
The efficiency of the qRT-PCR reaction was determined by assessing the ability of the 
primers to produce two copies of the target gene in each cycle, with the use of serial 
dilutions of the cDNA template (Figure 13). The annealing temperature and the primer 
concentrations were used as determined from the previous experiments (Sections 
2.11.2, 2.11.3). The master mix used for this experiment was the same as for primer 
concentration validation (Table 2.7, section 2.11.3), modified accordingly during 
optimisation to fit higher cDNA concentrations. The amounts of cDNA tested were 25ng, 
12.5ng, 6.25ng, 3.125ng and 1.5625ng per PCR reaction, corresponding to 1ng/μl, 0.5 
ng/μl, 0.25 ng/μl, 0.125 ng/μl, 0.0625 ng/μl per reaction. The thermocycler conditions 
are described in Table 2.8. and a representation of the expected amplification plots is 





Figure 2.11: Representative amplification plot of serial cDNA dilutions. Decreasing amount of cDNA added to the 
qRT-PCR reaction resulted in an increase in the Ct value. 
 
The Ct values were plotted against the log of the cDNA concentration, in order to 
determine the efficiency of the PCR reaction. The efficiency of the PCR reaction is 
calculated using the following formula: 
 
Efficiency = 10(-1/slope)-1 
 
Based on the above calculation, a slope of -3.315 suggests optimal efficiency, which is 
equal to 1 (100% efficiency), but any efficiency values between 90% and 110% were 
considered acceptable. Example of an efficiency curve can be found on Figure 2.12.  
 
Figure 2.12.: Example of efficiency curve, plotted as Ct values against log [cDNA]. The slope is -3.4249, suggesting 
an efficiency of 95.88%. Therefore, this primer pair was considered acceptable for use in gene expression 
experiments. 




















Accordingly, primers encoding for β-Actin, GLUT1 and ER-α and were used on the basis 
that they met inclusion criteria on the basis of efficiency (Table 2.10) and primers for 
RPL19 had, as mentioned, been previously designed in the laboratory. Primers for the 
remaining genes of interest had either extremely high or extremely low efficiency curves 
and therefore pre-validated primers were purchased (PrimerDesign Ltd), designed 
against cDNA libraries extracted from BOECs. The primer concentrations used for 
internally validated and externally designed primers are shown in Tables 2.9 and 2.10 
respectively.  
Table 2.9: Primer sequences for house-validated primers. 
Primer name Primer Sequence 
RPL19 Forward GAAAGGCAGGCATATGGGTA 
RPL19 Reverse TCATCCTCCTCATCCAGGTT 
b-actin Forward AGATCAAGATCATCGCGCCC 
b-actin Reverse TAACGCAGCTAACAGTCCGC 
SLC2A1 Forward TAACCGCAACGAGGAGAACC 
SLC2A1 Reverse AGAAAACAGCGTTGATGCCG 
ESR1 Forward TGGCCATTCATTCGCTCACT 
ESR1 Reverse CCTGGAATCCCTTTGGCTGT 
 
Table 2.10: Primer sequences for externally validated primers. 
Primer name Primer Sequence 
INSR Forward CAACGAGGCTTCGGTCATGA 
INSR Reverse GGAACGGAGGTAACTCTTCAGG 
OVGP1 Forward GGACCAGCATCTCCAGGGAA 
OVGP1 Reverse CGCTCTCCGGACAAAGCAG 
SLC2A3 Forward CTCGGTTGCTACCATAGGCTC 
SLC2A3 Reverse GCTCTTCCAAAGTGTAATTGAGAAAG 
 
For the genes which were externally validated, the master mix prepared and the 
thermocycler conditions are shown in Tables 2.11 and 2.12: 
Table 2.11: Master mix for externally validated primers. 
Component Volume (μl) 
Precision®PLUS qPCR Master Mix  10  
Primer/Probe mix  1  
Template (25ng)  5  
RNase/DNase free water  4  




Table 2.12: Thermocycler conditions for qRT-PCR for externally-validated primers. 
STEP TEMP (oC) Time 
Initial denaturation 95 2 minutes 
Annealing (x40 cycles) 
95 10 seconds 
60 60 seconds 
  
Melting curve 
95 15 seconds 
60 1 minute 
95 15 seconds 
 
 
The results of the qRT-PCR were exported and analysed. The threshold was adjusted to 
fit the linear part of the amplification curve and the ROX internal standard was 
confirmed to be stable throughout the assay for all the genes involved.  
 
The Ct values of the two reference genes (RPL19 and beta-actin) were averaged. For 
each sample and each gene, this average was subtracted from the Ct value of that gene, 
producing the ΔCt value. The ΔCt value from a sample which was determined as the 
control was then subtracted from the different ΔCt values of the test samples, producing 
a ΔΔCt value. The 2-ΔΔCt value was then calculated, which represents the fold change. 
This was set to 1 for the control samples and the respective fold changes were calculated 
for the target samples. These values were then assessed statistically. 
 
2.12. Measuring ion flow across an epithelial monolayer 
 
In order to determine the integrity of the epithelial monolayer in a dynamic manner, an 
Epithelial Voltage/Current Clamp (World Precision Instruments) system was used. This 
system can measure the potential difference between the apical and basal 
compartment of the epithelial cells and present the values in millivolts. The membrane 
potential is then modified and temporarily set to a specific value, which in this case was 
zero, so that the ion flux from the basal to the apical compartment can be measured. 




The voltage clamp was used to compare the ionic flux from apical and basal 
compartments through the epithelial cell monolayer, in response to different 
treatments. Cells were grown on SnapwellsTM permeable membranes which have been 
shown previously to have the same selective transportation properties as Transwells. 
BOECs were grown on Snapwells at a density of 0.5x106 cells/ml. Since EVOM 
voltohmmetre is not suitable for measuring cell resistance in Snapwells, the cells were 
grown for 7 days, same as the cells grown on Transwells, and then they were used for 
the voltage clamp experiments. For the acute hyperglycaemia experiments, the cells 
were cultured under normal glucose conditions, with differing treatments applied 
during the voltage clamp. For the chronic hyperglycaemia experiment, the cells were 
grown under treatment conditions and then the respective treatments were added on 
the basal side. 
 
The voltage clamp experiment briefly consisted of detaching the Snapwells and placing 
into an Ussing chamber. The chamber was sealed and Krebs Ringer buffer, prepared as 
described in section 2.5 and pre-warmed at 39oC and at 5% CO2, was added in both 
chambers. The chambers were also gassed with 95% O2 /5% CO2 and maintained at 37oC. 
The voltage was measured using of electrodes enclosed within glass rods in both the 
apical and basal compartment. The voltage was then clamped and the current was 
measured. Treatments were then added and the voltage and current were measured 
again. Finally, at the end of the experiment, ATP was added as a positive control, which 





Figure 2.13: Example of ATP control positive reaction using the voltage clamp. The voltage is increased and the 
current is decreased. 
 
2.13. In vitro embryo production 
 
2.13.1. Stocks for oocyte maturation, fertilisation and embryo production 
 
A series of stock solutions were necessary to enable the production of culture media for 
oocyte and embryo culture.  Epidermal Growth Factor (EGF) stock was prepared by 
dissolution of the contents of the EGF stock vial in 20ml of maturation medium (see 
below for maturation medium components). Fibroblast Growth Factor (FGF) stock was 
made by addition of 0.4ml maturation medium to each of two vials. Once prepared, the 
EGF and FGF stocks were mixed in the ratio 4ml stock EGF : 185μl stock FGF and stored 
at –20oC, for final concentrations of 0.4μg/ml EGF and 2.2ng/ml FGF. FSH: LH stock was 
made up by addition of 7.5ml M199 (1x) to 1 Menopur/Merional vial, to give a final 
concentration of 0.01 IU FSH, 0.01 IU LH. GlutaMAX was aliquoted into 1ml aliquoted 
and was stored at 5oC. M199 (10x) was stored at 5oC and gentamycin was added to it at 
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the opening of a new bottle. Mineral oil (M1840) was stored at 5oC. Finally, maturation 
additives were prepared as described in Table 2.13 and stored at -20oC. 
 






Embryo-tested water 24ml 
Glutamax II 1ml 
 
Stock B was prepared as per Table 2.14. The osmolarity was measured to be 430 and 
stock B was stored for 2 weeks at +5oC. 
Table 2.14: Stock B 
Chemical MW Concentration g/20ml 
NaHCO3 84.01 230mM 0.42 
 
Stock BSA fatty-acid free was prepared as per Table 2.15. It was stored for 6 weeks at 
+5oC. 
Table 2.15.: Stock BSA-fatty-acid free. 
Chemical Concentration Content/10ml 
BSA fatty acid free 20% w/v 2g 
 
Stock H was prepared as per Table 2.16. The osmolarity was measured to be 375 and 
stock H was stored for 6 weeks at +5oC. 
Table 2.16.: Stock H 
Chemical MW Concentration Content/50m
l 
Hepes free acid 238.30 126mM 1.5000g 




Heparin stock was prepared as per Table 2.17. The stock was stored for up to 3 months 
at -20oC. 




Stock K was prepared as per Table 2.18. The osmolarity was measured to be 105 and 
stock K was stored for 6 weeks at +5oC. 
 
Table 2.18.: Stock K 
Chemical MW Concentration Content/10ml 
Kanamycin Sulphate 382.60 130mM 0.5g 
 
Stock C was prepared as per Table 2.19. The osmolarity was measured to be 060 and 
stock Cwas stored for 2 weeks at +5oC. 
 
Table 2.19.: Stock C 
Chemical MW Concentration g/10ml 
Sodium Pyruvate 110.04 327mM 0.036 
 
Stock D was prepared as per Table 2.20. The osmolarity was measured to be 405 and 
stock D was stored for 6 weeks at +5oC. 
Table 2.20.: Stock D 
Chemical MW Concentration g/10ml 
CaCl2.2H2O 147.01 171mM 0.252 
 
Stock L was prepared as per Table 2.21. It was stored for 6 weeks at +5oC. 
Table 2.21.: Stock L 
Chemical Concentration Components 
Na Lactate Syrup 4.7% v/v 0.47ml 




Stock M was prepared as per Table 2.22. The osmolarity was measured to be 120 and 
stock M was stored for 6 weeks at +5oC.  
Table 2.22.: Stock M 
Chemical MW Concentration g/10ml 
MgCl2.6H2O 203.30 49mM 0.1 
 
Percoll additives were prepared as per Table 2.23, they were aliquoted and stored for 
up to three months at -20oC. 








Hepes Free Acid 0.2384 
Hepes Na+ Salt 0.2602 
Na Lactate Syrup 0.74 
 
SPTL solution was prepared as per Table 2.24, it was aliquoted and stored for up to three 











Table 2.24.: SPTL solution 
Component Conc (mM) Amount 
H2O - 50.15ml 
NaCl 100 0.292g 
KCl 3.78 0.014g 
NaH2PO4 0.38 0.003g 
Gentamycin 0.6% 0.313ml 
Hepes-Free acid 5.28 0.0745g 
Hepes-Na Salt 6.24 0.0814g 
Na-Lactate 0.42% 0.2313ml 
CaCl2.2H2O 1.67 0.0123g 
MgCl2.2H2O 0.32 0.0032g 
Phenol Red 0.5% 0.25ml 
 
TL solution was prepared as per Table 2.25 and it was stored for 6 weeks at 5oC. 
Table 2.25.: TL solution (10x) 
Chemical MW Concentration g/50ml 
NaCl 58.44 1.141mM 3.333 
KCl 74.55 32mM 0.119 
NaH2PO4.2H2O 119.98 5mM 0.031 
Gentamycin - 5% v/v 2.5ml 
 
Stock G was prepared as per Table 2.26. The osmolarity was measured to be 060mOsm 
and stock G was stored for 6 weeks at +5oC. 
Table 2.26.: Stock G 
Chemical MW Concentration g/10ml 






Stock GLN was prepared as per Table 2.27. The osmolarity was measured to be 003 and 
stock GLN was stored for 2 weeks at +5oC. 
Table 2.27.: Stock GLN 
Chemical MW Concentration Content/10m
l 
L-Glutamine 146.14 20mM 0.0146g 
 
Stock S2 was prepared as per Table 2.28 and it was stored for 6 weeks at +5oC. 
Table 2.28.: Stock S2 
Chemical MW Concentration g/50ml 
NaCl 58.44 1.077M 3.147 
KCl 74.55 143mM 0.534 
KH2PO4 136.09 12mM 0.081 
 
2.13.2. In vitro oocyte maturation 
 
2.13.2.1. Solution preparation before tissue arrival 
Ovaries were transported in warmed PBS supplemented with 1:2000 Antibiotic-
Antimycotic solution. During ovary transit to the laboratory, oocyte holding media was 
prepared as outlined in Table 2.29. 
Table 2.29.: Holding media. 
Sterile water 80ml 
















BSA Fr V 0.2ml 
Bovine maturation media (BMM) was also prepared as per Table 2.30. The solution was 










Table 2.30.: Bovine maturation media (BMM) 
Sterile water 8ml 

















Maturation additives 0.222ml 
FCS (optional) 1ml 
 
The osmolarity of these media was measured to be between 270 and 300 mOsm and 
they were filter-sterilised. Following that, 50ml of holding media were removed into a 
separate 50ml tube and 0.2ml of heparin were added. Both holding media tubes were 
pre-warmed at 37oC for at least 2 hours. 
 
Wash dishes and in vitro maturation dishes were prepared by adding 400μl BMM into 
each of the four wells of a dish. Water (3ml) with antibiotic/antimycotic (30μl) was 
added to the intermediate space between the wells in order to minimise evaporation. 
The dishes were incubated at 5% CO2 at 39oC for at least 2 hours before it was required 
to allow equilibration.  
 
2.13.2.2. Tissue collection and in vitro maturation 
Ovaries were harvested from 18- to 24-month old animals, and were transported to the 
lab approximately an hour after slaughter in phosphate buffer saline (PBS). The ovaries 
were rinsed first with water at 35oC, and then twice in pre-warmed 
PBS+antibiotic/antimycotic, before being immersed into the same solution.  Ovarian 
follicles between 2-8mm in diameter were punctured with a 18G needle fitted to a 
syringe and the contents aspirated into holding medium supplemented with heparin. 
The follicular aspirate was added to a 50ml falcon tube and allowed to sediment at 37oC 
for a minimum of 20 minutes. The supernatant was removed and discarded and the 
sedimented oocytes were resuspended in holding medium without heparin. These were 
then placed onto a 12cm petri dish with a grid scored on the underside and oocytes were 
selected under a stereomicroscope fitted with a heated stage set at 37oC. When the 
number of follicles allowed it, only oocytes with at least two layers of cumulus cells were 
selected. These were then washed twice more in holding medium and then washed 
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three times in maturation medium at which they allowed to mature for 24 hours (39oC, 
5% CO2).  
 
2.13.3. Fertilisation media preparation 
HEPES TALP and FERT TALP solutions were prepared as per Tables 2.31 and 2.32: 









































Table 2.32.: FERT TALP solution 







































The pH of FERT TALP was adjusted to 7.2 and the osmolarity of both solutions was 
measured to be between 270 and 290 mOsm, with care taken to ensure the osmolarity 
of the two differed by less than 10mOsm. Similar to BMM preparation, wash dishes and 
fertilisation dishes were prepared by placing 400μl of FERT TALP into each of the wells 
and also water in the space between them to prevent evaporation. These were placed 






2.13.4. In vitro fertilisation 
On the day following oocyte isolation, sperm was prepared for in vitro fertilisation. The 
sperm was thawed from liquid nitrogen in warm distilled water before being layered on 
top of discontinuous Percoll gradient for the separation of motile from immotile sperm 
and the retention of motile spermatozoa. The Percoll gradient consisting of a 45% 
Percoll solution was layered on top of a 90% Percoll solution (Byeong-Seon Jeong, 2001). 
Percoll gradient was prepared as per Table 2.33. 
 
Table 2.33.: Percoll gradient preparation 
90% Percoll 45% Percoll 
4.5ml Percoll 2.0ml 90% Percoll 
600µl Percoll additives 2.0ml 1x SPTL 
 
After centrifugation, the supernatant was removed and the pelleted sperm was 
resuspended in 4ml of HEPES TALP solution, followed by another centrifugation at 
1200rpm, for 5 minutes. The pelleted sperm was resuspended in 200μl of FERT TALP and 
a sperm count was performed using an Improved Neubauer haemocytometer.  
 
Whilst sperm was being prepared, matured oocytes were washed three times through 
FERT TALP medium before being placed into IVF droplets of the same medium. Sperm 
was added at a final concentration of 0.5x106 sperm/ml and the gametes co-incubated 













2.13.5. In vitro embryo culture solutions preparation 
HEPES synthetic oviduct fluid (SOF) was prepared as per Table 2.34 
Table 2.34.: HEPES SOF 














































Based on the glucose, lactate, pyruvate and amino acid concentrations detected in 
ivDOF (Chapter 4), the modified SOFaaBSA was prepared as per Table 2.35. 
 
Table 2.35.: Synthetic oviduct fluid for group embryo culture. All units are in μl. 
 7.3mM 8.5mM 11mM+I 11mM-I control 
Water (μl) 3779.53 4930.37 4281.32 2920.70 5590.00 
Stock S2 1000.00 1000.00 1000.00 1000.00 1000.00 
Stock B 1000.00 1000.00 1000.00 1000.00 1000.00 
Stock C 169.02 90.06 90.37 146.16 100.00 
Stock D 100.00 100.00 100.00 100.00 100.00 
Stock L 137.41 143.53 160.04 150.83 100.00 
Stock M 100.00 100.00 100.00 100.00 100.00 
Stock G 601.65 167.89 604.24 1486.37 250.00 
Stock GLN 1452.39 808.15 1004.03 1435.93 1000.00 
Tyrosine stock (10x) 1000.00 1000.00 1000.00 1000.00  
Amino acids non ess 200.00 
 
200.00  200.00  200.00  
100.00 
Amino acids ess 200.00 
Pen Strep 60.00 60.00 60.00 60.00 60.00 
Stock BSA 400.00 400.00 400.00 400.00 400.00 
The pH of all media was adjusted to 7.2 and media were aliquoted and stored at -20oC 
for a maximum period of 3 months. HEPES TALP was made up fresh and SOFaaBSA were 






Finally, the individual culture stock, used for metabolic analyses, was produced as 
follows (Table 2.36): 
 
Table 2.36.: Synthetic oviduct fluid for individual embryo culture 
  7.3mM 8.5mM 11mM 11mM-I control 
Water to 100ml to 100ml to 100ml to 100ml to 100ml 
NaCl (g) 0.629 0.629 0.629 0.629 0.629 
KCl (g) 0.053 0.053 0.053 0.053 0.053 
KH2PO4 (g) 0.016 0.016 0.016 0.016 0.016 
NaHCO3 (g) 0.21 0.21 0.21 0.21 0.21 
Glucose (g) 0.065 0.018 0.065 0.16 0.009 
Glutamine (g) 0.021219 0.011807 0.014669 0.020979 0.0029 
Pyruvate (ml) 6.141145 3.272044 3.283314 5.310658 0.0035g 
CaCl2.2H2O (g) 0.025 0.025 0.025 0.025 0.025 
MgCl12.H2O (g) 0.01 0.01 0.01 0.01 0.01 
Pen/Strep (mL) 0.5995 0.5995 0.5995 0.5995 0.5995 
amino acids (mL) 2 2 2 2 2 
BSA (g) 0.799 0.799 0.799 0.799 0.799 
Stock L (μl) 1374.089 1435.261 1600.424 1508.31  - 
Tyrosine stock (10x) 
(mL) 10 10 10 10  - 
 
For the four different treatments, a 9mM stock of pyruvate was made up. Stock L was 
also added, even though it was not present in the control group. 
 
For both the group embryo culture and the individual embryo culture experiments, the 
solutions were placed in embryo tested petri-dishes and were incubated at 39oC, 5% CO2 
for at least 2 hours before time for embryo culture. 
 
 
2.13.6. In vitro embryo culture  
After approximately 20-22h post fertilisation, presumptive embryos were selected and 
vortexed in HEPES SOF to remove cumulus cells and dead spermatozoa. The zygotes 
were then transferred into SOF medium and cultured in groups between 15 and 23 
embryos for 6 days at 39oC in 5% CO2/5%O2/90%N2. The rate of cleavage was assessed 
visually on day 2 of individual culture and the embryos were cultured. Blastocyst rates 




In order to determine the impact of the modified culture media on embryo metabolism 
at the cleavage stage, the embryos were vortexed and transferred immediately into 
individual culture in 4μl droplets of the individual culture medium for 20-25 hours. The 
time that the embryos were moved into and out of individual culture was monitored. 
Additionally, embryos on day 7 of group culture were transferred into individual culture, 
for 20-25 hours. The time that the embryos were moved into and out of individual 
culture was monitored. After embryo removal from the individual culture droplets, the 
dishes containing the droplets were sealed and stored immediately in -80oC for further 
metabolic analyses (Sections 2.7,2.8). 
 
2.14. Statistical analysis 
Statistical tests performed for each experiment are analysed in the respective chapter’s 




































3.1.1. Use of cattle as a model for studying the oviduct 
The importance of studying the reproductive system in the cow arises mainly from its 
commercial roles in the production of milk and meat for consumption. The past 40 years 
have seen a dramatic improvement in dairy cow performance in terms of milk yield 
(Oltenacu and Broom, 2010). However, this has corresponded with a decline in the 
reproductive efficiency of the dairy cows, attributed mainly to high levels of stress, a 
drop in appetite and poor metabolic health (Leroy et al., 2014). 
 
Beyond the importance of herd fertility for commercial agriculture, the cow provides a 
useful model for studying reproductive processes in general (Harper et al., 2012). Cows, 
similar to humans, ovulate a single oocyte which, following fertilisation, produces an 
embryo of comparable size between the two species. Embryonic Genome Activation 
occurs in similar developmental stages and the cow and human and a similar proportion 
of embryos progress to form blastocysts. Finally, their pattern of energy metabolism is 
also similar (Baumann et al., 2007).  
 
As a consequence, there are many studies that have exploited the use of bovine tissue 
in reproductive biology (Ellington et al., 1990; Hugentobler, Morris, et al., 2007; 
Hugentobler et al., 2008; Palma-Vera, Einspanier and Schoen, 2014; Marey et al., 2016). 
The bovine has similarities in genome structure (Elsik, Tellam and Worley, 2009) and 
embryonic development (Ménézo and Hérubel, 2002) to the human, and bovine tissue 
is relatively easy to obtain from local abattoirs, where meat goes to the food chain and 
the reproductive tracts would otherwise be disposed of. Additionally, co-culture of 
human sperm with bovine oviduct epithelium has been found to induce similar 
improvement in sperm function to the one described for the human oviduct epithelium 
(Ellington et al., 1998).  
  
3.1.2. Bovine Oviduct Epithelial Cells 
The oviduct is a tubular structure (Leese, 1988), lined with epithelial cells 
(Winuthayanon et al., 2015), which form a single cell monolayer (Clyman, 1966; 
Winuthayanon et al., 2015). The oviduct epithelial cells can be either secretory or 
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ciliated (Joshi, 1995), the former being involved in the secretion of oviduct fluid (Leese, 
1988), and the latter in gamete and embryo transport (Comer, Leese and Southgate, 
1998). Epithelial cells are joined together by tight junctions giving rise to a confluent 
layer (Furuse et al., 1993), the formation of which can be followed by measuring 
TransEpithelial Electrical Resistance (TEER) (Chen, Einspanier and Schoen, 2015). 
 
3.1.3. Use of Transwells as a system mimicking the in vivo environment 
Traditionally, cells tend to be cultured in flasks, as a cell culture flask is inexpensive, 
disposable, requires no cleaning or sterilization, and allows approximately 107 cells to 
be cultured in an adherent manner (Sigma-Aldrich, no date b). However, such an 
arrangement does not mimic the in vivo architecture of epithelial tissues such as the 
oviduct, which, as described in section 3.1.2, consists of a monolayer of cells connected 
to each other with tight junctions (Furuse et al., 1993) forming a polarised layer (Walter, 
1995). In the whole animal, the basal side is in contact with a layer of stroma and 
capillaries and the apical side is exposed to the oviduct lumen (Clyman, 1966). To mimic 
this arrangement in culture, the Transwell system is increasingly being used (Walter, 
1995; Gualtieri et al., 2013; Simintiras et al., 2016), as has been previously established 
for a variety of cell types (Pascoe et al., 1996; Watanabe et al., 2013). In the case of the 
oviduct, Simintiras et al used a transwell arrangement to study hormone transportation 




Figure 3.1.: In vitro model of the oviduct. (Simintiras et al., 2016) 
 
For the purposes of the present experiments, as described in Materials and methods 
(Section 2.1), the cells were physically removed from the bovine oviduct (Simintiras et 
al., 2016). This method was preferred to enzymatic epithelial cell removal, which is a 
commonly used technique for primary cell isolation, but there is the risk of alterations 
in fragile structures, such as cilia, from the enzyme activity, due to their larger surface 
area (Ulbrich et al., 2010).  
 
Potential markers of epithelial cell function 
 
In previous work (Simintiras et al., 2016), Simintiras et al used, among others, the 
following markers to characterise their model of bovine oviduct epithelial cells in vitro: 
(i) Amino acids: The importance of studying the impact of long-term culture 
in the amino acid composition of spent media derives from the important role of the 
latter in various processes associated with homeostasis and nutrition. This includes both 
their role as structural components of proteins, and their regulatory role in various 
processes such as stress response, metabolism, nucleic acid synthesis, osmoregulation 
and cell signalling (Wu, 2010).  
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(ii) Gene expression:  Gene expression profiling is important for the 
determination of cell identity in a variety of cellular processes, including differentiation 
of embryonic cells in the preimplantation-stage embryo and epithelial-to-mesenchymal 
transition (Toyoda et al., 2010). Bovine oviduct epithelial cells (BOECs) produce oviduct 
specific glycoproteins (OVGPs), which are suggested to be localized in secretory granules 
of the secretory cells (Oliphant and Ross, 1982). It has also been reported that BOECs 
express OVGP1 (Simintiras et al., 2016). 
 
The in vitro model had been established in the laboratory (Simintiras et al., 2016); 
therefore, some confirmatory experiments were performed in order to determine the 
successful isolation and culture of the cells as per the previous model. Additional 
experiments were also performed in order to further describe and explore the in vitro 
























3.2. Hypothesis and aims  
 
The work described in this chapter will test the hypothesis that the cell culture vessels 
used for BOEC culture and the long-term culture of BOECs in an air: liquid interface, may 
influence the gene expression profile of the cells and the composition of the in vitro 
Derived Oviduct Fluid (ivDOF) secreted by the cells. 
 
Consequently, the aims of this chapter were: 
(a) To determine the impact of the vessel used to culture the cells on the 
composition of spent media and on BOEC gene expression 
(b) To determine the impact of a long-term BOEC culture on oviduct 

























3.3. Experimental design 
 
All techniques described below were performed as detailed in Materials and Methods. 
 
In order to replicate and further validate the in vitro model of the oviduct described by 
(Simintiras et al., 2016), the cells were seeded and grown to confluence as described in 
section 2.1. The cells were visualised using confocal microscopy for the epithelial cell 
marker cytokeratin-18, and for haematoxylin and eosin staining. Transmission electron 
microscopy was used, as described in section 2.4 of Materials and Methods. The barrier 
properties of the epithelial cell monolayer were confirmed using TransEpithelial 
Electrical Resistance (TEER) measurements and fluorescein transport assay, which 
indicated that the epithelial monolayer enables the selective transport of molecules 
from the basal to the apical side of the cells. Since these experiments had previously 
been performed in the laboratory (Simintiras et al., 2016), not all were performed in 
triplicate, as had been the case in the original study. In particular, the staining 
experiments, described in more detail in (Simintiras et al., 2016) were only performed 
in one biological replicate. Also, for the purposes of all transport experiments performed 
in this thesis, the TransEpithelial Electrical resistance was measured at 48-hour intervals, 
to confirm formation of epithelial monolayer; however, in order to indicate the 
maintenance of a confluent monolayer, previously established in the laboratory 
(Simintiras and Sturmey, 2017), TEER measurements on a daily basis were only 
performed once. 
 
3.3.1. Impact of culture vessel on cell secretions and molecular mechanisms 
In order to determine the impact of the type of cell culture vessel on the gene expression 
patterns of the cells, BOECs were seeded and grown on Transwells and T25 flasks for 7 
days. On day 7, the medium was replaced and the cells incubated for 24 hours under 
standard culture conditions (39oC, 5% CO2). The spent medium was then collected and 
maintained at -20oC for short-term storage (up to 4 weeks). Long term storage was not 
performed. This experiment was performed in three biological replicates with two 
technical replicates in each. Glucose, lactate, pyruvate and amino acid concentrations 
of the spent media, as well as gassed media (39oC, 5% CO2) that had not been in contact 
with BOECs, were measured using ultrafluorometric assays and high-performance liquid 
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chromatography as described in sections 2.7, 2.8 of Materials and Methods. The cells 
were removed and gene expression experiments were performed as described on 
sections 2.9-2.11 of Materials and Methods. Gene expression experiments were 
performed for OVGP1 and oestrogen receptor 1 (ESR1), as these were previously 
reported to be expressed in the bovine oviduct epithelium (Simintiras et al., 2016). 
SLC2A1 and SLC2A3, which code for glucose transporters, and INSR, which codes for 
insulin receptor, were also assessed, as they were going to be used in the experiments 
described in subsequent chapters of this thesis. 
 
3.3.2. Impact of long-term culture of BOECs on ivDOF composition 
In order to determine the impact of extended culture on the volume of the in vitro 
Derived Oviduct fluid secreted by BOECs, the amino acid composition of the apical fluid 
and the resistance of the monolayer, BOECs were isolated and grown to confluence on 
Snapwells, and they were left in air: liquid interphase for 43 days. The amino acid 
composition of the fluid was determined using high performance liquid chromatography 
and the resistance of the monolayer was evaluated using TransEpithelial Electrical 
Resistance measurements respectively, as described on sections 2.8 and 2.1 of Materials 
and Methods. For reasons of time limitations, this experiment was only performed in 
one biological replicate, of between 3 and 10 technical replicates, according to the 
number of available Snapwells with an intact membrane; therefore, it was considered 
to be an observational experiment.  
 
3.3.3. Statistical analysis 
All statistical analyses were performed using GraphPad Prism 6. All data were analysed 
using the Shapiro-Wilk test in order to determine whether a parametric or non-
parametric analysis as required. When the data was normally distributed, One-Way 
ANOVA was used for analysis, with Tukey’s post-hoc, and the mean ± standard deviation 
plotted. Wherever the data were not normally distributed, or the n-number was too 
small to assess normality, a Kruskal-Wallis test was performed with Dunn’s post-hoc, and 
the median ± interquartile range plotted. For the statistical analysis of the amino acid 
data, Two-Way ANOVA with Tukey’s post-hoc was used and the mean ± standard 
deviation plotted. For the gene expression analysis, all datasets were too small to 
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determine whether the data were normally distributed and therefore a Mann-Whitney 




































3.4.1. Successful isolation of bovine oviduct epithelial cell population 
The identity of harvested cells was confirmed using confocal microscopy using the 


















Figure 3.2.: Epithelial cell staining with cytokeratin-18. Bovine Oviduct Epithelial Cells are positively stained for 
cytokeratin (3.1.a), whereas controls only show nuclear (DAPI) stain (3.1.b: primary antibody control, 3.1.c: 
secondary antibody control, 3.1.d: DAPI stain only). Representative of n=3, scaling bar represents 50μM. 
 
The epithelial cells were also visualised under an inverted microscope (data not shown), 
and they were also visualised in a bright-field microscope when they were also stained 
with haematoxylin and eosin. Positive haematoxylin and eosin staining was indicated by 
a purple colour-stained nucleus and a pink-colour stained cytoplasm, which confirmed 
the epithelial identity of the cells, as they were observed to be similar to previously 













Figure 3.3.: Haematoxylin and eosin staining of BOECs. Scaling bar represents 50μM. 
 
3.4.2. Successful formation of a single cell, semi-permeable BOEC monolayer 
Transmission Electron Microscopy of BOECs grown on a Transwell membrane confirmed 
that the cells grew as a single-cell monolayer, attaching to the membrane. Membrane 














Figure 3.4.: Cross-section of a Bovine Oviduct Epithelial Cell grow on a transwell membrane (indicated by T), with 
the apical compartment indicated (A). The  cell nucleus (N) is visible, as well as membrane protrusions at the apical 









After confirmation of the cells’ epithelial nature after isolation, the formation of a 
confluent monolayer was monitored with TransEpithelial Electrical Resistance (TEER) 
measurements over time. The data indicate that TEER increased slowly over days 1-3 of 
culture, then exponentially between days 3 and 6 after which it plateaued with no 
further increase (Figure 3.5).  
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Figure 3.5.: TransEpithelial Electrical Resistance with time of culture. Data are presented as mean from 10 technical 
replicates. 
 
Finally, after establishing the formation of a monolayer, its selective transport 
properties were examined using the inert molecule, fluorescein. Figure 3.6 shows that 
fluorescein flux across the monolayer was minimal indicating that the monolayer was 
intact. During this period, the TEER was stable. However, after addition of EDTA at 
180min, to disrupt the tight junctions, a flux of fluorescein from the basal to the apical 
compartment was observed, reflected as a reduction of fluorescence in the basal 
compartment and an increase of fluorescence in the apical compartment. EDTA addition 
also resulted in a sharp reduction of the Trans Epithelial Electrical Resistance, suggesting 
the disruption of the monolayer. Taken together, these findings confirm the presence of 





















Figure 3.6.: Fluorescein flux from the apical to the basal compartment of BOECs over time. EDTA was added on time 
point 180 (180 minutes after the beginning of incubation). n=3 biological replicates 
 
3.4.3. Long-term BOEC culture modified the amino acid composition of oviduct 
fluid 
 
An observational experiment was performed, seeking to investigate the impact of long-
term culture of BOECs in an air: liquid interphase on the secretion volumes, the TEER 
and the amino acid content of the fluid secreted by the cells. Figure 3.7 shows that the 
volume of ivDOF secreted by the cells during this extended-culture experiment was not 
significantly modified throughout the experiment. TEER over time for this experiment is 




























































































































































Figure 3.7.: The impact of long-term in vitro culture on the secretion volumes of ivDOF. n=3-10 technical replicates, 
depending on Snapwell availability 
 
The amino acid composition of ivDOF over the duration of the observation are given in 
figure 3.8.  These data revealed that the concentrations of nine amino acids in ivDOF; 
glutamine, glycine, threonine, arginine, alanine, valine, isoleucine, leucine and lysine 
were significantly altered over time. In particular, in all cases there was a trend for the 
amino acid concentration to increase towards the end of the incubation period 
(appendix). Only the amino acids whose concentrations were found to be significantly 
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Figure 3.8.: Bar charts representing the amino acid profile of ivDOF collected every 48 hours during long term BOEC 
culture, for the amino acids where the amino acid concentrations were modified in a statistically significant way. 
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n=3-10 technical replicates depending on ivDOF availability ±SD. a) glutamine, b) glycine, c) threonine, d) arginine, 
e) alanine, f) valine, g) isoleucine h) leucine, i) lysine  
 
 
The appendix contains tables with the amino acids that were significantly increased 
towards the end of the culture period (Table 3.1_Appendix, Figure 3.13_Appendix). 
 
3.4.4. Different culture systems for BOECs modify the amino acid composition 
of spent media but do not alter energy substrate concentrations or gene expression 
 
Next, the impact of different culture systems was assessed. BOECs were grown on T25 
flasks and on Transwells and the glucose, lactate and pyruvate concentrations, the 
amino acid concentrations of spent media and the gene expression levels in the cells 
were measured at day 7 of culture. 
 
Figure 3.9a shows that the concentration of glucose was not significantly altered by the 
culture vessel used, or compared to gassed medium. Similar to glucose, pyruvate 
concentration (Figure 3.9c) was not significantly modified in any of the culture vessels. 
Lactate concentration measured in spent media collected from the basal compartment 
of the Transwell was significantly higher than that in medium that had not been in 
contact with any culture vessel (Figure 3.9b). There was also a trend for a higher 
concentration of lactate in the apical compartment of the transwell and the T25 flask; 
however, these values did not reach significance. The above results show that the 
concentrations of glucose, lactate and pyruvate were essentially unchanged under the 
different culture systems used and that with the exception of lactate concentration, 
there were no other differences in the concentrations detected when the cells were 














































































































































































Figure 3.9.: Concentrations of a) glucose, b) lactate, c) pyruvate detected in media from cells under different culture 
conditions. n-=3 biological replicates 
The amino acid composition of spent medium from cells grown in flasks compared to 
those in Transwells showed a number of interesting differences. For example, there was 
significantly less serine in the basal compartment medium of cells grown in Transwells 
compared to the concentration in gassed medium (Figure 3.10 a). Glutamine, isoleucine 
and leucine (Figure 3.10 b, g and h respectively) concentrations were significantly lower 
in the spent media from the T25 flask compared to that from the apical and basal 
compartments of the transwell (p<0.001 and p<0.01 respectively for glutamine, p<0.05 
and p<0.01 for isoleucine, p<0.01 and p<0.001 for leucine). Glycine concentrations were 
significantly lower in gassed media compared to spent media in all vessels (p<0.001 for 
spent media from the apical compartment and p<0.0001 for spent media from the basal 
compartment and from the T25 flask). Additionally, marginally significant differences 
124 
 
were observed for arginine, valine and lysine concentrations (Figure 3.11 d, f and i) 
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Figure 3.10.: Amino acid concentrations detected in media collected from cells grown under different culture 
conditions. a) serine, b) glutamine, c) glycine, d) arginine, e) alanine, f) valine, g) isoleucine, h) leucine, i) lysine, n=3 
biological replicates 
 
Finally, analysis of the gene expression patterns of key genes associated with glucose 
transport and BOEC function, has shown that mode of culture does not significantly 
impact the gene expression profile of key genes expressed by BOECs (p>0.05) (Figure 
3.11). However, there was a trend towards significant differences, in that, with the 
exception of INSR, the gene expression levels were higher in cells grown on Transwells 
compared to the gene expression patterns of cells grown on T25 flasks; conversely, INSR 




































































































































































The data presented in this chapter have validated and expanded the in vitro model of 
the oviduct, which had previously been shown to mimic closely the in vivo  environment 
of the oviduct (Simintiras et al., 2016). A Bovine Oviduct Epithelial Cell population may 
now be readily isolated from bovine reproductive tracts, and used to grow a confluent 
epithelial cell monolayer, that enables the study of selective transport of molecules from 
the basal to the apical compartment. Repetition of some of the experiments previously 
performed, has confirmed the method to be robust and reproducible.  
 
In addition to the successful replication of previously performed experiments, 
Transmission Electron Microscopy was used to has confirm visually the formation of a 
single cell monolayer. It was not possible to confirm that the cells in this preparation 
adopted a columnar phenotype, possibly as a result of the cell positioning on the 
Transwell membrane at the time of fixation. However, the TEM data were in agreement 
with previous reports regarding ciliation, since cilia had been reported to disappear from 
BOEC surface under the in vitro conditions as epithelial cells become de-differentiated 
(Walter, 1995; Reischl et al., 1999; Ulbrich et al., 2010). This was reported to be restored 
in the porcine, after prolonged culture in air-liquid interface (Miessen et al., 2011), and 
in humans, following the addition of oestradiol to the basal medium (Comer, Leese and 
Southgate, 1998). Whether maintenance of an air-liquid interface also restores ciliation 
in the bovine, without the addition of oestradiol, remains to be confirmed, although 
Simintiras et al hinted at the restoration of a ciliated phenotype (Simintiras et al., 2016). 
 
An interesting finding highlighted in this chapter was that long-term culture of BOECs in 
an air:liquid interface did not change the volume and the TransEpithelial Electrical 
Resistance of the monolayer, suggesting there was no impact of the air:liquid interface 
model on cell survival or on the ability of the cells to maintain the monolayer integrity 
and produce ivDOF. However, this prolonged exposure to the air-liquid interface 
ultimately resulted in a modified ivDOF amino acid profile. In particular, culture over a 
43-day long period, in an air-liquid interface, led to a significant increase in 9 out of 17 
amino acids measured in the oviduct cell-derived apical fluid. Previous studies in the 
porcine discussed the importance of a 3-week culture period in an air-liquid interface, 
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as a minimum for the establishment of the characteristics of oviduct epithelial cells, as 
well as the ability of this cell type to be cultured in an air:liquid interface for up to 6 
weeks (Miessen et al., 2011). The work presented here, however, suggests that, even 
though this might be the case, long-term culture leads to significant alterations in the 
amino acid content of the fluid produced by the cells at the apical compartment. Indeed, 
when compared to the amino acid concentrations detected in bovine oviduct fluid 
collected with the use of catheter, which represents the in vivo Derived Oviduct Fluid 
(Hugentobler, Morris, et al., 2007), the amino acid concentrations detected during the 
first days of culture were comparable to the concentrations detected in vivo. However, 
after approximately 30 days of long-term culture of the cells in an air: liquid interface, 
the concentrations of some key amino acids increased significantly and reached levels 
that higher by 2-fold (for glutamine and glycine), 5-fold (for valine and leucine) 6-fold 
(for alanine), 10-fold (for threonine, isoleucine and lysine) and 20-fold (for arginine) 
compared to the levels reported in vivo. Although substrate differences might be 
predicted between the in vitro and the in vivo conditions (Simintiras et al., 2016), the 
amino acid profile over the long-term culture was significantly modified, since more than 
half of the amino acids examined were significantly higher than the conditions reported 
in vivo (Hugentobler et al., 2007), which suggests a potential discrepancy between the 
in vivo and in vitro extended culture conditions, which in turn needs to be taken into 
account when this type of experiments are performed.  
 
The impact of extended culture of oviduct epithelial cells has been reported previously 
in the porcine and was found to impact on gene expression, and in particular with genes 
related to amino acid degradation (Jankowski et al., 2018). The same study reported that 
long-term culture of pig oviduct epithelial cells led to decreased levels of gene 
expression related to the cells’ pluripotency (Jankowski et al., 2018). The above suggest 
that, although the in vitro model of the oviduct can mimic the in vivo environment, it 
cannot sustain this for long periods of time, in agreement with the findings presented in 
this chapter, which suggest a period of 36 days as a maximum time of maintenance of 
the air-liquid interface. This air-liquid interface, in vitro model of the bovine oviduct 
therefore provides a suitable model to investigate the function of the bovine oviduct as 





Finally, the impact of different culture systems, namely Transwells and culture flasks, in 
which to grow BOECs was investigated. The results show that BOECs expressed ESR1 and 
OVGP1 in both culture conditions, and consequently still retained their bovine oviduct 
epithelial cell characteristics; therefore, both culture conditions can be used for 
experiments related to BOEC work. Additionally, there was no impact of the culture 
conditions on the concentrations of glucose, lactate and pyruvate, which were found to 
be similar in spent media collected from either the apical or the basal compartment of 
a Transwell and in spent media collected from a T25 flask. Interestingly however, the 
culture conditions affected the amino acid composition of the above collected media, 
with nine amino acids being modified. Specifically, the concentrations of glutamine, 
isoleucine and leucine were significantly lower and alanine was significantly higher in 
media collected from T25 flasks compared to Transwells and gassed media. Even though 
the gene expression data suggest that there are differences at the transcriptomic level 
associated with the two different culture conditions, these differences were not found 
to be statistically significant.  
 
The differences observed under the two culture systems could potentially be attributed 
to the difference in the materials of which the two types of vessels are made; Transwell 
inserts are made of  polyester (Sigma), whereas T25 flasks are made of polystyrene 
(Sarstedt, no date). In addition, the cell distribution is different in the two vessels; as 
mentioned previously, epithelial cells growing in Transwells are exposed to media at 
both their apical and their basal compartments, thus resembling the in vivo conditions 
(Furuse et al., 1993), whereas cells grown in T25 flasks are exposed to media only 
through their apical compartment, since they adhere to the flask surface (Sarstedt). 
Finally, cell growth in flasks does not necessarily follow the single cell monolayer 
formation pattern, which has been observed with the use of Transwells (Simintiras et 
al., 2016), as visual assessment reveals the formation of epithelial cell clusters in the 
flasks, which are not uniformly distributed (Simintiras 2016). The results described in 
this chapter, together with the above described differences in cell culture in the two 
different vessels, indicate that the same culture conditions should be applied for each 
experiment, so that any comparisons performed between different treatments 
represent biological significance rather than the method of culture. Moreover, the fact 
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that some genes were differentially expressed between the two culture systems, but 
this difference did not reach significance, especially for the case of SLC2A3, suggests that 
a repetition of this experiment with higher n-numbers could further clarify the gene 
expression patterns of BOECs. 
 
Overall, the results of this chapter suggest that the in vitro model of the oviduct is a valid 
representation of the oviduct in vivo. There are, of course, limitations to the use of this 
model, and in particular to the cell culture time during which this remains valid. 
However, this remains a robust model for the isolation and culture of Bovine Oviduct 
Epithelial Cells and it could be very useful in the characterisation of various 
pathophysiological conditions, such as the investigation of the impact of hyperglycaemia 
in the composition of the BOEC secretions and the molecular mechanisms underlying 






















Obesity is a condition known to be associated with the development of metabolic 
syndrome, characterised by impaired glucose tolerance or impaired fasting glycaemia, 
as well as insulin resistance, dyslipidaemia, hypertension and central obesity (Eckel, 
Grundy, & Zimmet, 2005). According to the NHS, normal blood sugar levels for humans 
should be 4-7mM before a meal and below 8.5-9mM two hours after a meal (NHS, no 
date). Hugentobler et al. has reported that normal glucose concentrations in bovine 
plasma vary between 5.82mM and 7.70 mM, depending on the day of measurement 
(Hugentobler et al., 2008).  
 
Maternal provision of nutrients to the developing embryo is dependent on the 
nutritional status of the mother, as well as maternal metabolism, body size and body 
composition.  These, in turn, are in part established during the mother’s development 
from foetal life to adolescence (Martin-Gronert and Ozanne, 2006). It has been 
hypothesized that the existence of a mismatch between energy provision during foetal 
life, and during adolescence and adult life, can potentially result in the development of 
metabolic perturbations later in life (Martin-Gronert and Ozanne, 2006; Feuer and 
Rinaudo, 2016). Depending on the type, the extent, and the timing of the environmental 
challenge, prenatal development can be severely impaired (Feuer and Rinaudo, 2016). 
The changes that it may undergo could affect epigenetic modifications, which are 
processes associated with DNA accessibility and chromatin structure (Handy, Castro and 
Loscalzo, 2011) occurring during early development (reviewed by (Martin-Gronert and 
Ozanne, 2006)), or lead to metabolic perturbations at the cellular level, and potentially 
tissue and organ level later in development (Feuer and Rinaudo, 2016). While the impact 
of the metabolic syndrome on the later stages of foetal and placental development have 
been relatively well established, the impact of metabolic perturbations at the 
preimplantation stages of development, when the embryo is in the oviduct, have not 
been thoroughly investigated.  
 
As discussed in Chapter 1, the oviduct provides the environment for gamete maturation, 
fertilisation and early embryo development (Li and Winuthayanon, 2017). Importantly, 
the maternal transcriptome, which is essential for the oocyte and early embryo survival 
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and functions, is gradually degraded and replaced by the embryonic transcriptome, 
beginning with a process termed Embryonic Genome Activation. Consequently, any 
modifications to the environment of in which all the above processes occur, may result 
in severe perturbations in the embryo. Additionally, and considering the Developmental 
Origins of Health and Disease Hypothesis, discussed in the Introduction (Chapter 1), any 
diversion from the normal levels of nutrition provided to the embryo, whether it leads 
to decreased (Barker, 2004; Martin-Gronert and Ozanne, 2006; Rando and Simmons, 
2015) or increased nutrient supply, can result in detrimental foetal growth (Martin-
Gronert and Ozanne, 2006), and potentially the development of metabolic conditions 
later in life. 
 
The relationship between body mass index and fertility is J-shaped (Lake, Power and 
Cole, 1997), Abnormally high or low maternal weight is associated with reduced fertility 
(Grodstein, Goldman and Cramer, 1994), and obese women may need longer to 
conceive compared to women of normal weight (Jensen et al., 1999; Van Der Steeg et 
al., 2008). In mouse models of maternal obesity, obese animals were subfertile, as a 
result of the animals exhibiting prolonged or absent oestrous cycles and lacking follicular 
development in the ovary (Bermejo-Alvarez, Rosenfeld and Roberts, 2012). However, 
little is known about the implications of obesity on preimplantation embryo 
development. 
 
As mentioned in Chapter 1, the oviduct lumen has an environment that is metabolically 
distinct to the circulation, due to a combination of the transport of substrates from the 
circulation and bovine oviduct epithelial cell secretions (Leese, 1988). To date, the 
oviduct response to hyperglycaemia has not been investigated, however, a number of 
other studies have provided insight on the oviduct’s selective permeability properties. 
Simintiras et al (2016) reported that the oviduct epithelium is responsive to hormones, 
in particular to oestradiol and progesterone, which, when basally administered in 
pathophysiological levels, induce differences in the cells’ gene expression, as well as the 
amino acid composition of the fluid secreted by the cells (ivDOF) (Simintiras et al., 2016). 
A further recent study by Jordaens et al. (2017) has shown that the oviduct epithelium 
does not allow basally administered non-esterified fatty acids (NEFA) to cross the cells 
and reach the apical compartment, where the embryo resides for the first 5 days of 
134 
 
development would be; conversely, the monolayer can remove excess NEFA from the 
apical compartment (Jordaens, Van Hoeck, Maillo, et al., 2017).  These data indicate that 
the oviduct epithelium can regulate the environment for the gametes and the early 
embryo. Another study by the same group has shown that non-esterified fatty acids 
(NEFAs) are present in the oviduct, at concentrations reflecting plasma NEFA 
concentrations, and they are positively correlated with the levels of cholesterol and 
lactate, and negatively correlated with triglyceride levels in the oviduct fluid (Jordaens, 
Van Hoeck, De Bie, et al., 2017). These results suggest a role for the oviduct epithelium 
in buffering the effects of an adverse environment on the preimplantation embryo and 
in preventing potentially embryotoxic compounds from entering the oviduct lumen. 
 
In order to investigate the impact of a hyperglycaemic challenge on the secretions of the 
oviduct, the in vitro model of the oviduct, described in Materials and Methods, was used 
(section 2.6). The value of this model is that it mimics the in vivo environment in 
maintaining the oviduct cells as a confluent polarised monolayer enabling compounds 
of interest to be provided by the basal route with oviduct fluid available in the apical 




















4.2. Hypothesis and aims 
 
The research in this chapter sets out to test the hypothesis that hyperglycaemia impacts 
on secretions by Bovine Oviduct Epithelial Cells (BOECs) and creates an altered 
environment for the gametes and early embryo. 
  
Consequently, the aims of this chapter were: 
a) To describe the impact of acute and chronic hyperglycaemia, in the 
presence or absence of insulin on the luminal secretions of the oviduct 
b) To explore the impact of acute and chronic hyperglycaemia on the 



























4.3. Experimental design 
 
4.3.1. Materials and Methods 
Bovine Oviduct Epithelial Cells were harvested from bovine reproductive tracts and 
cultured in media containing DMEM-F12 as described in Materials and Methods (section 
2.1). Epithelial monolayer confluence was determined by TEER measurements as 
described in section 2.1 of Materials and Methods. After the cells had reached 
confluence, they were cultured in an air-liquid interphase, under treatments described 
in section 4.3.2 and 24 hours later, in vitro Derived Oviduct Fluid (ivDOF) was collected 
from the apical compartment and stored for further metabolic analyses.  
 
4.3.2. Treatments 
In order to investigate the impact of hyperglycaemia with or without the presence of 
insulin on the composition of ivDOF secretions, the following treatments were 
performed: 
 
1. 7.3mM glucose +20ng/mL insulin 
2. 8.5mM glucose +20ng/mL insulin 
3. 11mM glucose +20ng/mL insulin 
4. 7.3mM glucose (used to describe control conditions) 
5. 8.5mM glucose  
6. 11mM glucose  
7. 20ng/mL insulin experimental control 
8. Glucose – free media experimental control 
 
A concentration of 7.3mM glucose was chosen to represent normoglycaemia (i.e normal 
levels of glucose) as calculated for the media used for standard BOEC culture. This was 
within the range of normal glucose detected in the bovine circulation (Hugentobler et 
al., 2008). 8.5mM and 11mM were chosen to describe mild and severe hyperglycaemia, 
as their levels were higher than those physiologically observed (Hugentobler et al., 
2008). The concentration of basal insulin used is that, which, according to the literature 
produces a close to physiological phenotype for oviduct epithelial cells (20 ng/ml) 





Two different types of treatment were performed; acute and chronic (Figure 4.1). Acute 
treatment was performed in order to determine the impact of brief fluctuation in the 
glucose blood levels, due to, for instance, food consumption on oviduct fluid secretions. 
Chronic hyperglycaemia aimed to determine how a sustained high glucose challenge, 
which can be observed in metabolic disorders such as obesity and diabetes, affects the 
secretions of the oviduct. 
 
Briefly, to determine the impact of acute hyperglycaemia on BOEC secretions and 
physiology, the cells were grown under standard conditions for BOEC culture (section 
2.1, Materials and Methods) and as described in section 4.3.1. TEER was measured to 
confirm monolayer confluence, and the medium from the apical and basal compartment 
was aspirated off before the treatments described in section 4.3.2. were applied to the 
basal compartment. The apical ivDOF produced 24 hours later from the apical 
compartment, was collected and stored at -20oC for further analysis (Figure 4.1.a). 
 
To determine the impact of chronic hyperglycaemia on BOEC secretions and physiology, 
BOECs were grown to confluence under the treatment conditions described in section 
4.3.2. When TEER measurements confirmed the formation of a confluent monolayer, 
the medium from the top compartment was aspirated, the medium from the bottom 
compartment was replaced as above and, 24 hours later, the fluid created by the BOECs 





Figure 4.1: Experimental plan outline, for acute (4a) and chronic (4b) hyperglycaemia experiments. See text for 
details. 
 
4.3.3.1. Volume and composition of ivDOF 
The volume of ivDOF produced by BOECs was collected and glucose, lactate and 
pyruvate concentrations were determined using ultramicrofluorometric analysis as 
described in section 2.7. The concentrations of amino acid in the apical fluid were 
measured as described in section 2.8.  
4.3.3.2. Gene expression 
The gene expression levels of key genes (OVGP1, ESR1, SLC2A1, SLC2A3, INSR) were 
measured in BOECs in response to normo- and hyperglycaemic challenges, as described 
in section 2.11. 
4.3.4. Data analysis 
 
Details of n numbers and replicates are provided in the respective figure legends. All 
data were analysed using GraphPad Prism. Data normality was tested using Shapiro-Wilk 
test. Where data followed to the normal distribution, they were analysed using One-
way ANOVA, with Tukey’s post-hoc analysis and they were presented as mean ± 
standard deviation. Where data was confirmed as non-parametric, or if the n-number 
was too small to determine normality, the data were analysed using Kruskal-Wallis with 





concentrations are presented, as mean ± standard deviation, and analysed using Two-
way ANOVA with Tukey’s post-hoc. Gene expression data are presented as mean fold 





































4.4.1. Acute hyperglycaemia does not affect the secretion rates of the oviduct  
Exposing BOECs to elevated glucose had no impact on the overall volume of ivDOF 
created over 24 hours. Additionally, the inclusion of insulin did not affect the volume of 
ivDOF created over 24 hours. The volume of fluid secreted by the cells in the 11mM + 
insulin environment was found to be significantly lower compared to the insulin-only 































































































Figure 4.2.: Overall volume of secreted oviduct fluid (ivDOF) by BOECs in vitro, in response to treatments with 
normo- and hyper-glycaemic glucose concentrations and in the presence or absence of insulin. n=8-10 biological 
replicates 
 
4.4.2. Acute hyperglycaemia has minimal effect on the energy substrate 
concentrations of the oviduct-derived fluid  
The ivDOF collected after simulation of an acute hyperglycaemic challenge was used to 
measure the concentration of key energy substrates in the oviduct secretions after a 
glycaemic challenge. The results indicate that acute hyperglycaemia has minimal impact 
on the energy substrate content of ivDOF secreted by BOECs. However, in the absence 
of glucose in the basolateral compartment, there was a marked reduction in the amount 
141 
 
of glucose and lactate in the apical compartment, which was significantly lower 
compared to the 11mM-insulin treatment. Furthermore, the presence of insulin does 
not appear to alter the concentrations of lactate and pyruvate (Figures 4.3, 4.4, 4.5). 
Additionally, mild basal hyperglycaemia in the presence of insulin (8.5mM+insulin) 
resulted in significantly lower glucose concentration compared to severe basal 










































































































































Figure 4.3: Glucose concentration measured in ivDOF collected from cells acutely treated under different basal 












































































































































Figure 4.4: Lactate concentration measured in ivDOF collected from cells acutely treated under different basal 







































































































































Figure 4.5.: Pyruvate concentration measured in ivDOF collected from cells acutely treated under different basal 
glucose concentrations, in the presence or absence of insulin. n=3 biological replicates 
 
4.4.3. Amino acid composition in ivDOF is modified during acute basal 
hyperglycaemic conditions 
 
Figure 4.6. shows the concentrations of amino acids in ivDOF in response to an acute 
hyperglycaemic challenge. The concentrations of a number of amino acids were altered 
in response to increasing concentrations of glucose added basolaterally. These are 
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Figure 4.6.: The amino acid composition of ivDOF produced by cells treated to simulated hyperglycaemia for 24 hours. Amino acids with significant variance in response to treatment are indicated 
in subsequent figures, n=3 biological replicates
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Apical concentrations of glycine increased with increasing basal glucose concentrations, 
whereas insulin supplementation did not appear to have a significant effect (Figure 
4.7.a). On the contrary, glutamine concentrations in ivDOF did respond to the presence 
of  insulin; they were significantly higher in normoglycaemia and mild hyperglycaemia in 
the absence of insulin compared to mild hyperglycaemia in the presence of insulin. 
Finally, the concentrations of glycine, glutamine and alanine were reduced in the ivDOF 
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Figure 4.7.: The amino acid composition of ivDOF produced by cells treated to simulated hyperglycaemia for 24 
hours, only for the amino acids where significant differences were determined are shown, ie glycine (a), glutamine 
(b) and alanine (c). n=3 biological replicates 
Ion flux experiments for the acute conditions were performed (Figure 4.15_Appendix). 
However, due to technical difficulties with performance of the voltage clamp, these 
experiments were not pursued further. 
In the next series of experiments, the impact of sustained exposure of hyperglycaemic 
challenge (i.e. chronic) on the creation of ivDOF was investigated.  
 
4.4.4. Chronic hyperglycaemia induces insulin-dependent responses on the 
volume of ivDOF  
Figure 4.8 shows that, regardless of the glucose concentration, the presence of insulin 
for a sustained period results in significantly diminished volumes in the ivDOF produced 
by BOECs. This is further supported by the observation that the volume of ivDOF 
produced by cells treated with insulin in the absence of glucose, is comparable to the 
volume of insulin-treated samples, whereas volume produced by BOECs treated with 





































































































Figure 4.8.: Secretion volumes of BOECs under chronic hyperglycaemic conditions. n=6 for treatments, n=5 for 
controls, both mean±SD 
 
4.4.5. Chronic hyperglycaemia impacts on glucose concentration in ivDOF in an 
insulin-dependent manner  
Figure 4.9 shows that as basal concentrations glucose increase, so does that in the apical 
chamber. In particular, the concentrations of glucose in ivDOF created by cells treated 
with 7.3mM glucose+insulin and 8.5mM glucose + insulin are 1.1±0.3mM and 
1.0±0.54mM respectively. When basal glucose concentration is increased to 
11mM+insulin, ivDOF was found to contain 3.63±1.24mM glucose; a concentration that 
did not differ significantly to those concentrations detected under basal glucose 
concentrations of 7.3mM-insulin and 8.5mM-insulin. Finally, the concentration of 




















































































































































































































































Figure 4.9.: Glucose concentration of ivDOF produced by cells treated to simulated hyperglycaemia for 7 days under 
different treatments a) all treatments, b) no controls included in the statistical analysis, n=3 biological replicates 
 
4.4.6. Chronic hyperglycaemic treatments have no effect on lactate and 
pyruvate concentrations  
The effect of different glucose and insulin conditions added basally for a sustained 
period of time on lactate and pyruvate composition of ivDOF is shown in Figures 4.10, 
4.11. Figure 4.10 reveals that the addition of insulin had no significant impact on the 
concentrations of lactate in ivDOF (between 4.41±1.92mM and 5.54±3.61mM). 
Similarly, the concentrations of pyruvate were comparable among treatments (between 
0.29±0.28mM and 0.51±0.1mM). There was a trend for pyruvate concentration to 
decrease as basal glucose concentration increased from normo- (7.3mM) to 















Figure 4.10.: Lactate concentration of ivDOF produced by cells treated to simulated hyperglycaemia for 7 days 






































































































































Figure 4.11.: Pyruvate concentration of ivDOF produced by cells treated to simulated hyperglycaemia for 7 days 







































































































































4.4.7. Amino acid composition in ivDOF is significantly modified during chronic 
basal hyperglycaemic conditions  
The amino acid composition of basally treated samples under chronic hyperglycaemic 
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Figure 4.12.: The amino acid composition of ivDOF collected from cells basally treated under chronically hyperglycaemic conditions. n=3 biological replicates 
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Two-way ANOVA with Tukey’s post-hoc revealed that there were significant differences 
in the concentrations of glycine, alanine, glutamine and arginine between treatments. 
In particular, increasing basal glucose concentrations led to elevated glycine 
concentrations detected in the apical compartment. However, this was not the case in 
the absence of insulin, where glycine concentrations were similar across treatments, at 
approximately 600μM (Figure 4.13a).  
The concentrations of glutamine in ivDOF were significantly lower under hyperglycaemic 
conditions in the absence of insulin, compared to any glucose concentration in the 
presence of insulin, hinting at an insulin-dependent glutamine secretion (Figure 4.13b). 
Chronic treatment of BOECs with glucose had a mild effect on arginine concentration, 
notably in cells treated basally with 8.5mM glucose with insulin, compared to 7.3mM 
without insulin. However, the biological significance of this finding remains uncertain 
(Figure 4.13c). 
Finally, alanine concentrations followed a similar pattern to glycine, in that glycine 
concentration is significantly higher under chronic basal treatment of 11mM in the 
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 (d) 
Figure 4.13.: The amino acid concentrations in ivDOF produced by cells basally treated under chronic conditions, 
under different glucose concentrations with or without insulin. a) glycine, b) glutamine, c) arginine, d) alanine, n=3 
biological replicates 
4.4.8. Gene expression patterns are not affected by the hyperglycaemic 
treatments 
Gene expression studies revealed no changes in the expression patterns of many genes 
of interest, including those related to oviduct function (oestrogen receptor alpha, 
oviduct-specific glycoprotein, coded by genes ESR1, OVGP1 respectively), as well as 
genes associated with glucose transport in the epithelial cells (glucose transporters 1 
and 3, which are insulin-independent, and insulin receptor) (Figure 4.14). The results 
shown in the figure below, show no impact of any of the treatments on the expression 
of any of the genes tested, suggesting that the impact on the molecular mechanisms of 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.14.: Gene expression patterns of key genes associated with oviduct function (ESR1, OVGP1) and glucose 
transport (SLC2A1, SLC2A3, INSR) under different treatments. The above results show no impact of any of the above 
treatments, regardless of whether they were acute or chronic and regardless of the presence of insulin, on the gene 
expression patterns of the above genes. a) SLC2A1 acute treatment, b) SLC2A3 chronic treatment, c) ESR1 acute 
treatment, d) ESR1 chronic treatment, e) SLC2A3 acute treatment, f) SLC2A3 chronic treatment, g) INSR acute 
treatment, h) INSR chronic treatment, i) OVGP1 acute treatment, j) OVGP1 chronic treatment, n=3-4 biological 







The aim this chapter was to determine the impact of an acute and a chronic simulated 
hyperglycaemic challenge on the composition of bovine oviduct secretions, and to 
investigate the extent to which this is regulated at a gene level. The findings suggest that 
an acute hyperglycaemic challenge has only very modest effects on the physiology of 
the oviduct, in terms of secretion rates, metabolic substrate composition or the gene 
expression of key genes associated with the oviduct epithelial cell type or glucose 
transport into the cells. This is a reassuring finding, which supports the notion that 
oviduct fluid composition is not easily modified, especially when the levels of glucose or 
insulin in the circulation fluctuate according to food intake. In other words, the data 
suggest that the oviduct epithelium is resistant to short-term changes in nutrient 
availability, possibly to protect the embryo at the early stages of development. As 
mentioned in the introduction of this chapter, given that important events, such as 
embryonic genome activation, which occur while the embryo is in the oviduct, its 
gatekeeper function should be protective, and this work confirms that this is indeed the 
case.  
In contrast to short-term exposure to hyperglycaemia, chronic hyperglycaemia did affect 
the secretion volumes and the glucose concentration of ivDOF in an insulin dependent 
manner, with more glucose in the apical compartment in the absence of insulin 
compared to the presence of insulin. The detection of higher glucose concentrations and 
higher volume for insulin-deprived samples hints at a potentially detrimental situation 
to embryo development.  
Glycine concentrations in the oviduct-derived fluid were highest at the 11mM+insulin 
treatment. Interestingly, the glycine concentration pattern in the presence of insulin, 
appeared to increase under increasing glucose concentrations, a pattern similar to the 
one observed under acute hyperglycaemic conditions regardless of the presence of 
insulin (Figure 4.7a). However, this pattern was not seen in the absence of insulin, where 
increasing basal glucose concentrations result in similar apical glycine concentrations. 
This suggests an impact of high glucose concentrations on glycine secretion at the apical 
compartment. Combined with the data from acute hyperglycaemia, it appears that 
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glycine secretion into the apical compartment is glucose-dependent and not insulin-
dependent.  
Interestingly, the levels of glycine are comparable to the in vivo data when the cells are 
treated with 11mM+insulin (approximately 1500 μM) (Hugentobler et al., 2007), 
whereas the other concentrations induce lower glycine levels than the ones observed in 
vivo (around 800 μM). Glycine concentrations were previously found to be lower under 
in vitro conditions compared to the in vivo conditions (Simintiras et al., 2016), even 
though the present data suggest a value in between the previously reported in vitro and 
in vivo values. Consequently, it may be deduced that hyperglycaemic conditions in the 
presence of insulin result in abnormally high glycine concentrations, which will then be 
presented to the gametes and early embryo. Indeed, glycine is known to act as an 
osmolyte in early embryos (Dawson, Collins and Baltz, 1998; Baltz, 2001), glycine 
concentrations regulating the cell volume in early-stage embryos (Steeves et al., 2003) 
and glycine concentrations in the embryo being regulated by glycine transporters, 
depending on glycine availability in the embryo environment (Steeves et al., 2003; 
Steeves and Baltz, 2005). Glucose also has the potential to act as an osmolyte in different 
solutions, however, no osmotic variance was observed in the different media in the 
present study. Glycine has also  been found to be important in human intestinal 
epithelial cell protection from oxidative damage, by intracellular preservation of 
glutathione, of which glycine is a constituent amino acid, with cysteine and glutamate 
(Howard et al., 2010). An association between glucose and glycine transporter SLC6A9 
has been described in the nervous system of obese and diabetic rats, where introduction 
of a glycine transporter inhibitor restored glucose levels, improved glucose tolerance 
and restored the animals’ body weight (Yue et al., 2016). 
Glutamine concentrations were significantly lower in samples treated with a 
hyperglycaemic challenge in the presence of insulin, compared to the respective 
treatments without insulin. Glutamine may be metabolised by entering the TCA cycle 
and results in NADPH production, which in turn can modify the ratio of oxidised and 
reduced glutathione (GSH:GSSG), and therefore in altered cellular redox state (Curi et 
al., 2005). It is associated with insulin secretion by the pancreas, via the stimulation of 
glucose oxidation leading to increased ATP production (Newsholme et al., 2003), which 
results in membrane depolarisation and consequently insulin release (McClenaghan and 
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Flatt, 1999). An association between glutamine transporters and glucose has been 
described in cancer cell lines  where glucose deprivation resulted in glutamine 
transporter ASCT2 deglycosylation, and associated induction of other compensatory 
mechanisms of glutamine transport, mainly via LAT1 (Polet et al., 2016). Furthermore, 
reduced expression of SLC6A19, which is a glutamine transporter, as well as a more 
general neutral amino acid transporter, led to improved glycaemic control in mice, with 
the potential to be addressed as a therapeutic target for diabetes (Liu et al., 2018). 
Additionally, the gene expression of SNAT3, which is another glutamine transporter, 
increased significantly in obese and glucose-intolerant mice, where ammonium 
excretion was severely impaired (Busque, Stange and Wagner, 2014). Interestingly, 
Leary et al (2015) reported that glutamine depletion was higher in embryos produced 
by fertilisation of oocytes from obese women compared to women with normal BMI 
(Leary, Leese and Sturmey, 2015). Moreover, high glutamine uptake by the embryos 
have been associated with increased DNA damage (Sturmey et al., 2009), which in turn 
could be linked to the appearance of high glutamine levels in the apical fluid of insulin-
deprived cells.  Overall, there is a strong link between glutamine expression and glucose 
levels, as determined in various experimental conditions. 
Alanine concentrations were also found to be significantly higher in the 11mM glucose 
+insulin treatment compared to any other treatment. The concentrations of all other 
treatments are comparable to those observed in vivo (Hugentobler, Diskin, et al., 2007). 
Previously, alanine in the follicular fluid has been positively correlated with blastocyst 
formation (Matoba et al., 2014). Alanine is produced by embryos (Sturmey, Brison and 
Leese, 2008), possibly through pyruvate transamination for the purpose of recycling of 
ammonium ions (Donnay, Partridge and Leese, 1999; Orsi and Leese, 2004). Finally, 
arginine concentrations were significantly lower in the insulin-only treatment, but not 
the glucose-free treatment, compared to all other treatments. Elevated glucose has 
previously been associated with increased arginine transport in human umbilical vein  
endothelial cells (Flores et al., 2003); however, this was not observed in the present 
experiments. 
Overall, the different glucose and insulin conditions basally applied to BOECs lead to the 
secretion of modified apical fluid, suggesting that these conditions may impact on 
embryo development. The impact of amino acids on the early embryo has been 
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previously established, some amino acids having a stimulatory and others having an 
inhibitory effect on the mouse early embryo (Gardner and Lane, 1993). In the next 























A major health risk of prolonged overweight and obesity is the development of insulin 
insensitivity leading to the emergence of type 2 diabetes mellitus (T2DM).  A notable 
characteristic of T2DM is hyperglycaemia (Martyn, Kaneki, & Yasuhara, 2008).  T2DM 
has additional health impacts, including affecting fertility, however, even in the absence 
of T2DM, or in a so-called “pre-diabetic” state, obesity per se can have a dramatic impact 
on reproductive function. The relationship between obesity and reduced fertility has 
been attributed to dysregulation of steroidogenesis (Azziz, 1989; Robker et al., 2009) 
and/or production of poor quality oocytes (Metwally, Li and Ledger, 2007; Grindler and 
Moley, 2013). Indeed, the follicular microenvironment of women with abnormally high 
BMI shows signs of dyslipidaemia, hyperinsulinaemia and inflammatory response 
(Robker et al., 2009), due to the metabolic perturbations in the serum of obese women 
(Valckx et al., 2012). Excess body fat is more strongly associated with the appearance of 
ovulatory disturbances, when obesity onset occurs earlier in life (Azziz, 1989). High BMI 
(greater than 25kg/m2) reduces the number (Robker et al., 2009; Valckx et al., 2012) and 
size (Leary, Leese and Sturmey, 2015) of human oocytes. Since obesity and diabetes 
often coexist, and in many cases, T2DM remains undiagnosed, it is still unclear whether 
the poor quality of oocytes and consequently with poor embryo development is 
associated with hyperglycaemia, hyperinsulinaemia or high adiposity or with some 
combination of these conditions (Lane et al., 2015). 
 
Startlingly, fewer embryos are produced after fertilisation of oocytes of obese women 
compared to women with a BMI <30 kg/m2 (Robker et al., 2009; Valckx et al., 2012). 
Moreover, the blastocysts produced after in vitro fertilisation of oocytes of women with 
healthy BMI differ from the embryos of women with high BMI, in terms of 
developmental timing, glucose consumption, amino acid turnover and triglyceride levels 
(Leary, Leese and Sturmey, 2015). However, there is evidence that suggests that 
fertilisation of oocytes donated by women of healthy BMI does not impact on the rates 
of implantation of the resulting blastocysts or on spontaneous miscarriage, regardless 
of the BMI of the recipient (Styne-Gross, Elkind-Hirsch and Scott, 2005). This suggests an 




The extent to which the oviduct environment is modified in a hyperglycaemic response, 
and the subsequent impact on embryo physiology have not been investigated. This is 
crucial, given that the oviduct provides the environment for key developmental events, 
as discussed earlier in Chapter 1, including fertilisation (Ulbrich et al., 2010; Li and 
Winuthayanon, 2017), embryonic genome activation (Duranthon, Watson and 
Lonergan, 2008), early embryo epigenetic remodelling (Ulbrich et al., 2010; Li and 
Winuthayanon, 2017), cell lineage allocation (Wang and Dey, 2006) and development of 
the blastocyst (Wang and Dey, 2006). 
 
As described in Chapter 1, embryo metabolism is dynamic as development progresses 
from zygote to blastocyst. During the first stages of cleavage, glucose consumption is 
negligible, and although oxygen consumption is low, oxidation of substrates such as 
pyruvate and endogenous fatty acids provide the main source of ATP production. As 
development progresses, glucose consumption increases and so does oxygen 
consumption. Since glycolysis generates much less ATP than oxidative phosphorylation 
(2 versus 30 ATP molecules), it has been hypothesised that the increased glucose 
consumption is necessary for biosynthetic processes, through generation of carbon 
intermediates, which then feed into the pentose-phosphate pathway (Smith and 
Sturmey, 2013; Lewis and Sturmey, 2015). As reviewed by Leese (2012), and the increase 
in oxygen consumption at the blastocyst stage is associated with increased embryo 
requirement for ATP, for the formation of blastocoel cavity, as well as protein synthesis 
(Leese, 2012). Importantly, it has been shown that there is a link between glucose 
consumption (Gardner et al., 2011) or amino acid turnover (Houghton et al., 2002; 
Brison et al., 2004) and subsequent embryo viability to the blastocyst stage and beyond. 
 
Given the relationship between embryo metabolism and embryo viability (Houghton et 
al., 2002; Leese, 2002; Brison et al., 2004), it is striking that little is known about how an 
altered oviduct environment, in response to maternal conditions such as diabetes and 
obesity might impact the biochemistry and subsequent development of the 
preimplantation embryo.  Thus, the overall aim of the research in this chapter, was to 
determine the impact of an embryo environment, modified according to the secretions 
of the oviduct, as described in Chapter 4 for normoglycaemia and hyperglycaemia, on 
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5.2. Hypothesis and aims  
This chapter sets out to test the hypothesis that a hyperglycaemia-modified embryo 
culture environment can affect the developmental progression and metabolism of 
embryos at the cleavage and blastocyst stage.  
Consequently, the specific aims of this chapter were: 
a) To determine the impact of the modified environment on the cleavage 
and blastocyst rates of embryos 
b) To determine how the modified environment impacts on the metabolism 




5.3. Experimental design  
 
5.3.1. Treatments 
Informed by the results of Chapter 4, in which it was demonstrated that the secretions 
from bovine oviduct epithelial cells responded to the presence of elevated glucose and 
insulin, it was decided to test the response of the preimplantation embryo to four 
experimental conditions.  The data from Chapter 4 demonstrated that the presence of 
insulin had no significant effect on the concentrations of nutrients measured in oviduct 
cell secretions of cells grown in conditions designed to mimic normo- (7.3mM glucose) 
or mildly hyperglycaemic (8.5mM glucose).  Therefore, for the purposes of the 
experiments described in this chapter, the composition of ivDOF generated from cells 
grown in 7.3mM of glucose in the absence of insulin were selected as a baseline 
physiological comparator. Additionally, for the 8.5-modified environment, the 
8.5mM+insulin concentrations were used, as these were considered as more likely to be 
encountered physiologically. The 11mM+insulin and 11mM-insulin will be referred to as 
‘11+’ and ’11-’, respectively. The overall concentrations of glucose, lactate, pyruvate and 
amino acids used for this experiment are shown in Tables 5.1, 5.2 and 5.3, whereas the 
remaining components of embryo culture media were not modified.  
Table 5.1.:  Glucose, lactate and pyruvate concentrations for embryo culture, as detected in ivDOF. 
  7.3mM 8.5mM 11mM+insulin 11mM-insulin Control 
Glucose (mM) 3.6 1.0 3.6 8.9 1.5 
Lactate(mM) 4.5 4.7 5.2 4.9 3.3 










Table 5.2.: Amino acid concentrations used for embryo culture, as detected in ivDOF. 
Concentration (μM) 7.3mM 8.5mM 11mM+I 11mM-I 
Asparagine  44.6 35.2 31.2 49.1 
Serine 150.4 60.0 54.2 145.9 
Histidine 122.1 55.3 58.7 112.4 
Glutamine 1452.4 808.2 1004.0 1435.9 
Glycine 575.5 877.7 1565.4 701.1 
Threonine 450.4 207.0 399.1 420.2 
Arginine 836.5 467.8 655.9 819.9 
Alanine 817.5 630.6 1329.0 925.9 
Tyrosine 203.7 89.8 155.3 182.7 
Tryptophan 48.8 16.1 0.0 44.0 
Methionine 110.7 41.3 80.9 97.9 
Valine 319.0 114.2 176.7 273.5 
Phenylalanine 187.7 75.2 120.0 164.7 
Isoleucine 236.3 70.1 96.1 193.4 
Leucine 315.7 88.6 138.2 254.6 
Lysine 682.2 453.7 691.0 658.1 
 
Individual embryo culture was performed in order to assess the impact of the different 
culture conditions on embryo metabolism. For the individual culture, the respective 
concentrations of the controls were 0.5mM for glucose, 0.3mM for pyruvate and 0 for 













Table 5.3.: Amino acid concentrations used for control individual culture conditions. 
Amino acid Concentration 
(μM) 





















5.3.2. Embryo culture experiments 
Oocyte maturation, fertilisation and embryo culture were performed as described in 
Materials and Methods (Section 2.13). Embryos were allocated randomly to one of the 
five treatment conditions (‘7.3’-modified, ‘8.5’-modified, ‘11+’-modified, ‘11-’ -
modified, control). Three different experiments were performed: 
- The impact of modified embryo environment on embryo developmental 
progression: Embryos were cultured in groups of 15-25, according to embryo 
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availability, under the five conditions. Embryo cleavage and progression to blastocyst 
were monitored. 
- The impact of modified embryo environment on the metabolism of cleavage-
stage embryos: For this experiment, the embryos were placed into individual culture 
immediately after fertilisation, and incubated for 20-26 hours. The embryos were then 
removed from individual culture and the drops stored in -80oC for further metabolic 
analysis. All zygotes which had cleaved to create embryos with two (or more) 
blastomeres were classified as “cleaved”. 
- The impact of modified embryo environment on the metabolism of blastocyst-
stage embryos: For this experiment, the embryos were cultured in groups of 15-25 
embryos, according to embryo availability, under the five treatment culture conditions. 
On day 7 of embryo culture, embryos that had progressed to blastocyst were placed into 
individual culture conditions, and incubated under these conditions for 20-26 hours. The 
embryos were then removed from the individual culture conditions and the drops stored 
in -80oC for further metabolic analysis. 
 
5.3.3. Metabolic analyses 
As described in section 5.3.2, cleavage and blastocyst stage embryos were incubated for 
20-26 hours in individual culture drops. The embryos used for evaluation of cleavage 
stage embryo metabolism were returned into group culture conditions, but were not 
included in the cleavage and blastocyst rates or in further metabolic analyses. After 
completion of the experiments, the embryos were discarded and the individual culture 
drops collected and stored in -80oC. 
Enzymatic analyses of glucose, lactate and pyruvate were carried out as described in 
section 2.7 of Materials and methods. HPLC analysis of the amino acid composition of 
the spent medium was performed as described in section 2.8. 
Samples were thawed and diluted as appropriate for the assays in question (Table 5.4); 
for the purposes of glucose, lactate and pyruvate production, dilutions were made to 
ensure that values fitted the standard curve that was optimised for the 
ultramicrofluorometric assays. This was necessary, since the respective standard curves 
were not linear above the concentrations already established (Figure 5.25_Appendix). 
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In cases where the samples were expected to be within the standard curve, a dilution of 
1/2 was applied, to ensure the availability of duplicate samples for assay. 
Samples were diluted 1:12.5 for amino acid detection. The concentration of substrates 
in spent media were measured and compared to blank drops, thus allowing the overall 
change in concentrations to be determined. These values were converted into rates of 
consumption/production of the substrates by dividing the change in the moles of 
substrate by the duration of the assay.  
 
Table 5.4: Dilutions of spent media and blank media for ultramicrofluorometric assays 
 Glucose Lactate Pyruvate 
‘7.3’ 1/6 1/4 1/4 
‘8.5’ 1/3 1/4 1/2 
‘11+’ 1/6 1/4 1/2 
‘11-’ 1/15 1/4 1/4 
control 1/2 1/2 1/2 
 
5.3.4.  Statistical analysis 
Data on cleavage and blastocyst rates are presented as percentages, and all percentage 
data were arcsine-transformed prior to further analysis.  A Shapiro-Wilk normality test 
was performed on the arcsine-transformed data of percentages, and on the rates of 
consumption/production of glucose, lactate and pyruvate. This analysis was not 
performed on amino acid data, as Prism does not offer a non-parametric analysis and a 
respective normality test, as there is no high power non-parametric alternative to the 
two-way ANOVA. Wherever all groups were found to be normally distributed, a One-
Way ANOVA was performed, with Tukey’s multiple comparisons post-hoc.  In these 
cases, data are presented as mean ± standard deviation. If at least one of the groups 
was not normally distributed or had an n- number too small to determine normality, the 
Kruskal-Wallis test was performed, with Dunn’s multiple comparison post hoc; in such 
situations, data are presented as median ± interquartile range. For analysis of amino 
acid metabolism values, a Two-way ANOVA was performed, with Tukey’s multiple 
comparisons was performed. The amino acid data are presented as mean ± standard 
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deviation. In all figures of substrate consumption/production presented, positive values 
suggest substrate production and negative values suggest substrate consumption by the 
embryos. A One sample t-test was performed for individual amino acid data and a 
Wilcoxon Signed Rank Test was performed for the glucose, lactate and pyruvate data, in 
order to determine whether the mean and median values respectively differed 






5.4.1. Modified embryo environment does not impact on the cleavage rates of 
the embryos  
The cleavage rates of the embryos grown under modified group culture conditions are 
shown in Figure 5.1. Cleavage rates were unaffected by the treatment conditions, 





































Figure 5.1.: Cleavage rates in modified and control embryo environments. n=5 
5.4.2. Modified embryo environments significantly modify lactate and pyruvate 
production/consumption in cleavage-stage embryos  
Glucose depletion by cleavage-stage embryos was marginal under control conditions, as 
well as the ‘7.3’ and ‘8.5’ environment and did not differ between these groups. 
Surprisingly, embryos grown in medium that mimicked the oviduct fluid generated by 
severe hyperglycaemia consumed glucose (Figure 5.2). However, when only those 
embryos that cleaved were analysed, those embryos exposed to hyperglycaemia in 
combination with insulin consumed significant quantities of glucose, whereas in 
embryos exposed to hyperglycaemia without insulin, glucose was marginally produced 
(Fig 5.3a). The very low rates of glucose consumption/production were further 
supported by the fact that the median values for each culture environment were 
significantly different from zero only under the ‘11+’ conditions, when all embryos and 
cleaved embryos were assessed. Similar to pyruvate, when glucose 
consumption/production was compared in each of the environments, there was no 
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Figure 5.2.: Glucose consumption/production for cleavage stage embryos. n=16-18 depending on the availability 












































































Figure 5.3.: Glucose consumption/production for cleavage stage embryos a) embryos that cleaved (n=8-13), b) 
embryos that failed to cleave (n=5-10). 
Embryos grown under control conditions produced small amounts of lactate, whereas 
the embryos grown in the ‘8.5’ and ‘11-’ modified environments marginally produced 
this substrate, suggesting very low rates of the substrate utilisation or production by the 
embryos, which did not differ significantly from zero. The embryos grown under the ‘7.3’ 
conditions consumed lactate, whereas the embryos grown under the ‘11+’ conditions 








































statistically significant lactate consumption compared to ‘11+’ conditions, both when all 
embryos, and when cleaved embryos only were assessed. Additionally, lactate 
consumption was statistically significant compared to the control conditions when all 
embryos were assessed (Figures 5.4, 5.5). Similar to what was observed for the other 
two substrates, there was no statistically significant difference in lactate 
consumption/production when cleaved embryos were compared to uncleaved in each 









































Figure 5.4.: Lactate consumption/production for cleavage stage embryos. n=12-16 depending on the availability of 















































































Figure 5.5.: Lactate consumption/production for cleavage stage embryos a) for embryos that cleaved (n=6-11), b) 
for embryos that did not cleave (n=4-8) 
Pyruvate tended to be consumed by embryos of the control group, as well as the ‘7.3’ 
and ‘8.5’ groups; however, pyruvate consumption of the two latter groups did not differ 
significantly from zero. Similarly, pyruvate production by the embryos cultured under 
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the ‘11+’ conditions was not significantly different from zero. Conversely, the 
concentration of pyruvate in spent medium of embryos grown in the ‘11-’ groups had 
increased and pyruvate production under the ‘11-’ conditions was significantly higher 
compared to the 8.5-modified and control groups. Interestingly, the same pattern of 
pyruvate consumption/production was observed when analysis was restricted to only 
those embryos that had cleaved, (Figure 5.4a). When pyruvate consumption/production 
was examined in embryos that had failed to cleave, embryos derived from the 7.3mM 
treatments appeared to produce pyruvate and the embryos from ‘8.5’, ‘11+’ and control 
treatments consumed pyruvate; however, it is worth noting that pyruvate production 
was different from zero in only the ‘11-’ environment. Comparison of pyruvate 
consumption between cleaved and uncleaved embryos in each of the different 







































Figure 5.6.: Pyruvate consumption/production by cleavage stage embryos. n=16-18 depending on the availability 











































































Figure 5.7.: Pyruvate consumption/production by cleavage stage embryos a) embryos that cleaved (n=9-13), b) 




5.4.3. Hyperglycaemic embryo culture conditions significantly modify the rates 
of amino acid consumption/production at the cleavage stage  
The rates of amino acid consumption/production by embryos generated under normo- 
and hyperglycaemic embryo culture conditions are summarised in Figure 5.8. Due to the 
volume of data generated, these are presented in subsequent figures to highlight 
findings of note.  
Figure 5.9 shows the mean amino acid profile of embryos from the control group. These 
data showed that the embryos under control conditions consumed arginine and 
produced alanine, which, as discussed later, is in agreement with previous studies, and 
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Figure 5.9.: Rates of amino acid consumption/production of embryos grown under control conditions at cleavage 
stage (n=18) 
 
The embryo populations were further divided into cleaved and uncleaved embryos 
(Figures 5.10, 5.11). However, there were no differences in the amino acid 
consumption/production between the embryos that cleaved and the embryos that did 
not cleave (Figure 5.11), with the exception of glycine, which showed different rates of 
consumption in the ‘8.5’ and ‘11-’ environments (Figure 5.11.b,d). Assessment of glycine 
should therefore be performed both in the pooled embryo population and when 
embryos are split into cleaved and uncleaved. Statistical evaluation of all other amino 
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b) 
Figure 5.10.: Amino acid consumption/production rates for embryos grown in medium based on the secretions of 
cells exposed to normo- and hyperglycaemic conditions, for cleavage-stage embryos, a) for embryos that cleaved 
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e) 
 
Figure 5.11: Embryo population segregation into embryos that cleaved (n=5-8 depending on culture drop 
availability) and embryos that did not cleave (n=10-11 depending on culture drop availability) for a) ‘7.3', b) ‘8.5’, 
c) ‘11+’ d) ‘11-’ and e) control embryo environments. 
 
The impact on amino acid consumption/production of growing embryos in media whose 
composition was informed by the action of hyperglycaemia and insulin on BOEC 
secretions was next explored (Figures 5.12-5.13). Of note, when the whole embryo 
cohort was assessed, depletion of glycine was higher in the ‘11+’ conditions compared 
to all other conditions (Figure 5.12a). Similarly, glycine consumption was increased in 
the 8.5 group compared to control (Figure 5.12a). Arginine was produced by embryos 
grown under ‘11+’ conditions, as opposed to all other conditions, and this difference 
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b) 
Figure 5.12.: Glycine (a) and arginine (b) consumption/production rates under modified embryo culture conditions 
at cleavage stage. (n=16-18 depending on culture drop availability) 
Glycine showed net depletion and had an interesting profile. The overall mean profile 
for glycine depletion did not appear to change when embryos that had arrested were 
excluded from analysis (Fig 5.13a).  An exception to this was seen in the control group. 
When all embryos were included, there was a mean depletion of glycine; by contrast 
when only those embryos that cleaved during the culture duration were analysed there 
appeared to be a net mean production of glycine. Overall, embryos exposed to culture 
conditions based on the secretions from BOECs exposed to elevated glucose depleted 
glycine in the greatest amounts (Fig 5.12,5.13). No difference was found between 
cleaved and uncleaved embryos in any of the conditions examined. However, the results 
of this analysis must be interpreted with caution, as most of the values were not 
significantly different from zero, regardless of whether the entire embryo population or 
the segregated populations were assessed, with the exception of the arginine 
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Figure 5.13.: Rates of glycine (a) and arginine (b) consumption/production under normo- and hyperglycaemic group 
embryo culture conditions for cleavage stage embryos, when only cleaved embryos are assessed. (n=5-8 depending 


















































Figure 5.14.: Rates of glycine consumption/production under normo- and hyperglycaemic group embryo culture 
conditions for cleavage-stage embryos, when only uncleaved embryos are assessed. (n=10-11, depending on 
culture drop availability) 
Arginine also presented an interesting profile. When all embryos were assessed, this 
amino acid was marginally consumed/produced in all treatments with the exception of 
‘11-’, where it as depleted in comparatively high amounts (Figure 5.12b). However, 
when only cleaved embryos were assessed, arginine was produced by embryos in the 
‘7.3’ conditions, whereas it was consumed in all other conditions (Figure 5.13b). This is 
similar to what was observed when all embryos were included, with the exception of 
the ‘11+’, which no longer showed a small net arginine production when only cleaved 
embryos were assessed. Similar to glycine, the results of this analysis must be 
interpreted with caution, as only the 11- was significantly different from zero in the 
overall embryo population, as well as in the cleaved embryos. 
Finally, the amino acid profiles of those embryos that did not cleave during the period 
were scrutinised.  Only glycine consumption/production differed across the treatments, 
where embryos that remained developmentally static in medium based on secretions 
from BOECs exposed to 11mM glucose, as well as controls, secreted small amounts of 
glycine. This amino acid was consumed by embryos in all other treatments (Figure 5.14). 
Glycine consumption by the 11+ modified group was significantly different compared to 





5.4.4. Hyperglycaemic culture conditions do not affect the blastocyst rates of 
the embryos  
The blastocyst rates were unaffected by the culture conditions (Figure 5.15). Exposure 
to the ‘8.5’ and ‘11+’ environments appeared to lead to improved blastocyst rates, 
however, these did not reach significance.  Notably, blastocyst production was highly 
variable. In an attempt to mitigate variability, the effect of adding of FBS to the embryo 
culture media was tested, however, this did not have a notable effect on outcomes 





































Figure 5.15.: Blastocyst rates under normo- and hyperglycaemic modified embryo culture conditions. n=4-5, 
depending on embryo availability 
In addition, owing to tissue limitations, it was decided to focus on amino acid 
consumption/ production for blastocyst-stage embryos, the formation of which is an 
accepted marker of embryo quality (Sturmey et al., 2010). 
 
5.4.5. Amino acid consumption/production by blastocysts is significantly 
modified in response to a modified embryo culture environment 
The pattern of amino acid consumption/production of embryos grown in an 
environment based on the secretions of BOECs exposed to normo- and hyperglycaemic 
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Figure 5.16.: Amino acid consumption/production of blastocyst stage embryos grown in media whose composition was based on the secretions of BOECs cultured in conditions 




As with the data from cleavage stage embryos, arginine was consumed and alanine was 










































































































































Figure 5.17.: Amino acid consumption/production rates under control conditions in blastocyst stage embryos. n=12 
embryos 
 
Similar patterns of amino acid consumption were observed when blastocysts that either 
progressed or remained developmentally static, as well as when blastocysts remained 
or did not remain viable, were assessed (Figures 5.18, 5.19). Since glycine was 
significantly modified for the ‘11+’ treatment when embryos were segmented to 
degenerate and non-degenerate (Figure 5.18c) and embryos that progressed and did 
not progress (Figure 5.19c), this amino acid was assessed separately between 
treatments in these populations. Alanine was also observed to be different between 
embryos that progressed and did not progress in the ‘8.5’ environment, however it was 
not assessed separately because it was not found to be significant when all treatments 
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Figure 5.18: Embryo population segregation into blastocysts that degenerated (n=1-4 depending on embryo 
availability) and blastocysts that did not degenerate (n=5-8 depending on culture drop availability) for a) ‘7.3', b) 
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e) 
Figure 5.19.: Embryo population segregation into blastocysts that progressed (n=1-6 depending on embryo 
availability) and blastocysts that did not progress (n=2-6 depending on culture drop availability) for a) ‘7.3', b) ‘8.5’, 
c) ‘11+’ d) ‘11-’ and e) control embryo environments.  
The depletion/ appearance of glycine, arginine and lysine was influenced in blastocysts 
cultured in embryo culture modified according to oviduct secretions in hyperglycaemic 
conditions and in the presence or absence of insulin (Figure 5.20). Specifically, glycine 
was found to be marginally consumed by control embryos and marginally produced by 




‘8.5’ and ‘11+’ conditions, where glycine was consumed. Embryos grown under the ‘11+’ 
conditions, depleted glycine in high amounts and was significantly different to all other 
conditions (p<0.0001, Figure 5.20a). On the other hand, arginine was consumed in all 
treatments, apart from the ‘11-’ conditions, where it was produced, a difference which 
was statistically significant to the ‘11+’ conditions (p<0.05, Figure 5.20b). Lysine 
depletion was significantly different from zero in the ‘11+’ and control environments 
respectively, however this was not the case in the rest of the treatments. Finally, lysine 
production was observed for the ‘11-’ - modified and control treatments, an inverse of 
the pattern observed for the ‘7.3’, ‘8.5’ and ‘11+’ -modified treatments (Figure 5.20c). 
Interestingly, the rates of consumption/ production of all three amino acids presented 
a similar pattern, in that, in all cases, the amino acids were produced in the ‘11-’ 
treatment, but consumed in all other treatments, with the exception of lysine, which 
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c) 
Figure 5.20: Glycine (a), arginine (b) and lysine (c) consumption/production rates under modified embryo 




The amino acid profiles of embryos that had degenerated differed to those developed 
in culture (Figures 5.21,5.22). In embryos that degenerated during the assay period, 
glycine consumption was significantly different in the ‘7.3’ (p<0.05) and ‘11+’ (p<0.001) 
conditions from glycine production in the ’11-’ and control conditions, even though 
glycine production in these two latter cases was marginal. The rates of glycine 
consumption/ production were not significantly different from zero in degenerated 
embryos (Figure 5.22a). Similarly, in embryos that developed in culture, the patterns of 
amino acid consumption/production were similar to the overall results. Glycine was 
marginally consumed by all viable embryos, and the only difference observed compared 
to Figure 5.21 was the marginal glycine embryo consumption rather than production by 
the 11- -modified treatment (Figure 5.22b). Glycine consumption was significantly 
different from zero in the ‘8.5’ environment. Arginine followed the same pattern as in 
Figure 5.20, and consumption under control conditions were significantly different from 
































































































































































































































































































c o n tro l
b) 
Figure 5.21.: Rates of amino acid consumption/production for blastocyst stage embryos. a) degenerate embryos-
all amino acids b) non-degenerate embryos – all amino acids, n=1-4 for degenerate embryos, n=5-8 for non-
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c) 
Figure 5.22.: Rates of amino acid consumption/production for blastocyst-stage embryos. a) glycine rates for 
degenerated embryos, b) glycine rates for non-degenerated embryos, c) arginine rates for non-degenerated 





Finally, when the embryos that did not degenerate were assessed in terms of 
developmental progression (Figures 5.23, 5.24), the only amino acids that appeared to 
be significantly affected was glycine, which was depleted in embryos in the ‘11+’ 
conditions compared to the other conditions. However, in most cases, with the 
exception of glycine consumption in embryos that did not progress in the ‘8.5’ and ‘11+’ 
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b) 
Figure 5.23.: Rates of amino acid consumption/production of blastocyst-stage embryos that survived for the 
duration of the culture: a) embryos that progressed – all amino acids, b) embryos that did not progress – all amino 



































































































Figure 5.24.: Rates of glycine consumption/production of blastocyst-stage embryos that survived for the duration 
of the culture: a) embryos that progressed, embryos that did non progress, n=1-6 for embryos that progressed, 
n=2-6 for embryos that did not progress, depending on embryo availability. 
 
Glycine was depleted from the medium in cases when the embryo progressed, with 
highest rates observed for embryos grown in the ‘11+’ conditions. Additionally, glycine 
consumption by these embryos was higher than that of controls. On the other hand, in 
embryos that did not progress, glycine was marginally produced by embryos in the ‘11-
’ and control conditions, whereas it was consumed in the ‘7.3’, ‘8.5’ and ‘11+’ conditions, 
and these differences in the patterns of glycine consumption/production were 















Culturing BOEC cells in conditions designed to mimic mild and severe hyperglycaemia 
has an impact on the nutrient composition of the fluid created (Chapter 4). However, to 
understand the importance of these data, it was necessary to explore the effect of 
exposing the early embryo to such conditions. Endpoints were the ability to reach the 
key developmental stages of 2-cell and blastocysts, and consumption and production of 
nutrients under different embryo culture conditions. Overall, the modified 
environments did not have a major effect on embryo cleavage or blastocyst formation, 
however the nutrient turnover was significantly affected by the modified embryo 
culture conditions, mainly in terms of the rates of glucose, pyruvate, lactate and glycine 
consumption/production. 
 
5.5.1. Cleavage rates and blastocyst rates were unaffected by modified embryo 
environment 
Embryos were exposed to 5 different environments, the composition of 4 of which were 
based on BOEC secretory activity. None of the modified environments led to a change 
in the rates of cleavage or blastocyst formation. Interestingly, embryos grown in a 
medium based on the secretions of cells grown with 7.3mM glucose in the absence of 
insulin tended towards higher cleavage rate than the control conditions, however, these 
did not reach significance; therefore, repetition of this experiment at an appropriate 
power would clarify whether this difference observed was statistically valid.  
The cleavage and blastocyst rates were lower than those normally expected. One 
explanation for this might be the timing of the experiment, which was performed during 
summer 2018, which was unseasonably warm (MetOffice, 2018). It is therefore plausible 
that the oocytes used for these experiments had been collected from animals that were 
heat stressed. There is literature studying the effects of heat stress on high production 
cattle (Alves et al., 2013; Ahmed et al., 2017; Abdelatty et al., 2018). As well as the 
impacts on the animal, there are well-described effects of heat stress on the 
developmental competence of the oocyte (Ahmed et al., 2017), and the overall 




Despite this, the fact that there were no differences observed between treatment 
groups and study groups, leads us to conclude with some confidence that the conditions 
under investigation do not noticeably affect embryo development. 
 
5.5.2.  Modified embryo environment altered the rates of glucose, lactate and 
pyruvate consumption and production in cleavage-stage embryos 
The patterns of glucose, lactate and pyruvate consumption/production by cleavage 
stage embryos were affected as a result of culture in modified environments. Embryos 
in the control group consumed pyruvate and glucose and produced lactate; a pattern 
reported in a number of studies for the pre-implantation embryo (Thompson et al., 
1996; Leese et al., 2007; Sturmey, Brison and Leese, 2008; Gardner et al., 2011; Guerif 
et al., 2013; Krisher et al., 2015). To understand whether these data were influenced by 
the activity of embryos that did not cleave, the metabolic profile of embryos that failed 
to cleave with those that progressed was compared. In both categories the patterns of 
metabolic substrate consumption and production were similar, although in the case of 
glucose, there was a switch from marginal consumption to marginal production for 
cleaved embryos, whereas uncleaved embryos consumed significantly more glucose. 
However, as discussed in the results of this chapter, in all cases glucose 
consumption/production was not significantly different from zero and it would be 
difficult to account for a glucose secretion physiologically. This switch can also be 
attributed to the limitations of separating the embryos into categories, discussed later, 
in section 5.5.5.  
Pyruvate consumption is associated with embryo viability (Conaghan et al., 1993), and 
optimal embryo viability is associated with a limited range of pyruvate consumption 
(Guerif et al., 2013). This is also illustrated in the Goldilocks hypothesis, described by 
Leese et al. for the preimplantation embryo (Leese et al., 2016), where highest rates of 
developmental potential in the early embryo are observed within a specific range of 
nutrient profiles, which are neither too low nor too high. This hypothesis is a modified 
version of the previously described Quiet Embryo hypothesis, which suggested highest 
viability for embryos exhibiting lowest metabolism (Leese, 2002). Pyruvate consumption 




associated with increased embryo viability, however this was not the case for any of the 
other treatments. Even so, pyruvate consumption in the ‘7.3’ and ‘8.5’ environments 
followed very similar patterns to control conditions, although at lower levels, and the 
switch to pyruvate production observed in the ‘11+’ and ‘11-’ was not significantly 
different from zero. Consequently, repetition of this experiment with an increased 
number of embryos could determine whether the trends observed in pyruvate 
consumption/production by embryos cultured in environments based on the oviduct 
secretions are statistically significant. 
Glucose consumption has also been linked with embryo viability; higher glucose 
consumption has been associated with a greater higher chance of a successful 
pregnancy compared to lower (Gardner and Leese, 1987; Gardner et al., 2011). 
However, both studies reporting on this data measured the glucose uptake in blastocyst-
stage embryos, and therefore this assumption may not apply to cleavage-stage 
embryos. On the other hand according to the Goldilocks hypothesis, described earlier, 
it may be hypothesized that higher rates of glucose consumption observed by the 
embryos cultured in the ‘11+’ and ’11-’ environments could be related to lower viability 
and failure of these embryos to progress to later stages of development and 
implantation (Leese et al., 2016). Given the extreme modifications of that environment 
compared to the environment of the control conditions, it can be speculated that high 
glucose consumption is associated with an increased rate of glycolysis, associated with 
embryos which are less metabolically healthy (Leese et al., 2016). Given that the only 
treatment that was associated with glucose consumption significantly different from 
zero was the ‘11+’, and keeping in mind that there are conflicting theories regarding the 
impact of glucose consumption rates on embryo viability, further experiments with 
increased n-numbers are required in order to establish the impact of culture conditions 
based on ivDOF secretions, on embryo viability and metabolism.  
Finally, lactate production is known to follow a pattern that mirrors glucose 
consumption (Guerif et al., 2013). As mentioned earlier, according to the Goldilocks 
hypothesis, high embryo metabolism, and in particular, high rates of glucose 
consumption are associated with low viability (Leese et al., 2016). Given that high 
glucose consumption could be potentially associated with high rates of lactate 




in the ‘11+’ conditions. Due to the high variability in the rates observed in the other 
treatments, no safe conclusion can be drawn at this stage about them, and 
consequently, further experiments should be performed.  
An interesting observation is the similarity between the ‘8.5’ and the control conditions. 
Indeed, culture in a medium that was based on the secretions of cells exposed to mild 
hyperglycaemia (‘8.5’ group) led embryos to display a pattern of substrate consumption 
which was very similar to the control conditions, however, lactate was marginally 
consumed when all embryos were collectively assessed and analysis restricted to 
cleaved embryos, yet it was marginally produced by uncleaved embryos. As mentioned 
in the previous paragraph, the data on lactate production should be assessed with 
caution, due to their high variability. The similarity between the modified conditions and 
control could be possibly attributed to the fact that, as mentioned in the Experimental 
Design (section 5.3) of this chapter, the ‘8.5’ environment was based on concentrations 
of nutrients measured in the secretions of BOECs treated under 8.5mM+I conditions, 
which would potentially mimic more accurately the conditions physiologically. 
As mentioned earlier, in the cases of the embryos cultured in conditions mimicking 
ivDOF secretions by BOECs treated under 11+insulin and 11-insulin, glucose 
consumption was greatly increased. According to the thrifty genotype hypothesis, 
mentioned first by Neel (Neel, 1962), and further discussed by Leese (Leese, 2002) in the 
Quiet Embryo hypothesis, there are genes that offer an advantage over other genes, 
according to the presence of over- or under-nutrition. Consequently, we might 
hypothesize that a conversion of the main energy substrate from pyruvate to glucose is 
favoured in the ‘11+’ and ‘11-’ environments, especially since the glucose-to-pyruvate 
ratio in the culture medium was 2.6-fold and 4-fold respectively. Consequently, it is 
possible that glucose became an important substrate in cleavage stage embryos under 
these embryo culture conditions; however, this would require further investigation. The 
high variability observed in substrate consumption/ production for embryos cultured 
under the ’11-’ conditions, indicated by high interquartile range, indicates that a higher 
number of embryos would help us clarify the impact of these conditions on embryo 
metabolism. Glucose uptake by mouse preimplantation embryos is not known to be 
affected by the presence of insulin (Gardner and Leese, 1988). In the bovine, the 




morula stage, even though the combined presence of glucose and insulin in the culture 
system was associated with increased number of blastocyst cells (Matsui et al., 1995). 
To the best of our knowledge, there is no existing literature investigating glucose uptake 
in the presence of insulin in the bovine. 
Unfortunately, due to limited tissue availability, the impact of normo-and 
hyperglycaemic ivDOF mimicking conditions to the concentrations of glucose, lactate 
and pyruvate could not be performed for blastocyst stage embryos. 
 
5.5.3. Modified embryo environment altered the rates of amino acid 
consumption and production in cleavage-stage and blastocyst-stage embryos 
Embryo survival and the capacity to give rise to live births in clinical IVF has been 
previously associated with amino acid turnover (Houghton et al., 2002; Brison et al., 
2004). As observed for the rates of glucose, lactate and pyruvate consumption and 
production under control conditions, the amino acid profile of cleavage-stage embryos 
under control conditions (Figure 5.9) was similar to previously reported data (Partridge 
and Leese, 1996; Houghton et al., 2002; Brison et al., 2004; Sturmey, Brison and Leese, 
2008; Sturmey et al., 2010). In particular, arginine was consumed and alanine was 
produced by cleavage-stage embryos cultured under control conditions. This pattern 
was largely consistent regardless of whether the embryos had cleaved or not. The 
pattern of amino acid consumption/production for blastocyst-stage embryos cultured 
in control conditions also broadly followed expected profiles (Figure 5.17). This suggests 
that the embryos growing under control conditions had similar patterns of 
consumption/production as previously reported, and were therefore suitable for 
comparisons. 
In terms of the modified embryo environments, glycine consumption in cleavage-stage 
embryos was significantly higher in the 8.5 and 11+ -modified environments compared 
to the control group, while arginine was released in the 11+ conditions. The BOEC-
modified embryo environments induced significant differences in the rates of glycine 
consumption/production, with glycine consumption in blastocyst-stage embryos was 
higher in the ‘11+’ conditions, regardless whether the embryo progressed or arrested. 




environment in early embryos (Dawson, Collins and Baltz, 1998; Baltz and Zhou, 2012) 
and the increased rate of glycine consumption in the present work might involve a 
balanced influx and secretion of this amino acid, which, in turn, is a result of glycine 
transporter activity to maintain internal osmolarity to ensure embryo health and 
survival (Steeves et al., 2003; Steeves and Baltz, 2005).  
Interpretation of findings on arginine should be performed with caution, due to high 
sample variability, though it is worth noting that in blastocyst-stage embryos, arginine 
production by embryos in the ‘11-’ culture environment was significantly different from 
arginine depletion under control conditions (Figure 5.20).  
Overall, the variability in the rates of both amino acids’ consumption/production was 
quite high, with the exception of the rates for the embryos under control conditions, 
where variation was slightly decreased; consequently, repetition of these experiments 
would be required to clarify the pattern arginine depletion/production. 
 
5.5.4. Limitations of embryo segmentation 
The distinction of the embryos into cleaved and uncleaved embryos, when examined at 
cleavage stage, and between non-degenerate and degenerate, as well as progressed and 
non-progressed blastocysts introduces a number of potential limitations. First, it 
reduces the number of embryos examined per group, which will tend to lead to an 
increase of the sample variance. This is reinforced by the fact that when embryos were 
separated into cleaved and uncleaved, substrate consumption/production results were 
changed from significantly different from zero to no difference. In addition, there is no 
information on whether the embryos which were classified in a given category would 
remain in the state seen at the time of observation. For example, when an embryo is 
classified as uncleaved, this does not necessarily mean that it would remain uncleaved, 
since there is a possibility that it would cleave if left in individual culture for longer. Since 
there is a time window within which embryo development occurs, there is always a 
possibility for mis-allocation of the embryos into set categories and data from such 






Modified embryo culture conditions designed to mimic the nutritional environment to 
which early bovine embryos are exposed had no impact on the developmental 
progression through cleavage and towards the formation of the blastocyst. The embryos 
in the modified environments were able to withstand the changes in the environment 
and survive in rates comparable to control conditions. This is in contrast to work in mice, 
where varying embryo culture environments impacted on embryo metabolism but not 
on embryo survival (Morbeck et al., 2014; Morbeck, Baumann and Oglesbee, 2017). 
However, the results of the present work are in agreement with work performed in the 
human, where the timing of cleavage divisions as well as implantation and pregnancy 
rates were not affected by varying embryo culture conditions (Basile et al., 2013). 
The above suggest that in the experiments described in this chapter, embryos retained 
the ability of adapting to the modified embryo environment and surviving in the adverse 
conditions introduced. However, embryo adaptation and survival does not ensure the 
subsequent health of the embryo for the remaining pregnancy period or even 
postnatally. In addition to that, such modified culture conditions suggested some 
modest effects on embryo metabolism in terms of the consumption/production of 
nutrients. The impact that these metabolic alterations may have on further foetus 
development, as well as on the future health of the organism, in terms of the 






















6.1. Summary of findings 
 
The broad aim of the thesis was to study the effect of a hyperglycaemic challenge, in the 
presence or absence of physiologically relevant levels of insulin, on the secretions of 
bovine oviduct epithelial cells and on preimplantation embryo development and 
metabolism. This was done with the use of a previously established in vitro model of the 
oviduct, whereby the oviduct epithelium was cultured in a monolayer of polarised cells 
and then a hyperglycaemic challenge was introduced at the basal side of the cells, which 
represented blood. The measured glucose, lactate, pyruvate, and amino acid 
concentrations secreted by the oviduct epithelium were used for the development of 
modified embryo culture conditions, and the cleavage and blastocyst rates, as well as 
nutrient consumption/production by the embryos was investigated. 
 
The work in this thesis has demonstrated that the air-liquid interface model of bovine 
epithelial cell culture in vitro provides a valid approach for the investigation of the 
composition of oviduct secretions. It has been established that the method used for 
epithelial cell extraction results in the successful isolation of an oviduct epithelial cell 
population, which can then be cultured to form a single-cell monolayer, with selective 
barrier properties. It has been possible to further explore this model in a long-term 
culture experiment, which has shown successful cell growth in an air-liquid interface for 
as long as 36 days. After this time, the amino acid composition of the oviduct fluid was 
modified, with nine amino acids having increased concentrations compared to earlier 
days of culture in air-liquid interface.  
 
Importantly, the data in this thesis have confirmed that the content of the media in 
which the cells were incubated and the gene expression profile of the cells cultured in 
Transwells, produce a similar pattern to the much more widely used T25 flask. Cell 
culture in Transwells allows them to form a confluent monolayer of polarised cells, 
which enables access to both the apical and the basal compartment of the cells. This, in 
turn, facilitates transport of molecules across the monolayer. Overall, the above suggest 
that this model is successful, reproducible and can be used for experiments on the 





Having confirmed the validity of the air-liquid interface model of the oviduct, it has been 
used to measure the impact of physiologically relevant interventions on the gene 
expression and substrate composition of the oviduct cells and their secretory fluid. In 
this work, it was possible to re-create in the cell preparation the effect of one of the 
major consequences of metabolic syndrome, which is elevated glucose. A series of 
experiments were performed, described in Chapter 4, to investigate the impact of 
pathophysiological levels of elevated glucose on the secretory properties of the oviduct 
epithelial cells. The data revealed that exposing oviduct epithelial cells to elevated 
glucose for a prolonged period, in the presence or absence of insulin, resulted in altered 
composition of oviduct secretions. Notably, chronic exposure to hyperglycaemic 
conditions in the absence of insulin resulted in significantly modified concentrations of 
glutamine, glycine, arginine and alanine in the luminal secretions of the oviduct 
epithelial cells. By contrast, the cells of the oviduct appeared to buffer the luminal 
secretions in response to a short-duration treatment of hyperglycaemic conditions. 
Overall, the experiments did not find any impact of the above conditions on the gene 
expression profile of the cells.  
 
In order to understand the impact of the hyperglycaemic-modified luminal environment 
in more detail, experiments to explore the effect on embryos were undertaken.  Embryo 
culture in media modified according to the substrate and amino acid concentrations 
detected in the oviduct-cell derived fluid produced under pathophysiological conditions 
did not affect embryo cleavage or blastocyst rates. However, the metabolic profile of 
embryos was altered in response to culture in these conditions. Consumption of 
pyruvate was significantly modified under extremely hyperglycaemic conditions, both in 
the presence and in the absence of insulin, where it appeared to be marginally 
produced. In cleavage-stage embryos, lactate production was also significantly 
modified; however high variability did not allow for safe conclusions to be drawn with 
regards to the results. In addition, embryo culture in modified embryo environment was 
associated with significantly altered glycine and arginine consumption in both cleavage-






Figure 6.1: Summary of findings on the impact of hyperglycamia on early embryo environment and development. 
Chronic hyperglycaemia results are summarised, as these conditions appeared to have a more pronounced impact 
on secretion into the oviduct lumen. In green are highlighted the insulin-dependent effects of hyperglycaemia 
whereas the insulin-independent effects of hyperglycaemia are shown in red colour. Severe hyperglycaemia in the 
presence of insulin induced significantly higher glycine and alanine concentrations in the apical compartment, 
compared to all other treatments regardless of the presence or absence of basal insulin, whereas hyperglycaemia 
in the absence of insulin was associated with increased glucose and glutamine concentrations, and this was insulin-
dependent. In terms of the preimplantation embryo, cleavage-stage embryos produced pyruvate regardless of 
whether the initial basal treatment included insulin. Glycine uptake by both cleavage-stage and blastocyst stage 
embryos increased in all treatments, in particular in embryo culture medium modified according to the ‘11+insulin’ 
conditions.  
 
The importance of these findings is linked to the key role of these nutrients in embryo 
survival and viability. For example, in early mouse embryos, glycine can act as an 
osmolyte (Dawson, Collins and Baltz, 1998; Baltz, 2001), glutamine consumption has 
been associated with high DNA damage (Sturmey et al., 2009) and alanine (Donnay, 
Partridge and Leese, 1999) and arginine (Orsi and Leese, 2004) release may be 
associated with ammonium ion recycling. In particular, increased glycine secretion by 
the epithelial cells and subsequent increased glycine consumption by both cleavage-
stage and blastocyst-stage embryos, may be associated with cell and embryo response 
to adverse osmolarity and the importance of maintaining optimal osmolarity in the 





6.2. Strengths and limitations 
 
As with any piece of scientific study, this work has a number of strengths and limitations. 
Previous work performed in the laboratory has demonstrated the validity of the method 
of cell collection used and the robustness of the method of oviduct fluid production 
(Simintiras et al., 2016), as well as of those for oocyte isolation and maturation, 
fertilisation and embryo culture (Guerif et al., 2013). In addition, the metabolic content 
analyses of biological fluids are well-established and have been used in a variety of 
systems (Guerif et al., 2013; Leary, Leese and Sturmey, 2015; Simintiras et al., 2016). An 
experimentally tractable system was used throughout, in order to perform this study in 
a tightly defined, controlled manner. Exclusion of experiments that did not follow the 
appropriate standards was systematically performed; for example, experiments where 
the standard curves of glucose, lactate and pyruvate had a linearity below 98% were 
excluded, and the method of amino acid detection was validated prior to each 
chromatography experiment to confirm low levels of error. Finally, gene expression 
experiments were confirmed to be specific and efficient before the target samples were 
assessed.  
 
However, no piece of research or method comes without limitations. One limitation of 
the present work was the number of replicates for some of the experiments performed, 
due to time and tissue constraints, limiting the numbers of observations that could be 
made. This may have contributed to the high variability in some of the experiments.  In 
addition, and due to the same restrictions, spent media from blastocyst-stage embryos 
was analysed only in terms of its amino acid composition, a known marker of embryo 
quality (Sturmey et al., 2010), but not for glucose, lactate and pyruvate consumption/ 
production. Undertaking a full metabolic profile would have allowed a comparison with 
the respective cleavage-stage embryos as well as the determination of the impact of the 
modified embryo conditions. This limitation was further increased by the low blastocyst 
rates encountered, attributable to the extreme ambient heat at the time the embryo 




aspirated from the ovaries (Ahmed et al., 2017) as well as progression of zygotes to the 
blastocyst stage (Alves et al., 2013).  
Another limitation of the current work was the use of the bovine as a model species. To 
the best of our knowledge, there are no studies on the extent to which hyperglycaemia 
in the cow replicates the situation in the human. The only exception to this is the 
presence of insulin resistance during late pregnancy and early gestation, to ensure 
nutrient supply to the bovine mammary gland (Mair et al., 2016). It is possible that 
modified mouse strains may have provided a more useful in the representation of these 
conditions, however, the similarities between the human and the bovine in oocyte and 
embryo development (Ménézo and Hérubel, 2002; Elsik, Tellam and Worley, 2009) 
reinforce the usefulness of the use of the bovine in the study of mammalian 
reproductive processes (Ellington et al., 1998; Ménézo and Hérubel, 2002). In addition, 
there are a number of practical advantages to using bovine tissue; the approaches used 
in this thesis make use of material that would otherwise be discarded.  Moreover, the 
use of bovine slaughterhouse-derived material meant that experimental animals were 




















6.3. Future work 
 
6.3.1. In vitro model of the oviduct  
This research has raised a number of questions regarding the future research 
possibilities of using the in vitro model of the oviduct. Further to BOEC visualisation with 
Transmission Electron Microscopy described in Chapter 3, which demonstrated the 
presence of a single cell epithelium growing on the Transwell membrane, it would be 
valuable to repeat the observation on BOECs grown under conditions of the air-liquid 
interface. This would be of particular interest, as it would provide some indication of 
how well the in vivo appearance of the oviduct epithelium is retained in vitro; specifically 
the proportion of ciliated to secretory cells, previously observed in a related preparation 
in the porcine (Miessen et al., 2011) and in the human oviduct following oestradiol 
addition to the basal compartment (Comer, Leese and Southgate, 1998).  
 
It is well-established that the composition of the oviduct-derived fluid is modified 
according to the stage of the oestrous cycle (Aviles, Gutierrez-Adan and Coy, 2010), a 
change well-known for glycosidases (Carrasco et al., 2008) and steroid hormones 
(Aguilar and Reyley, 2005). It would therefore be of interest to exploit the air-liquid 
interface model to determine whether the different stages of the cycle impact on the 
gene expression profile and the energy substrate composition of BOECs, and compare 
to the data previously observed in vivo (Hugentobler et al., 2008). 
 
The interaction between the oviduct epithelium and sperm is a topic of great interest, 
both in the maintenance of the fertilisation capacity of sperm (Suarez, 2002) and sperm 
capacitation and hyperactivation (Coy et al., 2012). It would be of particular interest to 
investigate the potential impact of sperm on the maintenance of the integrity of the 
monolayer, as well as possible differences in monolayer potential, current and 
transepithelial resistance. The data might suggest a potential association of sperm 
binding to the oviduct sperm reservoir with modification of oviduct fluid secretion. This 
would align with observations that the presence of embryos and gametes can affect the 





The present and previous studies (Simintiras et al., 2016) in the laboratory have 
established the robustness of the in vitro model of the oviduct in producing an epithelial 
cell monolayer similar to the one observed in vivo. It would therefore be of interest to 
discover if this model could be translated to other organisms for the description of 
oviduct epithelia and secretions. Given the small size of a mouse oviduct, experiments 
on this species would be very difficult. However, with appropriate ethical approval, the 
human oviduct could be studied extensively using this model. Isolation and culture of 
Human Oviduct Epithelial Cells in an air-liquid interface and analysis of their secretions 
into the apical medium would be of special interest, since it would enable the 
composition to be compared with human embryo culture media used in IVF. This could 
be done under control conditions and following modification of the basal environment 
to mimic pathophysiological conditions, such as the ones examined in this thesis. 
 
6.3.2. Hyperglycaemia in the oviduct 
Experiments could also be carried out to discover how the secretion of other molecules 
into the oviduct fluid is affected by the modified basal conditions. Oviduct-specific 
glycoprotein has been previously detected in in vitro  Derived Oviduct Fluid produced 
using the air-liquid interface system as described in this thesis (Simintiras et al., 2016). 
In addition, growth factors, proteases and their inhibitors, and cytokines have also been 
detected in the oviduct fluid and they are known to promote development and 
maturation of gametes and embryos (Pillai et al., 2017). Furthermore, glycosidases in 
the oviduct fluid are potentially associated with sperm release into the oviduct lumen 
(Coy et al., 2012). Similarly, steroid hormones are secreted and are differentially 
expressed according to the stage of the oestrous cycle (Aguilar and Reyley, 2005). 
Protein detection by ELISA assays, would be useful in the determination of whether the 
treatments modify the amount of protein secreted by the cells.  
 
In addition, it would be of considerable interest to determine whether the 
hyperglycaemic treatments, in the presence or absence of insulin, influence the 
secretion of extracellular vesicles, which have previously been found to be secreted by 
the oviduct epithelial cells (Lopera-Vasquez et al., 2016). The composition of these 
vesicles and whether this is modified under these conditions could also be explored. 




NEFA composition of the oviduct lumen have previously been reported to reflect non-
esterified fatty acid (NEFA) concentrations in blood (Jordaens, Van Hoeck, De Bie, et al., 
2017). Whether the treatments described in this thesis have the potential to affect 
luminal NEFA concentrations remains to be determined.  
 
Related experiments could be carried out to discover if the levels of amino acids in 
oviduct fluid are attributable to differences in the gene and/or protein expression of the 
various amino acid transporters. Similar experiments could examine transporters for 
glucose, lactate, pyruvate and amino  acids in the blastomeres of cells of the blastocyst, 
trophoectoderm or inner cell mass cells (Purcell and Moley, 2009, reviewed by Gardner, 
2015, reviewed by Van Winkle et al., 2006) and whether their gene/protein expression 
is changed in the modified environments.  
 
Further to the work described in this thesis, insulin resistance combined with 
hyperinsulinaemia would be of interest to be studied. The use of an insulin antagonist 
followed by incubation in the presence of high levels of insulin would be able to mimic 
these conditions, and would potentially be the next step in mimicking the symptoms of 
obesity and diabetes. In addition, it would be fascinating to examine the impact of anti-
diabetic drugs, such as metformin, and whether these can restore the adverse effects of 
hyperglycaemia and insulin resistance. 
 
Also, further work should be performed on deciphering what the composition of oviduct 
secretions would be under a combination of symptoms which constitute obesity and 
diabetes, such as the combined introduction of high levels of glucose, insulin resistance, 
and inflammation-related factors, at levels at which these would be encountered in 
metabolic syndrome. This would enable safer predictions regarding the impact of these 
conditions on oviduct secretions.  
 
6.3.3. Embryo in the hyperglycaemic oviduct 
The work described in this thesis regarding the impact of the modified embryo 
environment on embryo cleavage rates, blastocyst rates and metabolism raises the 
question of whether there is an impact on sperm. Since sperm are present in the oviduct 




interaction between sperm and the oviduct epithelium (Fazeli, 2011) it would be of 
particular interest to determine whether the modified environment, which in this thesis 
has been found to affect oviduct secretions and embryo metabolism, has an impact on 
sperm physiology, motility and fertilisation capacity.  
 
Although the impact on the modified embryo environment was not shown to have an 
overtly detrimental effect on embryo survival and development, the results of this thesis 
cannot lead to conclusions about the long-term health of the embryos produced. 
Indeed, according to the Developmental Origins of Health and Disease Hypothesis 
(DOHAD), described in the Introduction, embryo exposure to adverse conditions at or 
around conception are associated with the development of chronic metabolic 
conditions (Martin-Gronert and Ozanne, 2006; Feuer and Rinaudo, 2016). Consequently, 
the adverse environment created under the modified conditions described in this thesis, 
may be associated with the development of chronic conditions that may not be obvious 
until later in life.  
 
In addition, modified embryo culture conditions are associated with a differentiated 
pattern of expression of imprinted genes (Doherty et al., 2000). Therefore, it is not 
unlikely that the modified environment may be associated with differences in imprinting 
in the embryo. Additionally, work in diabetic rats has shown an increased rate of cell 
death compared to control embryos and nuclear fragmentation, particularly in the inner 
cell mass cells (Pampfer et al., 1997), and high glucose has also been shown to be 
associated with cell allocation in the equine blastocyst (Choi et al., 2015). Whether these 
findings apply to the bovine embryos grown in the modified environment described in 
this thesis, remains a possibility for future research. Embryo transfer experiments, 
where embryos would be grown in culture under control or modified conditions to the 
blastocyst stage and then implanted into healthy cows, would allow the determination 
of whether the adverse environments described in this thesis have a long-term impact 
on the offspring health. 
 
An important finding of this work was that exposure to culture conditions informed by 
the effects of hyperglycaemia did not affect embryo development to the blastocyst 




to ensure further conceptus development and postnatal fitness in adverse conditions 
has been previously presented (Watkins et al., 2008). Embryonic developmental 
plasticity has been reviewed, and a variety of mechanisms are known to be used by the 
embryo to ensure developmental plasticity (Fleming et al., 2004). The embryo uses 
epigenetic, proliferative and metabolic adaptations to ensure its survival, which may be 
reflected in disturbances during pregnancy and foetal growth, as well as in the 
development of metabolic conditions later in life  (Fleming et al., 2004). Therefore, 
future work might focus on the determination of whether the conditions modified to 
mimic different adverse environments of early embryo development affect patterns of 
epigenetic modifications. This could be performed with the use of single-cell RNA 
sequencing, which is a marker of blastomere heterogeneity and has previously been 
used for experiments of genome activation in the first days of development (Lavagi et 
al., 2018) or with the use of bisulphite sequencing, which has been previously used in 
preimplantation embryos for observation of DNA demethylation patterns (Wu et al., 
2017). Based on the existing literature, comparison of the epigenome of embryos 
cultured in the modified environments would also be of great interest. 
Knowledge of the anticipated composition of the secretions of the oviduct epithelium in 
women with metabolic disturbances would be of crucial importance in the 
determination of the appropriate assisted reproduction treatment for them. The work 
described in this thesis is a first step towards this direction, as replication of the above 
experiments in humans would enable the prediction of the composition of embryo 
culture media used when obese or diabetic women wish to undergo IVF. This would 
introduce a whole new approach in personalisation of IVF culture media and would be 
very useful in further research in the field, although many steps are required until this 











6.4. Importance of work described in this thesis 
 
The oviduct has been described as a “neglected epithelium” (Leese et al., 2001), in that, 
historically, it has tended to be ignored since IVF was first developed to overcome the 
blockage of the Fallopian tube and works successfully without the need for the oviduct 
(Leese et al., 2001). On the contrary, extensive research has focused on the impact of a 
variety of factors on the ovary and the uterus. However, with the realisation that the 
oviduct plays a pivotal role in the events surrounding conception and has extensive 
interactions with the gametes and early embryo, there is renewed interest in this organ. 
 
This study contributes to the limited existing literature on the physiology of the oviduct. 
Of particular interest are the findings of glucose transporter expression in the oviduct 
tissue. Previous studies have determined the expression of GLUT1 and GLUT3 
transporters in the oviduct epithelium of rat and the bat (Tadokoro et al., 1995; Kuchiiwa 
et al., 2011; Roy and Krishna, 2013). Additionally, GLUT1 expression has been detected 
in fallopian tube adenocarcinomas (Kalir et al., 2005). The work described herein has 
confirmed the expression of these transporters in the bovine oviduct epithelium for the 
first time. In addition, to the best of our knowledge, this study is the first one to report 
the expression of the insulin receptor gene in the oviduct epithelial cells. These findings 
provide critical data in understanding the role of the insulin-glucose pathway in the 
oviduct epithelium and how this is affected by the maternal environment.  
 
This study provides another piece in the puzzle of the impact of maternal health and 
metabolic conditions on the pre-implantation embryo. Our knowledge this far has 
focused on the ovarian follicle, since this milieu can be sampled relatively simply.  By 
contrast, accessing the fallopian tubal environment is technically challenging.  Using the 
air-liquid interface model of the oviduct the data in this thesis has illuminated some 
understanding of the Fallopian tube and the effect of an abnormal basal environment 
on oviduct secretions and integrity, indicating the complexity of the impact of metabolic 
conditions on gametes and the preimplantation embryo. For example, non-esterified 
fatty acids detected in oviduct fluid may affect the barrier properties of the oviduct 
monolayer (Jordaens, Van Hoeck, De Bie, et al., 2017; Jordaens, Van Hoeck, Maillo, et 




impact of disturbed hormonal environment on the composition of oviduct-derived fluid 
(Simintiras et al., 2016), as well as the permeability of the epithelium to genistein 
(Simintiras and Sturmey, 2017). All these data illustrate the importance of investigating 
the impact of various pathophysiological conditions on the oviduct epithelium, its 
selective barrier properties and its secretions.  
 
Overall, the work described in this thesis has confirmed the usefulness of the air-liquid 
interface model in the generation and composition of oviduct secretions. In addition, 
the experiments focusing on the impact of hyperglycaemia, in the presence or absence 
of insulin, are important in helping us to understand the impact of maternal 








List of references 
 
Abdelatty, A. M. et al. (2018) ‘Influence of maternal nutrition and heat stress on bovine 
oocyte and embryo development’, International Journal of Veterinary Science and 
Medicine. Elsevier B.V., 6(November 2017), pp. S1–S5. doi: 
10.1016/j.ijvsm.2018.01.005. 
Abe, H. (1996) ‘The mammalian oviductal epithelium: Regional variations in cytological 
and functional aspects of the oviductal secretory cells’, Histology and Histopathology, 
11(3), pp. 743–768. 
Abe, H. and Hoshi, H. (1997) ‘Bovine oviductal epithelial cells : their cell culture and 
applications in studies for reproductive biology’, Cytotechnology, (23), pp. 171–183. 
Aguilar, J. and Reyley, M. (2005) ‘The uterine tubal fluid : secretion , composition and 
biological effects’, Anim Reprod, 2(2), pp. 91–105. 
Ahmed, J. A. et al. (2017) ‘Cumulus cell expansion and ultrastructural changes in in 
vitro matured bovine oocytes under heat stress’, Iranian Journal of Veterinary 
Research, 18(3), pp. 203–207. doi: 10.22099/ijvr.2017.4223. 
Alikani, M. (2005) ‘Epithelial cadherin distribution in abnormal human pre-
implantation embryos’, 20(12), pp. 3369–3375. doi: 10.1093/humrep/dei242. 
Allen, C. A. and Green, D. P. L. (1997) ‘The mammalian acrosome reaction: gateway to 
sperm fusion with the oocyte?’, ICSU press, pp. 241–247. 
Alves, M. F. et al. (2013) ‘Effect of heat stress on the maturation, fertilization and 
development rates of in vitro produced bovine embryos’, Open Journal of Animal 
Sciences, 03(03), pp. 174–178. doi: 10.4236/ojas.2013.33026. 
Andrade, Y. N. et al. (2005) ‘TRPV4 channel is involved in the coupling of fluid viscosity 
changes to epithelial ciliary activity’, Journal of Cell Biology, 168(6), pp. 869–874. doi: 
10.1083/jcb.200409070. 
Aviles, M., Gutierrez-Adan, A. and Coy, P. (2010) ‘Oviductal secretions: will they be key 





Azziz, R. (1989) ‘Reproductive endocrinologic alterations in female asymptomatic 
obesity.’, Fertility and sterility, 52(5), pp. 703–25. doi: 10.1016/S0015-0282(16)61020-
8. 
Baltz, J. M. (2001) ‘Osmoregulation and cell volume regulation in the preimplantation 
embryo’, Current Topics in Developmental Biology. Academic Press, 52, pp. 55–106. 
doi: 10.1016/S0070-2153(01)52009-8. 
Baltz, J. M. and Zhou, C. (2012) ‘Cell volume regulation in mammalian oocytes and 
preimplantation embryos’, Molecular Reproduction and Development, 79(12), pp. 821–
831. doi: 10.1002/mrd.22117. 
Barker, D. (1990) ‘The fetal and infant origins of adult disease’, BMJ, 301(156), p. 1111. 
Barker, D. et al. (2002) ‘Fetal origins of adult disease: strength of effects and biological 
basis’, Int J Epidemiol, 31, pp. 1235–1239. doi: 10.1093/ije/31.6.1235. 
Barker, D. J. P. (1997) ‘Fetal nutrition and cardiovascular disease in later life’, British 
Medical Bulletin, 53(1), pp. 96-108file:///C:/Users/krous/Box Sync/HYMS (K.Rous. doi: 
10.1002/9781119180432.ch4. 
Barker, D. J. P. (2004) ‘The developmental origins of chronic adult disease.’, Acta 
paediatrica. Supplementum, 93(6), pp. 26–33. doi: 10.1080/08035320410022730. 
Barker, D. J. P. and Martyn, C. N. (1992) ‘Maternal and Fetal Origins of Cardiovascular 
Disease’, J Epidemiol Community Health, 46, pp. 8–11. doi: 10.1007/978-1-4471-1889-
3_22. 
Basile, N. et al. (2013) ‘Type of culture media does not affect embryo kinetics: A time-
lapse analysis of sibling oocytes’, Human Reproduction, 28(3), pp. 634–641. doi: 
10.1093/humrep/des462. 
Baumann, C. G. et al. (2007) ‘The Quiet Embryo Hypothesis: Molecular Characteristics 
Favoring Viability’, Molecular reproduction and development, 74(7), pp. 815–820. doi: 
10.1002/mrd. 
Berg, J., Tymoczko, J. and Stryer, L. (2002a) ‘Acetyl Coenzyme A Carboxylase Plays a 
Key Role in Controlling Fatty Acid Metabolism.’, in Biochemistry. 5th editio. New York: 





Berg, J., Tymoczko, J. and Stryer, L. (2002b) ‘Amino Acids Are Made from Intermediates 
of the Citric Acid Cycle and Other Major Pathways.’, in Biochemistry. 5th editio. New 
York: W H Freeman, p. Section 24.2. Available at: 
https://www.ncbi.nlm.nih.gov/books/NBK22459/. 
Berg, J., Tymoczko, J. and Stryer, L. (2002c) ‘Glycolysis Is an Energy-Conversion 
Pathway in Many Organisms’, in Biochemistry. 5th editio. Freeman. Available at: 
http://www.ncbi.nlm.nih.gov/books/NBK22593/. 
Berg, J., Tymoczko, J. and Stryer, L. (2002d) ‘Oxidative Phosphorylation’, in 
Biochemistry. 5th edn. New York: W H Freeman, p. Biochemistry.Chapter 18. Available 
at: https://www.ncbi.nlm.nih.gov/books/NBK21208/. 
Berg, J., Tymoczko, J. and Stryer, L. (2002e) ‘Phosphatidate Is a Common Intermediate 
in the Synthesis of Phospholipids and Triacylglycerols.’, in Biochemistry. 5th editio. 
New York: W H Freeman; Available at: 
https://www.ncbi.nlm.nih.gov/books/NBK22593/. 
Berg, J., Tymoczko, J. and Stryer, L. (2002f) ‘The Pentose Phosphate Pathway 
Generates NADPH and Synthesizes Five-Carbon Sugars.’, in Biochemistry. 5th editio. 
New York: W H Freeman. Available at: 
https://www.ncbi.nlm.nih.gov/books/NBK22416/. 
Bermejo-Alvarez, P., Rosenfeld, C. S. and Roberts, R. M. (2012) ‘Effect of maternal 
obesity on estrous cyclicity, embryo development and blastocyst gene expression in a 
mouse model.’, Human reproduction (Oxford, England), 27(12), pp. 3513–22. doi: 
10.1093/humrep/des327. 
Braude P., Bolton V and Moore S. (1988) ‘Human gene expression first occurs between 
the four- and eight-cell stages of preimplantation development.’, Nature, 332, pp. 
459–461. Available at: https://www.nature.com/articles/332459a0.pdf. 
Brewer, C. J. and Balen, A. H. (2010) ‘The adverse effects of obesity on conception and 
implantation’, Reproduction, 140(3), pp. 347–364. doi: 10.1530/rep-09-0568. 




measurement of amino acid turnover’, Human Reproduction, 19(10), pp. 2319–2324. 
doi: 10.1093/humrep/deh409. 
Brison, D. R., Sturmey, R. G. and Leese, H. J. (2014) ‘Metabolic heterogeneity during 
preimplantation development: The missing link?’, Human Reproduction Update, 20(5), 
pp. 632–640. doi: 10.1093/humupd/dmu018. 
Broughton, D. E. and Moley, K. H. (2017) ‘Obesity and female infertility: potential 
mediators of obesity’s impact’, Fertility and Sterility. Elsevier Inc., 107(4), pp. 840–847. 
doi: 10.1016/j.fertnstert.2017.01.017. 
Burkart, A. D. et al. (2012) ‘Ovastacin, a cortical granule protease, cleaves ZP2 in the 
zona pellucida to prevent polyspermy’, Journal of Cell Biology, 197(1), pp. 37–44. doi: 
10.1083/jcb.201112094. 
Busque, S. M., Stange, G. and Wagner, C. A. (2014) ‘Dysregulation of the Glutamine 
Transporter Slc38a3 (SNAT3) and Ammoniagenic Enzymes in Obese, Glucose-Intolerant 
Mice’, Cellular Physiology and Biochemistry, 34, pp. 575–589. 
Bustin, S. A. et al. (2009) ‘The MIQE Guidelines: Minimum Information for Publication 
of Quantitative Real-Time PCR Experiments’, Clinical Chemistry, 55(4), pp. 1–12. doi: 
10.1373/clinchem.2008.112797. 
Byeong-Seon Jeong, X. Y. (2001) ‘Cysteine, glutathione, and percoll treatments 
improve porcine oocyte maturation and fertilization in vitro’, Molecular Reproduction 
and Development, 59(3), pp. 330–335. doi: 10.1002/mrd.1038. 
Bylander, A. et al. (2010) ‘Rapid effects of progesterone on ciliary beat frequency in the 
mouse fallopian tube’, Reproductive Biology and Endocrinology, 8, pp. 1–8. doi: 
10.1186/1477-7827-8-48. 
Camussi, G. et al. (2010) ‘Exosomes/microvesicles as a mechanism of cell-to-cell 
communication’, Kidney International. Elsevier Masson SAS, 78(9), pp. 838–848. doi: 
10.1038/ki.2010.278. 
Carrasco, L. C. et al. (2008) ‘Glycosidase determination in bovine oviducal fluid at the 
follicular and luteal phases of the oestrous cycle.’, Reproduction, fertility, and 




Chandra, R. and Liddle, R. A. (2009) ‘Neural and hormonal regulation of pancreatic 
secretion’, Current Opinion in Gastroenterology, 25(5), pp. 441–446. doi: 
10.1097/MOG.0b013e32832e9c41. 
Chen, S., Einspanier, R. and Schoen, J. (2013) ‘In Vitro Mimicking of Estrous Cycle 
Stages in Porcine Oviduct Epithelium Cells : Estradiol and Progesterone Regulate 
Differentiation , Gene Expression , and Cellular Function’, Biology of reproduction, 89, 
pp. 1–12. doi: 10.1095/biolreprod.113.108829. 
Chen, S., Einspanier, R. and Schoen, J. (2015) ‘Transepithelial electrical resistance 
(TEER): a functional parameter to monitor the quality of oviduct epithelial cells 
cultured on filter supports’, Histochemistry and Cell Biology. Springer Berlin 
Heidelberg, 144(5), pp. 509–515. doi: 10.1007/s00418-015-1351-1. 
Chian, R. C., Lapointe, S. and Sirard, M. a (1995) ‘Capacitation in vitro of bovine 
spermatozoa by oviduct epithelial cell monolayer conditioned medium.’, Molecular 
reproduction and development, 42(3), pp. 318–24. doi: 10.1002/mrd.1080420309. 
Choi, Y.-H. et al. (2015) ‘Cell lineage allocation in equine blastocysts produced in vitro 
under varying glucose concentrations.’, Reproduction (Cambridge, England), 150(1), 
pp. 31–41. doi: 10.1530/REP-14-0662. 
Clarke, I. J. and Cummins, J. T. (1985) ‘GnRH pulse frequency determines LH pulse 
amplitude by altering the amount of releasable LH in the pituitary glands of ewes’, 
Journal of Reproduction and Fertility, 73(2), pp. 425–431. doi: 10.1530/jrf.0.0730425. 
Clyman, M. J. (1966) ‘Electron microscopy of the human fallopian tube.’, Fertility and 
sterility. Elsevier Masson SAS, 17(3), pp. 281–301. doi: 10.1016/S0015-0282(16)35940-
4. 
Comer, M. T., Leese, H. J. and Southgate, J. (1998) ‘Induction of a differentiated ciliated 
cell phenotype in primary cultures of Fallopian tube epithelium.’, Human reproduction, 
13(11), pp. 3114–20. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9853867. 
Conaghan, J. et al. (1993) ‘Selection criteria for human embryo transfer: a comparison 
of pyruvate uptake and morphology.’, Journal of assisted reproduction and genetics. 




Conti, M. and Chang, R. J. (2016) ‘Endocrinology: Adult and Pediatric (Seventh Edition)- 
Volume II Learn more about Folliculogenesis’, in Endocrinology: Adult and Pediatric 
(Seventh Edition), pp. 2179–2191. 
Coticchio, G. et al. (2014) ‘Oocyte maturation: Gamete-somatic cells interactions, 
meiotic resumption, cytoskeletal dynamics and cytoplasmic reorganization’, Human 
Reproduction Update, 21(4), pp. 427–454. doi: 10.1093/humupd/dmv011. 
Coticchio, G. et al. (2019) ‘The enigmatic morula: mechanisms of development, cell 
fate determination, self-correction and implications for ART’, Human Reproduction 
Update, pp. 1–17. doi: 10.1093/humupd/dmz008. 
Coy, P. et al. (2008) ‘Oviduct-specific glycoprotein and heparin modulate sperm-zona 
pellucida interaction during fertilization and contribute to the control of polyspermy.’, 
Proceedings of the National Academy of Sciences of the United States of America, 
105(41), pp. 15809–15814. doi: 10.1073/pnas.0804422105. 
Coy, P. et al. (2012) ‘Roles of the oviduct in mammalian fertilization’, Society for 
Reproduction and Fertility, (October), pp. 1–34. 
Coy, P. and Avil, M. (2010) ‘What controls polyspermy in mammals , the oviduct or the 
oocyte ?’, 85, pp. 593–605. doi: 10.1111/j.1469-185X.2009.00117.x. 
Coy, P., Avile, M. and Monde, I. (2012) ‘The Oviduct : Functional Genomic and 
Proteomic Approach The Oviduct Provides the Most Efficient and Early Embryo 
Development’, Reproduction in Domestic Animals, 47, pp. 22–29. doi: 10.1111/j.1439-
0531.2012.02027.x. 
Cretoiu, S. M. et al. (2009) ‘Interstitial Cajal-like cells of human Fallopian tube express 
estrogen and progesterone receptors’, Journal of Molecular Histology, 40(5–6), pp. 
387–394. doi: 10.1007/s10735-009-9252-z. 
Cronin, J. G. et al. (2012) ‘Toll-Like Receptor 4 and MYD88-Dependent Signaling 
Mechanisms of the Innate Immune System Are Essential for the Response to 
Lipopolysaccharide by Epithelial and Stromal Cells of the Bovine Endometrium’, Biology 
of Reproduction, 86(2), pp. 51–51. doi: 10.1095/biolreprod.111.092718. 




fallopian tube.’, Reproductive biomedicine online. Reproductive Healthcare Ltd, Duck 
End Farm, Dry Drayton, Cambridge CB23 8DB, UK, 4(2), pp. 160–169. doi: 
10.1016/S1472-6483(10)61935-9. 
Curi, R. et al. (2005) ‘Molecular mechanisms of glutamine action’, Journal of Cellular 
Physiology, 204(2), pp. 392–401. doi: 10.1002/jcp.20339. 
Daliri, M. et al. (1999) ‘Expression of growth factor ligand and receptor genes in 
preimplantation stage water buffalo (Bubalus bubalis) embryos and oviduct epithelial 
cells’, J Reprod Fertil, 117, pp. 61–70. doi: 10.1530/jrf.0.1170061. 
Danesh Mesgaran, S. et al. (2016) ‘mRNA expression pattern of selected candidate 
genes differs in bovine oviductal epithelial cells in vitro compared with the in vivo state 
and during cell culture passages’, Reproductive Biology and Endocrinology. 
Reproductive Biology and Endocrinology, 14(1), p. 44. doi: 10.1186/s12958-016-0176-
7. 
Dawson, K. M., Collins, J. L. and Baltz, J. M. (1998) ‘Osmolarity-dependent glycine 
accumulation indicates a role for glycine as an organic osmolyte in early 
preimplantation mouse embryos.’, Biology of reproduction, 59(2), pp. 225–232. doi: 
10.1095/biolreprod59.2.225. 
DeBerardinis, R. J. and Chandel, N. S. (2016) ‘Fundamentals of cancer metabolism’, 
Science Advances, 2(5), pp. e1600200–e1600200. doi: 10.1126/sciadv.1600200. 
Dickens, C. J. et al. (1995) ‘Physiology: Human tubal fluid: Formation and composition 
during vascular perfusion of the fallopian tube’, Human Reproduction, 10(3), pp. 505–
508. doi: 10.1093/oxfordjournals.humrep.a135978. 
Dickens, C. J. et al. (1996) ‘Human Fallopian tubal epithelial cells in vitro: Establishment 
of polarity and potential role of intracellular calcium and extracellular ATP in fluid 
secretion’, Human Reproduction, 11(1), pp. 212–217. doi: 
10.1093/oxfordjournals.humrep.a019021. 
Dickens, C. J., Southgate, J. and Leese, H. J. (1993) ‘Use of primary cultures of rabbit 
oviduct epithelial cells to study the ionic basis of tubal fluid formation.’, J Reprod Fertil, 





Doherty, A. S. et al. (2000) ‘Differential effects of culture on imprinted H19 expression 
in the preimplantation mouse embryo’, Biology of Reproduction, 62(6), pp. 1526–1535. 
doi: 10.1095/biolreprod62.6.1526. 
Donnay, I., Partridge, R. J. and Leese, H. J. (1999) ‘Can embryo metabolism be used for 
selecting bovine embryos before transfer?’, Reproduction, Nutrition, Development., 
39(5–6), pp. 523–533. 
Downing, S. J. et al. (1997) ‘Electrophysiological basis of human fallopian tubal fluid 
formation.’, Journal of reproduction and fertility, 111(1), pp. 29–34. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9370964. 
Draper, C. F. et al. (2018) ‘Menstrual cycle rhythmicity: metabolic patterns in healthy 
women’, Scientific Reports, 8(1), pp. 1–15. doi: 10.1038/s41598-018-32647-0. 
Drews, B. et al. (2018) ‘Fatty acid profile of blood plasma and oviduct and uterine fluid 
during early and late luteal phase in the horse’, Theriogenology. Elsevier Ltd, 114, pp. 
258–265. doi: 10.1016/j.theriogenology.2018.04.003. 
Dumoulin, J. C. M. et al. (1998) ‘Effect of Ca2+/Mg2+-free medium on the biopsy 
procedure for preimplantation genetic diagnosis and further development of human 
embryos’, Human Reproduction, 13(10), pp. 2880–2883. doi: 
10.1093/humrep/13.10.2880. 
Dupont, J. and Scaramuzzi, R. J. (2016) ‘Insulin signalling and glucose transport in the 
ovary and ovarian function during the ovarian cycle’, Biochemical Journal, 473(11), pp. 
1483–1501. doi: 10.1042/BCJ20160124. 
Duranthon, V., Watson, A. J. and Lonergan, P. (2008) ‘Preimplantation embryo 
programming: Transcription epigenetics, and culture environment’, Reproduction, 
135(2), pp. 141–150. doi: 10.1530/REP-07-0324. 
Eckel, R. H., Grundy, S. M. and Zimmet, P. Z. (2005) ‘The metabolic syndrome’, Lancet, 
365(9468), pp. 1415–1428. doi: 10.1016/S0140-6736(05)66378-7. 
Edwards, L. J. and Leese, H. J. (1993) ‘Glucose transport and metabolism in rabbit 





Ehrenwald, E., Foote, R. H. and Parks, J. E. (1990) ‘Bovine oviductal fluid components 
and their potential role in sperm cholesterol efflux.’, Molecular reproduction and 
development, 25(2), pp. 195–204. doi: 10.1002/mrd.1080250213. 
Eisenbach, M. and Giojalas, L. C. (2006) ‘Sperm guidance in mammals — an unpaved 
road to the egg’, 7(April), pp. 276–285. doi: 10.1038/nrm1893. 
Ellington, J. A. et al. (1990) ‘Bovine 1-2-cell embryo development using a simple 
medium in three oviduct epithelial cell coculture systems.’, Biology of reproduction, 
43(1), pp. 97–104. doi: 10.1095/biolreprod43.1.97. 
Ellington, J. E. et al. (1998) ‘Human sperm function in co-culture with human, macaque 
or bovine oviduct epithelial cell monolayers’, Human Reproduction, 13(10), pp. 2797–
2804. doi: 10.1093/humrep/13.10.2797. 
Elsik, C. G., Tellam, R. L. and Worley, K. C. (2009) ‘The Genome Sequence of Taurine 
Cattle: A window to ruminant biology and evolution’, Science, 324(5926), pp. 522–528. 
doi: 10.1002/hbm.20705. 
Farnworth, P. G. (1995) ‘Gonadotrophin secretion revisited. How many ways can FSH 
leave a gonadotroph?’, Journal of Endocrinology, 145, pp. 387–395. 
Fazeli, A. (2011) ‘Maternal communication with gametes and embryo: A personal 
opinion’, Reproduction in Domestic Animals, 46(SUPPL. 2), pp. 75–78. doi: 
10.1111/j.1439-0531.2011.01870.x. 
Ferraz, M. A. M. M. et al. (2018) ‘An oviduct-on-a-chip provides an enhanced in vitro 
environment for zygote genome reprogramming’, Nature Communications. Springer 
US, 9(1). doi: 10.1038/s41467-018-07119-8. 
Feuer, S. and Rinaudo, P. (2016) ‘From Embryos to Adults: A DOHaD Perspective on In 
Vitro Fertilization and Other Assisted Reproductive Technologies’, Healthcare, 4(3), p. 
51. doi: 10.3390/healthcare4030051. 
Fleming, T. P. et al. (2004) ‘The Embryo and Its Future’, Biology of Reproduction, 71(4), 
pp. 1046–1054. doi: 10.1095/biolreprod.104.030957. 
Flores, C. et al. (2003) ‘Rapid stimulation of L-arginine transport by D-glucose involves 




Research, 92(1), pp. 64–72. doi: 10.1161/01.RES.0000048197.78764.D6. 
Forde, N. et al. (2011) ‘Oestrous cycles in Bos taurus cattle’, Animal Reproduction 
Science. Elsevier B.V., 124(3–4), pp. 163–169. doi: 10.1016/j.anireprosci.2010.08.025. 
Frolova, A. I. and Moley, K. H. (2011a) ‘Glucose transporters in the uterus: an analysis 
of tissue distribution and proposed physiological roles’, Reproduction, 142(2), pp. 211–
220. doi: 10.1002/cncr.27633.Percutaneous. 
Frolova, A. I. and Moley, K. H. (2011b) ‘Quantitative analysis of glucose transporter 
mRNAs in endometrial stromal cells reveals critical role of GLUT1 in uterine 
receptivity.’, Endocrinology. United States, 152(5), pp. 2123–2128. doi: 
10.1210/en.2010-1266. 
Furuse, M. et al. (1993) ‘Occludin a Novel Integral Membrane Protein Localizing At 
Tight Junctions’, The Journal of Cell Biology, 123(6), pp. 1777–1788. 
Gandolfi, F. and Moor, R. M. (1987) ‘Stimulation of early embryonic development in 
the sheep by co- culture with oviduct epithelial cells’, J.Reprod.Fertil., 81, pp. 23–28. 
Gardner, D. K. et al. (2011) ‘Glucose consumption of single post-compaction human 
embryos is predictive of embryo sex and live birth outcome’, Human Reproduction, 
26(8), pp. 1981–1986. doi: 10.1093/humrep/der143. 
Gardner, D. K. (2015) ‘Lactate production by the mammalian blastocyst: Manipulating 
the microenvironment for uterine implantation and invasion?’, BioEssays, 37(4), pp. 
364–371. doi: 10.1002/bies.201400155. 
Gardner, D. K. and Lane, M. (1993) ‘Amino acids and ammonium regulate mouse 
embryo development in culture.’, Biology of reproduction, 48(2), pp. 377–385. doi: 
10.1095/biolreprod48.2.377. 
Gardner, D. K. and Leese, H. J. (1987) ‘Assessment of embryo viability prior to transfer 
by the noninvasive measurement of glucose uptake’, Journal of Experimental Zoology, 
242(1), pp. 103–105. doi: 10.1002/jez.1402420115. 
Gardner, D. K. and Leese, H. J. (1988) ‘The role of glucose and pyruvate transport in 
regulating nutrient utilization by preimplantation mouse embryos.’, Development 





Georgiou, A. S. et al. (2005) ‘Gametes Alter the Oviductal Secretory Proteome’, 
Molecular and Cellular proteomics, 4(11), pp. 1785–1796. doi: 10.1074/mcp.M500119-
MCP200. 
Georgiou, A. S. et al. (2007) ‘Modulation of the oviductal environment by gametes’, 
Journal of Proteome Research, 6(12), pp. 4656–4666. doi: 10.1021/pr070349m. 
Ghersevich, S., Massa, E. and Zumoffen, C. (2015) ‘Oviductal secretion and gamete 
interaction’, Reproduction, 149(1), pp. R1–R14. doi: 10.1530/REP-14-0145. 
Gillespie, K. M. (2006) ‘Type 1 diabetes: pathogenesis and prevention’, Cmaj, 175(2), 
pp. 165–170. doi: 10.1503/cmaj.060244. 
Göke, B. (2008) ‘Islet cell function: α and β cells - Partners towards normoglycaemia’, 
International Journal of Clinical Practice, 62(SUPPL. 159), pp. 2–7. doi: 10.1111/j.1742-
1241.2007.01686.x. 
Gosden, R. and Lee, B. (2010) ‘Portrait of an oocyte : our obscure origin’, Growth 
(Lakeland), 120(4), pp. 973–983. doi: 10.1172/JCI41294.explain. 
Gott, A. L. et al. (1988) ‘The Mechanism and Control of Rabbit Oviduct Fluid 
Formation1’, Biology of Reproduction, 39(4), pp. 758–763. doi: 
10.1095/biolreprod39.4.758. 
Gould, G. W. and Holman, G. D. (1993) ‘The glucose transporter family: structure, 
function and tissue-specific expression.’, Biochemical Journal, 295(Pt 2), pp. 329–341. 
Greene, M. F. et al. (1989) ‘First-trimester hemoglobin A1 and risk for major 
malformation and spontaneous abortion in diabetic pregnancy.’, Teratology, 39(3), pp. 
225–31. doi: 10.1002/tera.1420390303. 
Grindler, N. M. and Moley, K. H. (2013) ‘Maternal obesity, infertility and mitochondrial 
dysfunction: Potential mechanisms emerging from mouse model systems’, Molecular 
Human Reproduction, 19(8), pp. 487–494. doi: 10.1093/molehr/gat026. 
Grodstein, F., Goldman, M. B. and Cramer, D. W. (1994) ‘Body Mass Index and 





Gualtieri, R. et al. (2013) ‘Bovine oviductal monolayers cultured under three-dimension 
conditions secrete factors able to release spermatozoa adhering to the tubal reservoir 
in vitro’, Theriogenology. Elsevier Inc, 79(3), pp. 429–435. doi: 
10.1016/j.theriogenology.2012.10.014. 
Gualtieri, R., Santella, L. and Dale, B. (1992) ‘Tight Junctions and Cavitation in the 
Human Pre-Embryo’, 87, pp. 81–87. 
Guerif, F. et al. (2013) ‘A Simple Approach for COnsumption and RElease (CORE) 
Analysis of Metabolic Activity in Single Mammalian Embryos’, PLoS ONE, 8(8). doi: 
10.1371/journal.pone.0067834. 
Han, H. S. et al. (2016) ‘Regulation of glucose metabolism from a liver-centric 
perspective’, Experimental and Molecular Medicine. Nature Publishing Group, 48(3), 
pp. e218-10. doi: 10.1038/emm.2015.122. 
Handy, D. E., Castro, R. and Loscalzo, J. (2011) ‘Epigenetic Modifications: Basic 
Mechanisms and Role in Cardiovascular Disease’, Circulation., 123(19), pp. 2145–2156. 
doi: 10.1038/mp.2011.182.doi. 
Harper, J. et al. (2012) ‘When and how should new technology be introduced into the 
IVF laboratory?’, Human Reproduction, 27(2), pp. 303–313. doi: 
10.1093/humrep/der414. 
Hillier, S. G. (1994) ‘Current concepts of the roles of follicle stimulating hormone and 
luteinizing hormone in folliculogenesis’, Human Reproduction, 9(2), pp. 188–191. doi: 
10.1093/oxfordjournals.humrep.a138480. 
Hinsch, K. D. and Hinsch, E. (1999) ‘The zona pellucida “receptors” ZP1, ZP2 and ZP3.’, 
Andrologia. Germany, 31(5), pp. 320–322. 
Van Hoeck, V. et al. (2013) ‘Oocyte developmental failure in response to elevated 
nonesterified fatty acid concentrations: Mechanistic insights’, Reproduction, 145(1), 
pp. 33–44. doi: 10.1530/REP-12-0174. 
Houghton, F. D. et al. (1996) ‘Oxygen consumption and energy metabolism of the early 





Houghton, F. D. et al. (2002) ‘Non-invasive amino acid turnover predicts human 
embryo developmental capacity’, Human Reproduction, 17(4), pp. 999–1005. doi: 
10.1093/humrep/deg389. 
Howard, A. et al. (2010) ‘Glycine transporter GLYT1 is essential for glycine-mediated 
protection of human intestinal epithelial cells against oxidative damage’, Journal of 
Physiology, 588(6), pp. 995–1009. doi: 10.1113/jphysiol.2009.186262. 
Hugentobler, S. et al. (2004) ‘In situ oviduct and uterine pH in cattle’, 61, pp. 1419–
1427. doi: 10.1016/j.theriogenology.2003.08.008. 
Hugentobler, S. A., Diskin, M. G., et al. (2007) ‘Amino Acids in Oviduct and Uterine 
Fluid and Blood Plasma During the Estrous Cycle in the Bovine’, Molecular reproduction 
and development, 454(74), pp. 445–454. doi: 10.1002/mrd. 
Hugentobler, S. A., Morris, D. G., et al. (2007) ‘Ion concentrations in oviduct and 
uterine fluid and blood serum during the estrous cycle in the bovine’, Theriogenology, 
68, pp. 538–548. doi: 10.1016/j.theriogenology.2007.04.049. 
Hugentobler, S. A. et al. (2008) ‘Energy Substrates in Bovine Oviduct and Uterine Fluid 
and Blood Plasma During the Oestrous Cycle’, Molecular reproduction and 
development, 503(October 2007), pp. 496–503. doi: 10.1002/mrd. 
Humpherson, P. G., Leese, H. J. and Sturmey, R. G. (2005) ‘Amino acid metabolism of 
the porcine blastocyst’, Theriogenology, 64(8), pp. 1852–1866. doi: 
10.1016/j.theriogenology.2005.04.019. 
Hunter, R. H. F. (2012) ‘Components of oviduct physiology in eutherian mammals’, 
Cambridge Philosophical Society, 87, pp. 244–255. doi: 10.1111/j.1469-
185X.2011.00196.x. 
Ichikawa, S. et al. (1985) ‘Effects of proteinase inhibitors on preimplantation embryos 
in the rat.’, Journal of reproduction and fertility, 73(2), pp. 385–90. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/3838771. 
Jaffe, L. A. and Egbert, J. R. (2018) ‘Communication Within the Ovarian Follicle’, pp. 
237–260. doi: 10.1146/annurev-physiol-022516-034102.Regulation. 




during porcine oviductal epithelial cells (OECs) primary culture in vitro – a signaling 
pathways activation approach’, Medical Journal of Cell Biology, 6(1), pp. 18–26. doi: 
10.2478/acb-2018-0004. 
Jansz, N. and Torres-Padilla, M. E. (2019) ‘Genome activation and architecture in the 
early mammalian embryo’, Current Opinion in Genetics and Development. Elsevier Ltd, 
55, pp. 52–58. doi: 10.1016/j.gde.2019.04.011. 
Jensen, T. K. et al. (1999) ‘Fecundability in Relation to Body Mass and Menstrual Cycle 
Patterns’, Epidemiology, 10(4), pp. 422–428. 
Johnson, M. H. (2007) Essential Reproduction. 6th edn. Blackwell Publishing. 
Johnson, M. H. and McConnell, J. M. L. (2004) ‘Lineage allocation and cell polarity 
during mouse embryogenesis’, Seminars in Cell and Developmental Biology, 15(5), pp. 
583–597. doi: 10.1016/j.semcdb.2004.04.002. 
Jordaens, L., Van Hoeck, V., Maillo, V., et al. (2017) ‘Maternal metabolic stress may 
affect oviduct gatekeeper function’, Reproduction, 153(6), pp. 759–773. doi: 
10.1530/REP-16-0569. 
Jordaens, L., Van Hoeck, V., De Bie, J., et al. (2017) ‘Non-esterified fatty acids in early 
luteal bovine oviduct fluid mirror plasma concentrations: An ex vivo approach’, 
Reproductive Biology. Society for Biology of Reproduction &amp; the Institute of 
Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn, 
17(3), pp. 281–284. doi: 10.1016/j.repbio.2017.05.009. 
Joshi, M. S. (1995) ‘Isolation, cell culture, and characterization of oviduct epithelial cells 
of the cow’, Microsc Res Tech, 31(6), pp. 507–518. doi: 10.1002/jemt.1070310607. 
Kakar, S. S., Rahe, C. H. and Neill, J. D. (1993) ‘Molecular cloning, sequencing, and 
characterizing the bovine receptor for gonadotropin releasing hormone (GNRH)’, 
Domestic Animal Endocrinology, 10(4), pp. 335–342. doi: 10.1016/0739-
7240(93)90037-C. 
Kalir, T. et al. (2005) ‘Immunohistochemical detection of glucose transporter GLUT1 in 
benign and malignant fallopian tube epithelia, with comparison to ovarian 







Keating, N. and Quinlan, L. R. (2008) ‘Effect of Basolateral Adenosine Triphosphate on 
Chloride Secretion by Bovine Oviductal Epithelium1’, Biology of Reproduction, 78(6), 
pp. 1119–1126. doi: 10.1095/biolreprod.107.065508. 
Keating, N. and Quinlan, L. R. (2012) ‘Small conductance potassium channels drive ATP-
activated chloride secretion in the oviduct’, AJP: Cell Physiology, 302(1), pp. C100–
C109. doi: 10.1152/ajpcell.00503.2010. 
Kenny, D. A. et al. (2002) ‘Effect of Elevated Systemic Concentrations of Ammonia and 
Urea on the Metabolite and Ionic Composition of Oviductal Fluid in Cattle1’, Biology of 
Reproduction, 66(6), pp. 1797–1804. doi: 10.1095/biolreprod66.6.1797. 
Kessler, M. et al. (2015) ‘The Notch and Wnt pathways regulate stemness and 
differentiation in human fallopian tube organoids’, Nature Communications. Nature 
Publishing Group, 6(May), pp. 1–11. doi: 10.1038/ncomms9989. 
Krisher, R. L. et al. (2015) ‘Applying metabolomic analyses to the practice of 
embryology : physiology , development and assisted reproductive technology’, pp. 
602–620. 
Kuchiiwa, T. et al. (2011) ‘Cellular expression of monocarboxylate transporters in the 
female reproductive organ of mice: implications for the genital lactate shuttle.’, 
Histochemistry and cell biology, 135(4), pp. 351–60. doi: 10.1007/s00418-011-0794-2. 
Lake, J. K., Power, C. and Cole, T. J. (1997) ‘Women ’ s reproductive health : the role of 
body mass index in early and adult life’, International journal of obesity, 21, pp. 432–
438. 
Lam, X. et al. (2000) ‘Assay and importance of adhesive interaction between hamster 
(Mesocricetus auratus) oocyte-cumulus complexes and the oviductal epithelium.’, 
Biology of reproduction, 62(3), pp. 579–88. doi: 10.1095/biolreprod62.3.579. 
de Lamirande, E., Leclerc, P. and Gagnon, C. (1997) ‘Capacitation as a regulatory event 




human reproduction, 3(3), pp. 175–94. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/9237244. 
Lamothe, P., Bousquet, D. and Guay, P. (1977) ‘Cyclic variation of F prostaglandins in 
the uterine fluids of the cow’, Reproduction, 50(2), pp. 381–382. doi: 
10.1530/jrf.0.0500381. 
Lane, M. et al. (2015) ‘Peri-conception parental obesity, reproductive health, and 
transgenerational impacts’, Trends in Endocrinology and Metabolism. Elsevier Ltd, 
26(2), pp. 84–90. doi: 10.1016/j.tem.2014.11.005. 
Lash, M. M. and Armstrong, A. (2009) ‘Impact of obesity on women’s health’, Fertility 
and Sterility. Elsevier Ltd, 91(5), pp. 1712–1716. doi: 10.1016/j.fertnstert.2008.02.141. 
Latham, K. E. (2001) ‘Embryonic genome activation’, Frontiers in Bioscience, 6(1), p. 
d748. doi: 10.2741/latham. 
Lavagi, I. et al. (2018) ‘Single-cell RNA sequencing reveals developmental 
heterogeneity of blastomeres during major genome activation in bovine embryos’, 
Scientific Reports. Springer US, 8(1), pp. 1–12. doi: 10.1038/s41598-018-22248-2. 
Leary, C., Leese, H. J. and Sturmey, R. G. (2015) ‘Human embryos from overweight and 
obese women display phenotypic and metabolic abnormalities’, Human Reproduction, 
30(1), pp. 122–132. doi: 10.1093/humrep/deu276. 
Leese, H. J. (1983) ‘Studies on the movement of glucose, pyruvate and lactate into the 
ampulla and isthmus of the rabbit oviduct.’, Quarterly journal of experimental 
physiology, 68, pp. 89–96. 
Leese, H. J. (1988) ‘The formation and function of oviduct fluid.’, J Reprod Fertil, 82, pp. 
843–856. doi: 10.1530/jrf.0.0820843. 
Leese, H. J. et al. (2001) ‘Formation of Fallopian tubal fluid: Role of a neglected 
epithelium’, Reproduction, 121(3), pp. 339–346. doi: 10.1530/reprod/121.3.339. 
Leese, H. J. (2002) ‘Quiet please , do not disturb : a hypothesis of embryo metabolism 
and viability’, BioEssays, 24(9), pp. 845–849. doi: 10.1002/bies.10137. 
Leese, H. J. et al. (2007) ‘Embryo viability and metabolism: Obeying the quiet rules’, 




Leese, H. J. et al. (2008) ‘Female reproductive tract fluids: composition, mechanism of 
formation and potential role in the developmental origins of health and disease’, 
Reproduction, fertility, and development, 20, pp. 1–8. doi: 10.1071/RD07153. 
Leese, H. J. (2012) ‘Metabolism of the preimplantation embryo: 40 Years on’, 
Reproduction, 143(4), pp. 417–427. doi: 10.1530/REP-11-0484. 
Leese, H. J. et al. (2016) ‘Biological optimization, the Goldilocks principle, and how 
much is lagom in the preimplantation embryo’, Molecular Reproduction and 
Development, 83(9), pp. 748–754. doi: 10.1002/mrd.22684. 
Leese, H. J. and Barton, A. M. (1984) ‘Pyruvate and glucose uptake by mouse ova and 
preimplantation embryos’, Journal of Reproduction and Fertility, 72(1), pp. 9–13. doi: 
10.1530/jrf.0.0720009. 
Leese, H. J. and Gray, S. M. (1985) ‘Vascular perfusion: a novel means of studying 
oviduct function.’, The American journal of physiology, 248(5 Pt 1), pp. E624–E632. 
Leroy, J. et al. (2014) ‘Dietary Fat Supplementation and the Consequences for Oocyte 
and Embryo Quality : Hype or Significant Benefit for Dairy Cow Reproduction ?’, Reprod 
Dom Anim, 49, pp. 353–361. doi: 10.1111/rda.12308. 
Lewis, N. and Sturmey, R. G. (2015) ‘Embryo metabolism: what does it really mean?’, 
Anim. Reprod, 12(3), pp. 521–528. 
Li, S. and Winuthayanon, W. (2017) ‘Oviduct: Roles in fertilization and early embryo 
development’, Journal of Endocrinology, 232(1), pp. R1–R26. doi: 10.1530/JOE-16-
0302. 
Libersky, E. A. and Boatman, D. E. (1995) ‘Progesterone concentrations in serum, 
follicular fluid, and oviductal fluid of the golden hamster during the periovulatory 
period.’, Biology of reproduction, 53(3), pp. 477–82. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/7578669. 
Lim, H. et al. (1997) ‘Multiple female reproductive failures in cyclooxygenase 2-
deficient mice’, Cell, 91(2), pp. 197–208. doi: 10.1016/S0092-8674(00)80402-X. 
Liu, Y. et al. (2018) ‘The role of ASCT2 in cancer: A review’, European Journal of 




Lloyd, R. E. et al. (2009) ‘Effects of oviductal fluid on the development, quality, and 
gene expression of porcine blastocysts produced in vitro’, Reproduction, 137(4), pp. 
679–687. doi: 10.1530/REP-08-0405. 
Lonergan, P. et al. (2016) ‘Embryo development in dairy cattle’, Theriogenology. 
Elsevier Inc, 86(1), pp. 270–277. doi: 10.1016/j.theriogenology.2016.04.040. 
Lopera-Vasquez, R. et al. (2016) ‘Extracellular Vesicles from BOEC in In Vitro Embryo 
Development and Quality’, PLoS ONE, 11(2), pp. 1–23. doi: 
10.1371/journal.pone.0148083. 
Lowry, O. H. et al. (1951) ‘Protein measurement with the folin phenol reagent’, Journal 
of Biological Chemistry, 193(1), pp. 265–275. 
Lucas-Herald, A. K. and Bashamboo, A. (2014) ‘Gonadal development’, Endocrine 
Development, 27, pp. 1–16. doi: 10.1159/000363608. 
Lyons, R. A., Saridogan, E. and Djahanbakhch, O. (2006) ‘The reproductive significance 
of human Fallopian tube cilia’, 12(4), pp. 363–372. doi: 10.1093/humupd/dml012. 
Magoffin, D. A. (2005) ‘Ovarian theca cell’, International Journal of Biochemistry and 
Cell Biology, 37(7), pp. 1344–1349. doi: 10.1016/j.biocel.2005.01.016. 
Mahmood, T. et al. (1998) ‘The effect of ovarian steroids on epithelial ciliary beat 
frequency in the human Fallopian tube’, Human Reproduction, 13(11), pp. 2991–2994. 
doi: 10.1016/j.fertnstert.2007.07.1379. 
Maillo, V. et al. (2015) ‘Oviduct-Embryo Interactions in Cattle: Two-Way Traffic or a 
One-Way Street?’, Biology of Reproduction, 92(6), pp. 144–144. doi: 
10.1095/biolreprod.115.127969. 
Maillo, V. et al. (2016) ‘Maternal-embryo interaction in the bovine oviduct: Evidence 
from in vivo and in vitro studies’, Theriogenology. Elsevier Inc, 86(1), pp. 443–450. doi: 
10.1016/j.theriogenology.2016.04.060. 
Mair, B. et al. (2016) ‘Glucose concentration in capillary blood of dairy cows obtained 
by a minimally invasive lancet technique and determined with three different hand-





Marey, M. A. et al. (2016) ‘Angiotensin II increases sperm phagocytosis by neutrophils 
in vitro: A possible physiological role in the bovine oviduct.’, Molecular reproduction 
and development, (August 2015), pp. 1–31. doi: 10.1002/mrd.22672. 
Maro, B. and Verlhac, M. (2002) ‘Polar body formation : new rules for assymetric 
divisions’, Nature Cell Biology, 4(December), pp. 281–283. 
Martin-Gronert, M. S. and Ozanne, S. E. (2006) ‘Maternal nutrition during pregnancy 
and health of the offspring’, Biochemical Society Transactions, 34, pp. 779–782. doi: 
10.1042/BST0340779. 
Matoba, S. et al. (2014) ‘Predictive value of bovine follicular components as markers of 
oocyte developmental potential’, Reproduction, Fertility and Development, 26(2), pp. 
337–345. doi: 10.1071/RD13007. 
Matsuda, Y. et al. (2018) ‘Impact of placental weight and fetal/placental weight ratio Z 
score on fetal growth and the perinatal outcome’, International Journal of Medical 
Sciences, 15(5), pp. 484–491. doi: 10.7150/ijms.23107. 
Matsui, M. et al. (1995) ‘Stimulatory effects of insulin on the development of bovine 
embryos fertilised in vitro’, J. Vet. Med.Sci, 57(2), pp. 331–336. 
Matzuk, M. M. et al. (2002) ‘Intercellular Communication in the Mammalian Ovary: 
Oocytes Carry the Conversation’, Science, 296(June), pp. 2178–2180. Available at: 
http://science.sciencemag.org/. 
McClenaghan, N. H. and Flatt, P. R. (1999) ‘Engineering cultured insulin-secreting 
pancreatic B-cell lines’, Journal of Molecular Medicine, 77(1), pp. 235–243. doi: 
10.1007/s001090050344. 
McCracken, J. A., Custer, E. E. and Lamsa, J. C. (2019) ‘Luteolysis : A Neuroendocrine-
Mediated Event’, Physiological Reviews, 79(2), pp. 263–324. 
McNutt, T. et al. (1992) ‘Adsorption of oviductal fluid proteins by the bovine sperm 
membrane during in vitro capacitation’, Mol Reprod Dev, 33(3), pp. 313–23. 
Ménézo, Y. J. R. and Hérubel, F. (2002) ‘Mouse and bovine models for human IVF.’, 
Reproductive biomedicine online. Reproductive Healthcare Ltd, Duck End Farm, Dry 





MetOffice (2018) ‘Met Office weather record’. Available at: 
https://www.metoffice.gov.uk/about-us/press-office/news/weather-and-
climate/2018/end-of-summer-stats. 
Metwally, M., Li, T. C. and Ledger, W. L. (2007) ‘The impact of obesity on female 
reproductive function’, Obesity Reviews, 8(6), pp. 515–523. doi: 10.1111/j.1467-
789X.2007.00406.x. 
Miao, Y.-L. and Williams (2013) ‘Calcium signaling in mammalian egg activation and 
embryo development: Influence of subcellular localization’, 79(11), pp. 742–756. doi: 
10.1002/mrd.22078.Calcium. 
Miessen, K. et al. (2011) ‘Modelling the porcine oviduct epithelium: A polarized in vitro 
system suitable for long-term cultivation’, Theriogenology. Elsevier Inc., 76(5), pp. 900–
910. doi: 10.1016/j.theriogenology.2011.04.021. 
Moley, K. H., Chi, M. M. and Mueckler, M. M. (1998) ‘Maternal hyperglycemia alters 
glucose transport and utilization in mouse preimplantation embryos.’, The American 
journal of physiology, 275(1 Pt 1), pp. E38–E47. 
Morbeck, D. E. et al. (2014) ‘Composition of commercial media used for human 
embryo culture’, Fertility and Sterility. Elsevier Inc., 102(3), pp. 759-766.e9. doi: 
10.1016/j.fertnstert.2014.05.043. 
Morbeck, D. E., Baumann, N. A. and Oglesbee, D. (2017) ‘Composition of single-step 
media used for human embryo culture’, Fertility and Sterility. Elsevier Inc., 107(4), pp. 
1055-1060.e1. doi: 10.1016/j.fertnstert.2017.01.007. 
Muglia, U. and Motta, P. M. (2001) ‘A new morpho-functional classification of the 
Fallopian tube based on its three-dimensional myoarchitecture’, Histology and 
Histopathology, 16(1), pp. 227–237. 
Murray, M. K. (1995) ‘Epithelial lining of the sheep ampulla oviduct undergoes 
pregnancy-associated morphological changes in secretory status and cell height.’, 
Biology of reproduction, 53(3), pp. 653–63. doi: 10.1530/jrf.0.1060173. 




Clinical Forms’, Reprod Dom Anim, 35, pp. 193–200. 
Neel, J. V. (1962) ‘Diabetes Mellitus: A “Thrifty” Genotype Rendered Detrimental by 
“Progress”?’, Am J Hum Genet., 14(4), pp. 353–362. doi: 
10.1093/acprof:oso/9780199234707.001.0001. 
Newsholme, P. et al. (2003) ‘Glutamine and glutamate-their central role in cell 
metabolism and function’, Cell Biochemistry and Function, 21(1), pp. 1–9. doi: 
10.1002/cbf.1003. 
Ng, S. K. et al. (2010) ‘Risk factors and obstetric complications of large for gestational 
age births with adjustments for community effects: results from a new cohort study.’, 




Ng, Y. H. et al. (2013) ‘Endometrial Exosomes/Microvesicles in the Uterine 
Microenvironment: A New Paradigm for Embryo-Endometrial Cross Talk at 
Implantation’, PLoS ONE, 8(3). doi: 10.1371/journal.pone.0058502. 
NHS (no date) NHS hyperglycaemia (high blood sugar). Available at: 
http://www.nhs.uk/conditions/Hyperglycaemia/Pages/Introduction.aspx. 
Nichol, R. et al. (1998) ‘Concentrations of energy substrates in oviduct fluid in 
unilaterally ovariectomised pigs.’, Research in veterinary science, 65(3), pp. 263–4. doi: 
10.1016/S0034-5288(98)90154-0. 
Nishimoto, H. et al. (2006) ‘Gene expression of glucose transporter (GLUT) 1, 3 and 4 in 
bovine follicle and corpus luteum.’, The Journal of endocrinology, 188(1), pp. 111–119. 
doi: 10.1677/joe.1.06210. 
Noach, A. B. J. et al. (1993) ‘Cell-polarity dependent effect of chelation on the 
paracellular permeability of confluent caco-2 cell monolayers’, International Journal of 
Pharmaceutics. Elsevier, 90(3), pp. 229–237. doi: 10.1016/0378-5173(93)90195-L. 
Okada, H., Tsuzuki, T. and Murata, H. (2018) ‘Decidualization of the human 





Oliphant, G. et al. (1978) ‘The permeability of rabbit oviduct to proteins present in the 
serum’, Biol Reprod, 18(3), pp. 516–520. Available at: 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Cit
ation&list_uids=566582. 
Oliphant, G. and Ross, P. A. T. R. (1982) ‘Demonstration of Production and Isolation of 
Three Sulfated Glycoproteins from the Rabbit Oviduct’, Biology of reproduction, 544, 
pp. 537–544. 
Oltenacu, P. and Broom, D. (2010) The impact of genetic selection for increased milk 
yield on the welfare of dairy cows, Animal Welfare. 
Orihuela, Â. (2000) ‘Some factors affecting the behavioural manifestation of oestrus in 
cattle  a review - Applied Animal Behaviour Science’, 70, pp. 1–16. 
Orsi, N. M. and Leese, H. J. (2004) ‘Ammonium exposure and pyruvate affect the amino 
acid metabolism of bovine blastocysts in vitro’, Reproduction, 127(1), pp. 131–140. doi: 
10.1530/rep.1.00031. 
Ostrowska, M., Jarczak, J. and Zwierzchowski, L. (2015) ‘Glucose transporters in cattle - 
a review’, Animal Science Papers and Reports, 33(3), pp. 191–212. 
Ouyang, F. et al. (2013) ‘Placental weight mediates the effects of prenatal factors on 
fetal growth: The extent differs by preterm status’, Obesity, 21(3), pp. 609–620. doi: 
10.1002/oby.20254. 
Palma-Vera, S., Einspanier, R. and Schoen, J. (2014) ‘Bovine oviductal epithelial cells : 
Long term culture characterization and impact of insulin on cell morphology’, 
Phytochemistry Letters. Society for Biology of Reproduction &amp; the Institute of 
Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn, 
14(3), pp. 206–212. doi: 10.1016/j.repbio.2014.04.006. 
Pampfer, S. et al. (1997) ‘Increased cell death in rat blastocysts exposed to maternal 
diabetes in utero and to high glucose or tumor necrosis factor-alpha in vitro.’, 
Development (Cambridge, England), 124(23), pp. 4827–4836. 




susceptibility of inner cell mass and trophectoderm cell lineages - A review’, Placenta, 
21(SUPPL.1), pp. 3–10. doi: 10.1053/plac.1999.0519. 
Partridge, R. J. and Leese, H. J. (1996) ‘Consumption of amino acids by bovine 
preimplantation embryos’, Reproduction, Fertility and Development, 8(6), pp. 945–950. 
doi: 10.1071/RD9960945. 
Pascoe, W. S. et al. (1996) ‘Differential targeting of facilitative glucose transporters in 
polarized epithelial cells’, Am J Physiol, 271(2 Pt 1), pp. C547-54. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/8769994. 
Pillai, V. V. et al. (2017) ‘Profiling of proteins secreted in the bovine oviduct reveals 
diverse functions of this luminal microenvironment’, PLoS ONE, 12(11), pp. 1–22. doi: 
10.1371/journal.pone.0188105. 
Polet, F. et al. (2016) ‘Inhibition of glucose metabolism prevents glycosylation of the 
glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in 
leukemia cells.’, Oncotarget, 7(29), pp. 46371–46383. doi: 10.1093/jhered/esi116. 
Prados, F. J. et al. (2012) ‘The cleavage stage embryo’, 27, pp. 50–71. doi: 
10.1093/humrep/des224. 
Purcell, S. H. and Moley, K. H. (2009) ‘Glucose transporters in gametes and 
preimplantation embryos’, Trends in Endocrinology and Metabolism, 20(10), pp. 483–
489. doi: 10.1016/j.tem.2009.06.006. 
Quinton, P. M. (1990) ‘Cystic fibrosis: a disease in electrolyte transport.’, The FASEB 
journal : official publication of the Federation of American Societies for Experimental 
Biology, 4(10), pp. 2709–2717. doi: 10.1016/S0140-6736(08)61162-9. 
Rando, O. J. and Simmons, R. A. (2015) ‘I’m eating for two: Parental dietary effects on 
offspring metabolism’, Cell. Elsevier Inc., 161(1), pp. 93–105. doi: 
10.1016/j.cell.2015.02.021. 
Ravelli,  a C. J. et al. (1998) ‘Glucose-tolerance in adults after prenatal exposure to 
famine’, The Lancet, 351, pp. 173–177. doi: 10.1016/S0140-6736(97)07244-9. 
Reik, W., Dean, W. and Walter, J. (2001) ‘Epigenetic reprogramming in mammalian 





Reischl, J. et al. (1999) ‘Factors affecting proliferation and dedifferentiation of primary 
bovine oviduct epithelial cells in vitro.’, Cell and tissue research, 296(2), pp. 371–83. 
doi: 10.1007/s004410051297. 
Richardson, L. L. and Oliphant, G. (1981) ‘Steroid concentrations in rabbit oviducal fluid 
during oestrous and pseudopregnancy’, J.Reprod.Fertil., 62, pp. 427–431. 
Rio, D. C. et al. (2010) ‘Purification of RNA using TRIzol (TRI Reagent)’, Cold Spring 
Harbor Protocols, 5(6), pp. 2010–2013. doi: 10.1101/pdb.prot5439. 
Roberts, K. A. et al. (2011) ‘Placental structure and inflammation in pregnancies 
associated with obesity’, Placenta. Elsevier Ltd, 32(3), pp. 247–254. doi: 
10.1016/j.placenta.2010.12.023. 
Robker, R. L. et al. (2009) ‘Obese women exhibit differences in ovarian metabolites, 
hormones, and gene expression compared with moderate-weight women’, Journal of 
Clinical Endocrinology and Metabolism, 94(5), pp. 1533–1540. doi: 10.1210/jc.2008-
2648. 
Roblero, L. S. and Riffo, M. D. (1986) ‘High potassium concentration improves 
preimplantation development of mouse embryos in vitro.’, Fertility and sterility. United 
States, 45(3), pp. 412–416. 
Röder, P. V et al. (2016) ‘Pancreatic regulation of glucose homeostasis’, Experimental 
and Molecular Medicine, 48(3), p. e219. doi: 10.1038/emm.2016.6. 
Rottmayer, R. et al. (2001) ‘A bovine oviduct epithelial cell suspension culture system 
suitable for studying embryo–maternal interactions: morphological and functional 
characterization’, Reproduction, 132, pp. 637–648. doi: 10.1530/rep.1.01136. 
Roy, V. K. and Krishna, A. (2013) ‘Changes in glucose and carnitine levels and their 
transporters in utero-tubal junction in relation to sperm storage in the vespertilionid 
bat, Scotophilus heathi’, Journal of Experimental Zoology Part A: Ecological Genetics 
and Physiology, 319(9), pp. 517–526. doi: 10.1002/jez.1815. 
Sarma, U. C., Findlay, J. K. and Hutt, K. J. (2019) ‘Oocytes from stem cells’, Best Practice 





Sarstedt (no date) Sarstedt T25 flasks. Available at: 
https://www.sarstedt.com/en/products/laboratory/cell-tissue-
culture/cultivation/product/83.3910.002/. 
Saunders, C. M. et al. (2002) ‘PLC zeta: a sperm-specific trigger of Ca(2+) oscillations in 
eggs and embryo development.’, Development (Cambridge, England), 129(15), pp. 
3533–44. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12117804. 
Schally, A. V. et al. (1971) ‘Gonadotropin-releasing hormone: One polypeptide 
regulates secretion of luteinizing and follicle-stimulating hormones’, Science, 
173(4001), pp. 1036–1038. doi: 10.1126/science.173.4001.1036. 
Schuel, H. (2006) ‘Tuning the oviduct to the anandamide tone’, Journal of Clinical 
Investigation, 116(8), pp. 2087–2090. doi: 10.1172/JCI27179.13. 
Schulte, M. M. B., Tsai, J. H. and Moley, K. H. (2015) ‘Obesity and PCOS: The effect of 
metabolic derangements on endometrial receptivity at the time of implantation’, 
Reproductive Sciences, 22(1), pp. 6–14. doi: 10.1177/1933719114561552. 
Sen, S. and Simmons, R. A. (2010) ‘Maternal antioxidant supplementation prevents 
adiposity in the offspring of western diet-fed rats’, Diabetes, 59(12), pp. 3058–3065. 
doi: 10.2337/db10-0301. 
Sigma-Aldrich (no date a) Aprotinin (from bovine lung). Available at: 
http://www.sigmaaldrich.com/life-science/metabolomics/enzyme-explorer/aprotinin-
monograph.html. 
Sigma-Aldrich (no date b) ‘Sigma Aldrich website’. Available at: 
https://www.sigmaaldrich.com/technical-documents/protocols/biology/alternative-
culture.html. 
Sigma (no date) Sigma Alrdich Transwells. Available at: 
https://www.sigmaaldrich.com/catalog/product/sigma/cls3450?lang=en&region=GB. 
da Silveira, J. C. et al. (2012) ‘Cell-Secreted Vesicles in Equine Ovarian Follicular Fluid 
Contain miRNAs and Proteins: A Possible New Form of Cell Communication Within the 





Silvestris, E. et al. (2018) ‘Obesity as disruptor of the female fertility’, Reproductive 
Biology and Endocrinology. Reproductive Biology and Endocrinology, 16(1), pp. 1–13. 
doi: 10.1186/s12958-018-0336-z. 
Simintiras, C. A. (2016) Developing a Novel In Vitro Preparation to Study the 
Mechanisms Underlying Oviduct Fluid Formation in Health and Disease. Hull York 
Medical School. 
Simintiras, C. A. et al. (2016) ‘Modelling oviduct fluid formation in vitro.’, Reproduction 
(Cambridge, England), (153), pp. 23–33. doi: 10.1530/REP-15-0508. 
Simintiras, C. A. and Sturmey, R. G. (2017) ‘Genistein crosses the bioartificial oviduct 
and alters secretion composition’, Reproductive Toxicology. Elsevier Inc., 71, pp. 63–
70. doi: 10.1016/j.reprotox.2017.04.010. 
Simmen, F. A. and Simmen, R. C. M. (1991) ‘Peptide Growth Factors and Proto-
oncogenes in Mammalian Conceptus Development’, Biology of Reproduction, 44(1), 
pp. 1–5. doi: 10.1095/biolreprod44.1.1. 
Simón, C., Gimeno, M. J. and Frances, A. (1996) ‘Cytokines-adhesion molecules-
invasive proteinases, the missing paracine/autocrine link in embryonic implantation’, 
Molecular human reproduction, 2(6), pp. 405–424. doi: 10.3109/09513599609116190. 
Singh Grewal, A. et al. (2015) ‘Updates on Aldose Reductase Inhibitors for 
Management of Diabetic Complications and Non-diabetic Diseases’, Mini-Reviews in 
Medicinal Chemistry, 16(2), pp. 120–162. doi: 10.2174/1389557515666150909143737. 
Sirard, M. A. (2012) ‘Factors affecting oocyte and embryo transcriptomes’, 
Reproduction in Domestic Animals, 47(SUPPL.4), pp. 148–155. doi: 10.1111/j.1439-
0531.2012.02069.x. 
Smith, D. G. and Sturmey, R. G. (2013) ‘Parallels between embryo and cancer cell 
metabolism.’, Biochemical Society transactions, 41(2), pp. 664–9. doi: 
10.1042/BST20120352. 
Smith, T. T. and Yanagimachi, R. (1991) ‘Attachment and release of spermatozoa from 




pp. 567–73. doi: 10.1530/jrf.0.0910567. 
Van Der Steeg, J. W. et al. (2008) ‘Obesity affects spontaneous pregnancy chances in 
subfertile, ovulatory women’, Human Reproduction, 23(2), pp. 324–328. doi: 
10.1093/humrep/dem371. 
Steeves, C. L. et al. (2003) ‘The glycine neurotransmitter transporter GLYT1 is an 
organic osmolyte transporter regulating cell volume in cleavage-stage embryos’, 
Proceedings of the National Academy of Sciences, 100(24), pp. 13982–13987. doi: 
10.1073/pnas.2334537100. 
Steeves, C. L. and Baltz, J. M. (2005) ‘Regulation of intracellular glycine as an organic 
osmolyte in early preimplantation mouse embryos’, Journal of Cellular Physiology, 
204(1), pp. 273–279. doi: 10.1002/jcp.20284. 
Stryer, L. (1995) Biochemistry. 
Stumvoll, M., Goldstein, B. J. and Haeften, T. W. Van (2005) ‘Haeften_Pathogenesis of 
type 2 diabetes.pdf’, The Lancet, 365, pp. 1333–1346. 
Sturmey et al. (2009) ‘DNA damage and metabolic activity in the preimplantation 
embryo’, Human Reproduction, 24(1), pp. 81–91. doi: 10.1093/humrep/den346. 
Sturmey, R. G. et al. (2009) ‘Role of fatty acids in energy provision during oocyte 
maturation and early embryo development’, Reproduction in Domestic Animals, 44, 
pp. 50–58. doi: 10.1111/j.1439-0531.2009.01402.x. 
Sturmey, R. G. et al. (2010) ‘Amino acid metabolism of bovine blastocysts: A biomarker 
of sex and viability’, Molecular Reproduction and Development, 77(3), pp. 285–296. 
doi: 10.1002/mrd.21145. 
Sturmey, R. G., Brison, D. R. and Leese, H. J. (2008) ‘Assessing embryo viability by 
measurement of amino acid turnover’, Reproductive BioMedicine Online. Reproductive 
Healthcare Ltd, Duck End Farm, Dry Drayton, Cambridge CB23 8DB, UK, 17(4), pp. 486–
496. doi: 10.1016/S1472-6483(10)60234-9. 
Sturmey, R. G. and Leese, H. J. (2003) ‘Energy metabolism in pig oocytes and early 
embryos’, Reproduction, 126, pp. 197–204. doi: 10.1530/rep.0.1260197. 




implantation rates or pregnancy outcome in women attempting conception through 
oocyte donation’, Fertility and Sterility, 83(6), pp. 1629–1634. doi: 
10.1016/j.fertnstert.2005.01.099. 
Suarez, S. S. (2002) ‘Formation of a reservoir of sperm in the oviduct’, Reproduction in 
Domestic Animals, 37(3), pp. 140–143. doi: 10.1046/j.1439-0531.2002.00346.x. 
Suarez, S. S. and Ho, H. C. (2003) ‘Hyperactivated motility in sperm’, Reproduction in 
Domestic Animals, 38(2), pp. 119–124. doi: 10.1046/j.1439-0531.2003.00397.x. 
Swain, J. E. (2010) ‘Optimizing the culture environment in the IVF laboratory: Impact of 
pH and buffer capacity on gamete and embryo quality’, Reproductive BioMedicine 
Online. Reproductive Healthcare Ltd., 21(1), pp. 6–16. doi: 
10.1016/j.rbmo.2010.03.012. 
Tadokoro, C. et al. (1995) ‘Expression and localisation of glucose transporter 1 (GLUT1) 
in the rat oviduct: A possible supplier of glucose to embryo during early embryonic 
development’, Biochemical and Biophysical Research Communications, 214(3), pp. 
1211–1218. 
Takeuchi, K. et al. (1991) ‘Isolation and Monolayer Culture of Human Fallopian Tube 
Epithelial Cells’, Cellular and Developmental Biology, 27A, pp. 720–724. Available at: 
http://medical-dictionary.thefreedictionary.com/fallopian+tube. 
Tarry-adkins, J. L. and Ozanne, S. E. (2016) ‘Nutrition in early life and age-associated 
diseases’, Ageing Research Reviews. Elsevier B.V. doi: 10.1016/j.arr.2016.08.003. 
Tay, J. I. et al. (1997) ‘Human tubal fluid: production, nutrient composition and 
response to adrenergic agents’, Hum Reprod, 12(11), pp. 2451–2456. doi: 
10.1093/humrep/12.11.2451. 
Tay, J. I. (2003) Human Fallopian Tubes; In vitro Vascular Perfusion and Tubal 
Contractility. University of Leicester. 
Thompson, J. G. et al. (1996) ‘Oxygen uptake and carbohydrate metabolism by in vitro 
derived bovine embryos’, Reproduction, 106(1993), pp. 299–306. doi: 
10.1530/jrf.0.1060299. 




Profiling’, Current Medicinal Chemistry, 17(28), pp. 3245–3252. doi: 
10.2174/092986710792231932. 
Türkay Korgun, E. et al. (2001) ‘Glucose Transporter Expression in Rat Embryo and 
Uterus During Decidualization, Implantation, and Early Postimplantation’, Biology of 
Reproduction, 65(5), pp. 1364–1370. doi: 10.1095/biolreprod65.5.1364. 
Ulbrich, S. E. et al. (2009) ‘Quantitative characterization of prostaglandins in the uterus 
of early pregnant cattle’, Reproduction, 138(2), pp. 371–382. doi: 10.1530/REP-09-
0081. 
Ulbrich, S. E. et al. (2010) ‘In vitro systems for intercepting early embryo-maternal 
cross-talk in the bovine oviduct’, Theriogenology. Elsevier Inc., 73(6), pp. 802–816. doi: 
10.1016/j.theriogenology.2009.09.036. 
Unger, R. H. and Orci, L. (1975) ‘The essential role of glucagon in the pathogenesis of 
diabetes mellitus.’, Lancet (London, England). England, 1(7897), pp. 14–16. doi: 
10.1016/s0140-6736(75)92375-2. 
Ungewitte, E. K. and Yao, H. H.-C. (2013) ‘How to Make a Gonad: Cellular Mechanisms 
Governing Formation of the Testes and Ovaries’, Sex Dev., 7(1–3), pp. 7–20. doi: 
10.1038/jid.2014.371. 
Valckx, S. D. M. et al. (2012) ‘BMI-related metabolic composition of the follicular fluid 
of women undergoing assisted reproductive treatment and the consequences for 
oocyte and embryo quality’, Human Reproduction, 27(12), pp. 3531–3539. doi: 
10.1093/humrep/des350. 
Walker, S. K. et al. (1996) ‘Development of ovine embryos in synthetic oviductal fluid 
containing amino acids at oviductal fluid concentrations’, Biol Reprod, 55(3), pp. 703–
708. doi: 10.1095/biolreprod55.3.703. 
Walter, I. (1995) ‘Culture of bovine oviduct epithelial cells (BOEC).’, The Anatomical 
record, 243(3), pp. 347–56. doi: 10.1002/ar.1092430309. 
Wang, H. and Dey, S. K. (2006) ‘Roadmap to embryo implantation: clues from mouse 
models’, Nat Rev Genet, 7(3), pp. 185–199. doi: 10.1038/nrg1808. 




tube through prostaglandins and progestagens’, Human Reproduction, 23(10), pp. 
2359–2368. doi: 10.1093/humrep/den260. 
Watanabe, T. et al. (2013) ‘Paracellular barrier and tight junction protein expression in 
the immortalized brain endothelial cell lines bEND.3, bEND.5 and mouse brain 
endothelial cell 4.’, Biological & pharmaceutical bulletin, 36(3), pp. 492–5. doi: 
10.1248/bpb.b12-00915. 
Watkins, A. J. et al. (2008) ‘Adaptive Responses by Mouse Early Embryos to Maternal 
Diet Protect Fetal Growth but Predispose to Adult Onset Disease’, Biology of 
Reproduction, 78(2), pp. 299–306. doi: 10.1095/biolreprod.107.064220. 
Watkins, A. J., Papenbrock, T. and Fleming, T. P. (2008) ‘The preimplantation embryo: 
Handle with care’, Seminars in Reproductive Medicine, 26(2), pp. 175–185. doi: 
10.1055/s-2008-1042956. 
Welt, C. K. et al. (2001) ‘Differential regulation of inhibin A and inhibin B by luteinizing 
hormone, follicle-stimulating hormone, and stage of follicle development’, Journal of 
Clinical Endocrinology and Metabolism, 86(6), pp. 2531–2537. doi: 
10.1210/jc.86.6.2531. 
White, M. D. et al. (2018) ‘Instructions for Assembling the Early Mammalian Embryo’, 
Developmental Cell. Elsevier Inc., 45(6), pp. 667–679. doi: 
10.1016/j.devcel.2018.05.013. 
WHO (1995) ‘Physical status: the use and interpretation of anthropometry. Report of a 
WHO Expert Committee.’, World Health Organization technical report series, pp. 1–
452. doi: 854. 
WHO (no date) The World Health Organisation, 
http://www.who.int/topics/obesity/en/. doi: http://www.who.int/topics/obesity/en/. 
Widmaier, E. P., Raff, H. and Strang, K. T. (2006) Vander’s Human Physiology. 10th edn. 
McGraw Hill International Edition. 
Van Winkle, L. J. et al. (2006) ‘System B0,+ amino acid transport regulates the 
penetration stage of blastocyst implantation with possible long-term developmental 





Winuthayanon, W. et al. (2015) ‘Oviductal estrogen receptor α signaling prevents 
protease-mediated embryo death’, eLife, 4(December2015), pp. 1–28. doi: 
10.7554/eLife.10453. 
World Health Organization (2000) ‘Obesity: Preventing and Managing the Global 
Epidemic. Report of a WHO Consultation. World Health Organ Tech Rep Ser’, Who, pp. 
1–253. 
Wu, G. (2010) ‘Functional Amino Acids in Growth, Reproduction and Health’, Adv. 
Nutr., (4), pp. 31–37. doi: 10.3945/an.110.1008.1. 
Wu, J. et al. (2018) ‘Chromatin analysis in human early development reveals epigenetic 
transition during ZGA’, Nature, 557, pp. 256-file:///C:/Users/krous/Box Sync/HYMS 
(K.Roussi. doi: 10.1038/s41586-018-0080-8. 
Wu, X. et al. (2017) ‘Simultaneous mapping of active DNA demethylation and sister 
chromatid exchange in single cells’, Genes and Development, 31(5), pp. 511–523. doi: 
10.1101/gad.294843.116. 
Xenopoulos, P., Kang, M. and Hadjantonakis, A.-K. (2012) ‘Cell Lineage Allocation 
Within the Inner Cell Mass of the Mouse Blastocyst’, Results Probl Cell Differ., 55, pp. 
185–202. doi: 10.1016/b978-0-12-597951-1.x5000-8. 
Xiao, S. et al. (2017) ‘A microfluidic culture model of the human reproductive tract and 
28-day menstrual cycle’, Nature Communications. Nature Publishing Group, 8. doi: 
10.1038/ncomms14584. 
Xu, Z. et al. (1995) ‘Expression of messenger ribonucleic acid encoding cytochrome 
P450 side-chain cleavage, cytochrome p450 17 alpha-hydroxylase, and cytochrome 
P450 aromatase in bovine follicles during the first follicular wave’, Endocrinology, 
136(3), pp. 981–989. doi: 10.1210/endo.136.3.7867608. 
Yanagimachi, R. (1994) ‘Mammalian fertilization’, in Knobil, E. and Neil, J. (eds) The 
Physiology of Reproduction. New York, p. 189. 
Yang, Penghua et al. (2016) ‘High glucose suppresses embryonic stem cell 




communications. Elsevier Ltd, 472(2), pp. 306–312. doi: 10.1016/j.bbrc.2016.02.117. 
Yue, J. T. Y. et al. (2016) ‘Inhibition of glycine transporter-1 in the dorsal vagal complex 
improves metabolic homeostasis in diabetes and obesity’, Nature Communications. 
Nature Publishing Group, 7, pp. 1–11. doi: 10.1038/ncomms13501. 
Zhang, C. et al. (2012) ‘The effect of Gonadotropin on glucose transport and apoptosis 























• Chapter 2 
List of chemicals used 
Chemical substance Supplier, Product number 
Adenosine 5′-triphosphate disodium salt hydrate, 99% (ATP) Sigma, A26209 
Adenosine triphosphate (ATP) Sigma, A6419 
Alanine Sigma, A-7627 
Amino acid standard solution Sigma, AAS18 
Amphotericin B Invitrogen 15290026 
Antibiotic antimycotic (Ab-Am) Fisher, 11580486 
Antimycin A Sigma, A8674 
Aprotinin from bovine lung Sigma-Aldrich, A6279 
Arginine Sigma, A-5131 
Asparagine Sigma, A-4284 
Aspartate Sigma, A-4534 
Bovine Serum Albumin (BSA) Sigma-Aldrich Α7030 
CaCl2·2H2O Sigma, C7902 
Calcium chloride dihydrate (CaCl2.2H2O) Sigma, C7902 
Chloroform, for HPLC, stabilized with amylene Fisher Scientific, C/4966/17 
Cysteine Sigma, C-1276 
Cytokeratin-18 mouse primary antibody  Applied Biosystems, ab82254 
D-ABA Acros Organics, 142140050 
D-Glucose  Sigma, G6152 
Dithiothreitol  D0632, Sigma-Aldrich 
DMEM Sigma-Aldrich D5546 
DNA ladder ThermoFischer Scientific, SM0373 
EDTA Sigma ED4SS 
Embryo-tested water Fresenius Kabi 
Epidermal Growth Factor from murine submaxillary gland Sigma, E4127 
EPPS  Sigma, E9502 
Essential amino acids Sigma, M7145 
Fetal Bovine Serum (FBS) ThermoFischer Scientific, 10270106 
Fibroblast Growth Factor from bovine pituitary Sigma, F3133 
Fluorescein Sigma Aldrich, F6377 
Glacial Acetic Acid Sigma, CHE1018 
Glucose standard, 5.0mmol/L, 30ml Analox instruments LTD, GMRD-010 
GlutaMAX, 100x Thermo-Fisher Scientific, 35050061 
Glycine Sigma, G6388 
Glycine, ≥99% Sigma, G7126 
goat anti-mouse, secondary, FITC-conjugated antibody  Applied Biosystems, ab6785 
Hank’s Balanced Salt Solution (-phenol red, -CaCl2, –MgCl2) Sigma-Aldrich, H6648 




Heparin sodium salt Sigma, H3393 
HEPES Sigma, H3375 
HEPES sodium salt Sigma, H3784 
HEPES solution, 1M, pH 7.0-7.6, sterile-filtered, BioReagent, suitable for 
cell culture 
Sigma-Aldrich, H0887 
Hexokinase/Glucose-6-phosphatase (H3K/G6P) Roche,10127825001 
High Capacity cDNA Reverse Transcription Kit  ThermoFisher Scientific 4368814 
Hi-Res Standard Agarose Molecular Biology Products (formerly 
Bioproducts Ltd), A4-0700  
Histidine H-8125 
Hydrazine sulphate  Sigma, H3376 
Hydromount National Diagnostics, HS-106 
Insulin Sigma-Aldrich, I0516 
Isoleucine Acros Organics, 166170250 
Isopropanol, for HPLC Fisher Scientific, P/7507/17 
Lactate Standard, 5.0mmol/L, 25ml Analox instruments LTD, GMRD-079 
Leucine Acros Organics, 125121000 
L-Glutamine Sigma-Aldrich G7513 
L-Lactate Dehydrogenase (L-LDH), from rabbit muscle Roche 10127884001 
Loading dye  ThermoFischer Scientific, R0611 
Lysine Sigma, L-5626 
M199 Sigma Aldrich, M0650 
Magnesium sulphate Sigma, M2643 
Magnesium sulphate Fisher, M/1050 
Magnesium sulphate heptahydrate (MgSO4.7H2O) Sigma, M7774 
Menopur/Merional (75IU) Ferring Pharmaceuticals Ltd 
Methanol Methanol, M/4056/17 
Methionine Sigma, M-9625 
Mineral oil Sigma Aldrich, M8410 
Monobasic potassium phosphate (KH2PO4) Sigma, P5655 
NAD  Roche 127 981 
NAD, Grade II, free acid Roche 10127981001 
NADH Di sodium salt Roche, 10 128 023 001 
NADP Roche, 128 040 
Newborn Calf Serum (NCS) Sigma-Aldrich N4762 
Nutrient Mix F12 Sigma-Aldrich N8641 
O-phthaldialdehyde  Sigma-Aldrich, P0532  
Pen/Strep Invitrogen 15140122 
Penicillin G Sigma, P4697 
Penicillin/Streptomycin Sigma, P0781 
Percoll Sigma, P1644 
Phenylalanine Acros Organics, 130310250 
Phtaldialdehyde Reagant (OPA) Sigma, P0532 
Platinum Taq DNA polymerase Invitrogen, 10966018 
Poly-L-lysine Sigma, P1524 
Potassium chloride (KCl) Sigma, P5405 
PrecisionPLUS MasterMix with ROX premixed with SYBRgreen mini kit PrimerDesign, Mini-PrecisionPLUS-R-SY 
Proline Sigma, P-0380 
Pyruvate standard 0.45mM/L Analox, GMRD-140-E 
saline solution, 3-7 TIU/mg protein   
Serine Sigma, S-4500 
Sodium bicarbonate (NaHCO3) Sigma, S5761 
Sodium chloride (NaCl) Sigma, S5886 
Sodium DL-lactate solution Sigma, L1375 




Sodium hydroxide Fisher, S4920/60 
Sodium pyruvate Sigma, P5280 
Sodium pyruvate Sigma, P2256 
Streptomycin Sigma, S1277 
SYBR Green PCR Master Mix ThermoFischer Scientific, 4309155 
SYBR™ Safe™ DNA Invitrogen, 10328162 
Tetrahydrofuran (THF) Sigma, 34865 
Threonine Sigma, T-8625 
Trizol  Thermo-Fischer Scientific, 15596026 
Trypan Blue solution, 0.4%, liquid, sterile-filtered, suitable for cell 
culture 
Sigma T8154 
Trypsin Sigma-Aldrich, 59427C 
Tryptophan Sigma, T-0254 
Tyrosine Sigma, T-1020 
Valine Sigma, V-0500 
VECTASHIELD anti-fade mounting medium with DAPI Vector Laboratories, H-1200 
β-mercaptoethanol Sigma M6250 
(L-)Glutamate Sigma, G-1251 
(L-)Glutamine Sigma, G8540 
1% eosin, aqueous solution BDH 
100% Hematoxylin Solution, Harris Modified  Sigma-Aldrich, HHS128 
2-deoxy-glucose Sigma, D8375 
 
List of equipment used 
Equipment Used Used For 
Nanodrop 2000c, Thermo Scientific RNA extraction 
EVOM voltohmmetre, World Precision Instruments TEER measurement 
STX2 Electrodes of EVOM voltohmmetre, World 
Precision Instruments 
TEER measurement 
Voltage/Current Clamp (World Precision Instruments) Voltage clamp experiment 
Applied Biosystems 2720 Thermal Cycler cDNA synthesis 
BioRad C1000 Touch Thermal Cycler PCR Thermocycler 
StepOne Plus Real-Time PCR system, Applied 
Biosciences 
qRT-PCR 
Molecular Imager VersaDoc™ MP 4000 System  DNA gel imaging 
BMG plate readerFLUOstar Omega Microplate Reader - 
BMG LABTECH 
Glucose, Lactate, Pyruvate assays 
Agilent 1100/1200 High Performance Liquid Chromatography 
Class II cabinet Cell culture and maintenance 












List of consumables 
Consumables  
96-Well PCR Plates, Skirted, Low Profile Starlabs, E1403-5200 
MicroAmp Fast Optical 96-Well Reaction Plate, 0.1 mL Applied Biosystems, 
4346907 
Corning TranswellTM 0.4µm PolyEthylene Tetraphtalate cell culture inserts Corning 3450 
Corning 12mm Snapwell Insert with 0.4 μm pore, pore density 1 x 108 pores/cm2, 
polycarbonate membrane 
Corning Costar 3407 
Falcon® 60 mm x 15 mm Not TC-treated Treated Bacteriological Petri Dish, 20/Pack, 
500/Case 
Corning, 351007 
Nunc™ 4-Well Dishes for IVF, Nunclon Delta Surface ThermoScientific, 176740 
Tissue Culture Flask, 25cm, Adherent Surface, Canted Neck, Non-Vented Cap, Sterile, 
Non-Pyrogenic, Non-Cytotoxic 
Sarstedt, 83.3910 
Tissue Culture Flask, 75cm, Adherent Surface, Canted Neck, Non-Vented Cap, Sterile, 
Non-Pyrogenic, Non-Cytotoxic 
Sarstedt, 83.3911 
Tube Conical Skirted Base 50ml 115x28mm Polypropylene Screen Printed  Sarstedt, 62.559.001 
Serological Pipette 5ml Individually Wrapped Sterile Non Pyrogenic  Sarstedt, 86.1253.001 
Serological Pipette 10ml Individually Wrapped Sterile Non Pyrogenic  Sarstedt, 86.1254.001 
Serological Pipette 25ml Individually Wrapped Sterile Non Pyrogenic Sarstedt, 86.1685.001 
Micro Tube Conical Base Push Cap 0.5ml Standard Neutral  Sarstedt, 72.699 
Micro Tube Conical Base Push Cap 1.5ml Standard Neutral  Sarstedt, 72.690.001 
Tip Standard 10μl Bagged  Sarstedt, 70.1130 
Tip Standard 200μl Bagged  Sarstedt, 70.760.002 





























































































































Figure 3.12_Appendix: Impact of long-term in vitro culture on the TransEpithelial Electrical Resistance over 
time. n=1-7 technical replicates, depending on snapwell availability and ability to measure TEER, median+ 
interquartile range 
 
Figure 3.13_Appendix.: Summary of amino acid composition after long-term BOEC culture. As it was described 










































Day 1  ns ns ns ns ns ns ns Ns ns ns ns ns * ns **** 
Day 3   ns ns ns ns ns ns Ns ns ns ns ns ns ns **** 
Day 6    ns ns ns ns ns Ns ns ns ns ns ns ns **** 
Day 8     ns ns ns ns Ns ns ns ns ns ** ns **** 
Day 10      ns ns ns Ns ns ns ns ns ns ns **** 
Day 13       ns ns Ns ns ns ns ns * ns **** 
Day 15        ns ns ns ns ns ns * ns **** 
Day 17         ns ns ns ns ns ns ns **** 
Day 20          ns ns ns ns ns ns **** 
Day 24           ns ns ns ns ns **** 
Day 27            ns ns ns ns **** 
Day 31             ns * ns **** 
Day 36              ns ns *** 
Day 38               ns ** 
Day 41                **** 
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Day 1   ns ns ns ns ns ns ns ns ns ns ns *** *** *** **** 
Day 3     ns ns ns ns ns ns ns ns ns ns ns ns ns **** 
Day 6       ns ns ns ns ns ns ns ns ns ns ns ns **** 
Day 8         ns ns ns ns ns ns ns ns *** *** **** **** 
Day 10           ns ns ns ns ns ns ns ns ns ns **** 
Day 13             ns ns ns ns ns ns ** ** ** **** 
Day 15               ns ns ns ns ns ** * ** **** 
Day 17                 ns ns ns ns ns ns ns **** 
Day 20                   ns ns ns ns ns ns **** 
Day 24                     ns ns ns ns ns **** 
Day 27                       ns ns ns ns **** 
Day 31                         * * * **** 
Day 36                           ns ns **** 
Day 38                             ns **** 
Day 41                               **** 












































Day 1   ns ns ns ns ns ns ns ns ns ns ns ns ns ns ** 
Day 3     ns ns ns ns ns ns ns ns ns ns ns ns ns * 
Day 6       ns ns ns ns ns ns ns ns ns ns ns ns * 
Day 8         ns ns ns ns ns ns ns ns ns ns ns ** 
Day 10           ns ns ns ns ns ns ns ns ns ns * 
Day 13             ns ns ns ns ns ns ns ns ns * 
Day 15               ns ns ns ns ns ns ns ns * 
Day 17                 ns ns ns ns ns ns ns ns 
Day 20                   ns ns ns ns ns ns ns 
Day 24                     ns ns ns ns ns ns 
Day 27                       ns ns ns ns ns 
Day 31                         ns ns ns * 
Day 36                           ns ns ns 
Day 38                             ns ns 
Day 41                               ns 













































Day 1   ns ns ns ns ns ns ns ns ns ns ns ns ns ns **** 
Day 3     ns ns ns ns ns ns ns ns ns ns ns ns ns *** 
Day 6       ns ns ns ns ns ns ns ns ns ns ns ns *** 
Day 8         ns ns ns ns ns ns ns ns ns ns ns **** 
Day 10           ns ns ns ns ns ns ns ns ns ns *** 
Day 13             ns ns ns ns ns ns ns ns ns **** 
Day 15               ns ns ns ns ns ns ns ns *** 
Day 17                 ns ns ns ns ns ns ns ** 
Day 20                   ns ns ns ns ns ns ns 
Day 24                     ns ns ns ns ns ** 
Day 27                       ns ns ns ns ns 
Day 31                         ns ns ns ** 
Day 36                           ns ns ns 
Day 38                             ns ns 
Day 41                               ns 
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Day 1   ns ns ns ns ns ns ns ns ns ns ns ns ns ns **** 
Day 3     ns ns ns ns ns ns ns ns ns ns ns ns ns **** 
Day 6       ns ns ns ns ns ns ns ns ns ns ns ns *** 
Day 8         ns ns ns ns ns ns ns ns ns ns ns **** 
Day 10           ns ns ns ns ns ns ns ns ns ns *** 
Day 13             ns ns ns ns ns ns ns ns ns **** 
Day 15               ns ns ns ns ns ns ns ns *** 
Day 17                 ns ns ns ns ns ns ns ** 
Day 20                   ns ns ns ns ns ns * 
Day 24                     ns ns ns ns ns ** 
Day 27                       ns ns ns ns ns 
Day 31                         ns ns ns *** 
Day 36                           ns ns ns 
Day 38                             ns ns 
Day 41                               ns 




• Chapter 4 
 
Ion flux across the BOEC monolayer is relevant to the basal glucose concentrations 
In order to determine whether the differences observed in the volume of fluid secreted 
by the cells (Figure 4.8) were attributed to differences in the ion flux across the 
monolayer, attempts to determine the impact of the treatments on the ion flux from 
the basal to the apical compartment of the cells were made. For this purpose, BOECs 
were grown on Snapwells and the voltage clamp experiment was performed as 
described in section 2.12 of Materials and Methods. ATP was used as a positive control, 
as it has been previously used to induce an increase in potential difference and current 
(Downing et al., 1997)(Dickens et al., 1996). This experiment was successful for the acute 
treatment, as shown in Figure 4.15_Appendix, where it is shown that the impact of all 
treatments is comparable to cell treatment with 2-deoxy-glucose, which is transported 
but not metabolised. However, the experiment could not be replicated for the chronic 
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Figure 4.15_Appendix: Ion flux experiment for acute treatment under normo- and hyperglycaemic conditions, in 






Discussion of this experiment 
This experiment suggests that hyperglycaemic treatments, regardless of the presence of 
insulin, modify the resistance of the monolayer to a very similar pattern to the one of 2-
deoxyglucose, which is not metabolised by the cells. The fact that glucose binding to the 
glucose transporters induces the same response to epithelium polarisation as 2-
deoxyglucose, suggests that this induction is not associated with glucose metabolism. 
The only treatment where this was not observed was the 11- treatment, however, the 
difference between treatment with glucose and treatment 2-deoxy glucose did not 
induce a significant difference in resistance. This suggests that the membrane potential 
is affected by treatment addition, even though high variability did not allow for 
significance to be determined. Repetition of this experiment and optimisation for 
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Figure 5.25_Appendix: Examples of standard curves beyond the established linearity. Glucose is not 
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Figure 5.27_Appendix: Comparison of glucose consumption/production in cleaved and uncleaved 




















































































































Figure 5.28_Appendix: Comparison of lactate consumption/production in cleaved and uncleaved 























































































































Figure 5.29_Appendix: Comparison of pyruvate consumption/production in cleaved and uncleaved 
embryos, under different embryo environments a) ‘7.3’ b) ‘8.5’, c) ‘11+’, d) ‘11-’,e) control 
 
